Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

M
Ma Z.	-	EXPRESSION OF MT1-MMP IN HUMAN VASCULAR ENDOTHELIAL CELL LINES AND THE CONSTRUCTION OF ITS EUKARYOTIC EXPRESSION VECTOR
Ma Y.	-	CHANGES OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Ma T.	-	THE ROLES OF SERUM MATRIX METALLOPROTEINASES IN PATIENTS WITH CORONARY ARTERY DISEASE AND ATRIAL FIBRILLATION TO HEART FAILURE
Ma D.D.F.	-	EFFECT OF SCLEROSANTS ON ANTITHROMBOTIC MECHANISMS, ENDOTHELIAL CELLS AND FIBRINOLYSIS
Ma D.X.	-	THE CONSTRUCTION OF A HUMANIZED PHAGE ANTIBODY LIBRARY OF ANTI-PLATELET GPIIB/IIIA SINGLE CHAIN FV
Ma T.	-	THE ROLES OF TUMOR NECROSIS FACTOR-? AND CELL ADHESION MOLECULES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND HEART FAILURE
Ma L.	-	COMPARISON OF EFFICACY AND SAFETY OF INTRAVENOUS AND INTRA-ARTERIAL THROMBOLYSIS IN ACUTE ISCHEMIC STROKE
Ma H.I.	-	EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
Ma Q.	-	DIFFERENCES IN THE OLIGOSACCHARIDE COMPOSITION OF GENERIC VERSIONS OF ENOXAPARIN AND DALTEPARIN
Maaloufová J.	-	MAJOR ABDOMINAL SURGERY IN A PATIENT WITH SEVERE HAEMOPHILIA A AND HIGH INHIBITOR TITRE
Maas C.	-	THE USE OF TISSUE-TYPE PLASMINOGEN ACTIVATOR TO DETECT MISFOLDED PROTEINS IN BIOPHARMACEUTICALS
	-	ACTIVATION OF FACTOR XII BY MISFOLDED PROTEIN AGGREGATES; IMPLICATIONS FOR CONTACT ACTIVATION
	-	ELEVATED PLASMIN-ALPHA2-ANTIPLASMIN LEVELS IN SYSTEMIC AMYLOIDOSIS INDICATE ACTIVATION OF THE FIBRINOLYTIC SYSTEM
Maas-Enriquez M.	-	POSTMARKETING SURVEILLANCE STUDY OF SUCROSE-FORMULATED RECOMBINANT FACTOR VIII FOR SEVERE HEMOPHILIA A: FINAL RESULTS
	-	INHIBITOR DEVELOPMENT IN PATIENTS WITH HEMOPHILIA A TREATED WITH SUCROSE-FORMULATED RECOMBINANT FACTOR VIII
Maatouk H.	-	EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR
Macarone Palmieri N.	-	BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS
	-	PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS
	-	DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION
	-	LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY
Macaulay I.C.	-	NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
Maccagno F.	-	PROTHROMBOTIC FACTORS IN INFANTS WITH NEONATAL CEREBRAL INFARCTION
MacCallum P.K.	-	LACK OF EFFECT OF INFLUENZA IMMUNISATION ON ANTICOAGULANT CONTROL IN PATIENTS ON LONG-TERM WARFARIN
MacCallum P.	-	LABORATORY DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA: HELP OR HINDRANCE?
	-	CLINICAL DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Maccarrone M.	-	MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
Macchi L.	-	INCIDENCE OF ANTITHROMBIN LEVEL ON "HEMOFILTER CIRCUIT" THROMBOSIS DURING EARLY CONTINUOUS VENOVENOUS HEMOFILTRATION IN POST CARDIOPULMONARY BYPASS PATIENTS
Macchi C.	-	PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
Macchi L.	-	ASPIRIN PREVENTS PLATELET ACTIVATION AFTER CORONARY ARTERY BYPASS SURGERY DESPITE AN INCREASE IN THROMBOXANE A2 SYNTHESIS
Macchi C.	-	EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
MacCluer J.W.	-	GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
Macfarlane D.J.	-	SENSITIVITY AND SAFETY OF PULMONARY EMBOLI IMAGING WITH RADIOLABELED ANTI-D-DIMER MONOCLONAL ANTIBODY FRAGMENTS
MacGillivray R.T.A.	-	MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
	-	HOMOZYGOUS FACTOR V DEFICIENCY WITH MILD CLINICAL PHENOTYPE
	-	A COMPARISON OF THE MEMBRANE BINDING PROPERTIES OF THE GAMMA-CARBOXY GLUTAMIC ACID PROTEINS OF BLOOD COAGULATION
MacGregor D.	-	HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN
	-	THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS
Machado R.R.	-	THROMBOSIS IN PRETERM INFANTS: A REPORT OF FIVE CASES TREATED WITH HIGH DOSE OF TISSUE PLASMINOGEN ACTIVATOR (R-TPA)
Machin S.	-	SOUTH EAST ENGLAND THROMBOTIC THROMBOCYTOPENIC PURPURA REGISTRY
Machin S.J.	-	DECREASED ADAMTS13 AND ANTI-ADAMTS13 IN THE ANTIPHOSPHOLIPID SYNDROME (APS)
	-	SIX ADULT ONSET TTP PATIENTS WITH SEVERAL ADAMTS13 POLYMORPHISMS AND A MISSENSE MUTATION (R1060W) THAT EXHIBITS DEFECTIVE SECRETION IN VITRO
	-	A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS
	-	ADAMTS 13 IN NON-THROMBOTIC THROMBOCYTOPENIC PURPURA CONDITIONS
	-	QUALITY MONITORING OF FRESH-FROZEN PLASMA (FFP) AND THE EFFECT OF WHOLE BLOOD STORAGE AT 4C OVERNIGHT
	-	ACCEPTABILITY AND EFFICACY OF PATIENT SELF-TESTING IN PATIENTS NEW TO THE ANTICOAGULATION CLINIC
Machin M.	-	BIOMECHANICAL PROPERTIES OF VON WILLEBRAND FACTOR BINDING TO PLATELET GLYCOPROTEIN IB RECAPITULATED BY THE DIMERIC A1 DOMAIN
Machin S.J.	-	PREGNANCY MORBIDITY IS ASSOCIATED WITH LOW PLASMA TISSUE FACTOR PATHWAY INHIBITOR LEVELS, INCREASED THROMBIN GENERATION AND RESISTANCE TO ACTIVATED PROTEIN C
	-	TREATMENT OF IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA WITH MABTHERA (RITUXIMAB)
Machin S.	-	FXI/ADAMTS13 COMPLEX IN PLASMA
Macholdt C.	-	THE VALUE OF ROTEM THROMBOLELASTOMETRY TO DETECT DISTURBED HAEMOSTASIS AND BLEEDING RISK IN ON-PUMP CARDIAC SURGERY
Maciejewska-Sniezek M.	-	C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
Mackay I.	-	ARTERIAL STIFFNESS, ENDOTHELIAL FUNCTION AND THE RISK OF ISCHAEMIC STROKE
Mackie I.J.	-	HUMAN VASCULAR ENDOTHELIAL CELLS INFLUENCE THE WHOLE BLOOD THROMBIN GENERATION ASSAY
	-	QUALITY MONITORING OF FRESH-FROZEN PLASMA (FFP) AND THE EFFECT OF WHOLE BLOOD STORAGE AT 4C OVERNIGHT
	-	DECREASED ADAMTS13 AND ANTI-ADAMTS13 IN THE ANTIPHOSPHOLIPID SYNDROME (APS)
	-	SIX ADULT ONSET TTP PATIENTS WITH SEVERAL ADAMTS13 POLYMORPHISMS AND A MISSENSE MUTATION (R1060W) THAT EXHIBITS DEFECTIVE SECRETION IN VITRO
	-	A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS
	-	WHOLE BLOOD AND PLASMA THROMBIN GENERATION ASSAYS IN PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM
Mackie I.	-	FXI/ADAMTS13 COMPLEX IN PLASMA
Mackie I.J.	-	PREGNANCY MORBIDITY IS ASSOCIATED WITH LOW PLASMA TISSUE FACTOR PATHWAY INHIBITOR LEVELS, INCREASED THROMBIN GENERATION AND RESISTANCE TO ACTIVATED PROTEIN C
MacKintosh C.	-	REGULATION OF PHOSPHODIESTERASE 3A IN HUMAN PLATELETS IS MEDIATED BY PROTEIN KINASE C
Mackman N.	-	SMOOTH MUSCLE-DERIVED TISSUE FACTOR IS CRITICAL FOR ARTERIAL THROMBOSIS AFTER FECL3 INJURY
	-	PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY
	-	TISSUE FACTOR AND MICROPARTICLES
Maclean R.	-	ANTI XA ASSAYS FOR DANAPAROID: ASSESSMENT OF PRE ANALYTICAL AND ANALYTICAL VARIABLES
	-	GENETIC ANALYSIS IN HYPOFIBRINOGENEMIA IN ELEVEN FAMILIES
MacMahon S.	-	COMPARISON OF THE ASSOCIATIONS BETWEEN HAEMOSTATIC AND INFLAMMATORY VARIABLES AND CHD RISK: FLETCHER CHALLENGE STUDY
MacQuarrie J.L.	-	HISTIDINE-RICH GLYCOPROTEIN (HRG) MODULATES THE FUNCTION OF FXII IN HEMOSTASIS
Mada S.	-	CBL-B: A PHYSIOLOGICALLY IMPORTANT SIGNALING MOLECULE FOR COLLAGEN-DEPENDENT ACTIVATION
Madan B.	-	UNEXPECTED FINDING OF RAISED UNDERCARBOXYLATED FII (PIVKA-II) IN FVII DEFICIENCY
Maddineni J.	-	DIFFERENTIATION OF LOW MOLECULAR WEIGHT HEPARINS AS STUDIED BY MOLECULAR WEIGHT PROFILE AND HEPARINASE-I DEPOLYMERIZATION: PHARMACOLOGIC IMPLICATIONS
	-	POTENTIAL ROLE OF ADAMTS13/FXI COMPLEXES IN THE PATHOGENESIS OF ESRD
	-	DIFFERENTIAL ACTIVATION OF PROTHROMBIN BY FACTOR XA, TAIPAN VENOM AND ECARIN. PHARMACOLOGIC IMPLICATIONS
	-	PROTEINOMIC PROFILING OF TISSUE FACTOR MEDIATED PROTHROMBIN ACTIVATION PRODUCTS AND THEIR INHIBITION BY DIRECT ANTITHROMBIN AND ANTI-XA AGENTS
	-	ARGATROBAN IS CAPABLE OF PASSING THROUGH THE BLOOD BRAIN BARRIER. POTENTIAL IMPLICATIONS IN THE MANAGEMENT OF THROMBOTIC STROKE
	-	TRYPSIN MEDIATED ACTIVATION OF THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR (CARBOXYPEPTIDASE U)
Maddox B.D.	-	ACTIVATION OF PLATELETS BY A VON WILLEBRAND FACTOR-BINDING PEPTIDE SEQUENCE PRESENT IN COLLAGEN III
Maddury J.	-	NONINVASIVELY MEASURED AORTIC PULSE WAVE VELOCITY FOR DETECTION OF OBSTRUCTIVE CORONARY ARTERY DISEASE
Madeo D.	-	ANTITHROMBIN DEFICIENCY IN THE GENERAL POPULATION IS RARELY DUE TO AT GENE MUTATIONS, WHICH ARE MAINLY REPRESENTED BY ALA384SER MUTATION
	-	HETEROGENEITY OF PHENOTYPES IN PATIENTS WITH VON WILLEBRAND DISEASE ASSOCIATED WITH NULL MUTATIONS: AN OBSERVATION IN FAMILIES WITH THREE NOVEL MUTATIONS
Mäder G.	-	A ROLE OF THE ADAMTS13 GENE IN ACUTE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Madhani M.	-	LACK OF EFFECT OF INFLUENZA IMMUNISATION ON ANTICOAGULANT CONTROL IN PATIENTS ON LONG-TERM WARFARIN
	-	AN EVALUATION OF A PHARMACY INPATIENT ANTICOAGULATION SERVICE IN GENERAL & EMERGENCY MEDICINE
Madhusudhan T.	-	FACTOR V LEIDEN PROTECTS AGAINST DIABETIC NEPHROPATHY IN MICE
Madlener K.	-	ACTIVATED PROTEIN C INHIBITION BY PROTEIN C INHIBITOR IS NOT ACCELERATED BY THE SYNTHETIC PENTASACCHARIDE FONDAPARINUX
Madoiwa S.	-	SILENCING OF A TARGETED PROTEIN IN IN VIVO PLATELETS USING A LENTIVIRAL VECTOR DELIVERING SHORT HAIRPIN RNA SEQUENCE
	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
	-	INDUCTION OF FACTOR VIII SPECIFIC UNRESPONSIVENESS BY INTRATHYMIC FACTOR VIII INJECTION IN MURINE HEMOPHILIA A
Madonna R.	-	PROSTACYCLIN IMPROVES TRANSCORONARY MYOCARDIAL DELIVERY OF ADIPOSE TISSUE-DERIVED STROMAL CELLS
	-	HIGH INSULIN IMPAIRS PI-3 KINASE/AKT-MEDIATED INSULIN SIGNALING IN HUMAN ENDOTHELIAL CELLS: AN IN VITRO INDUCTION OF INSULIN RESISTANCE?
	-	HIGH GLUCOSE INHIBITS NITRIC OXIDE PRODUCTION THROUGH AN HYPEROSMOLAR EFFECT, WITHOUT INDUCING ENDOTHELIAL CELL ADHESION SURFACE EXPRESSION IN HUMAN ENDOTHELIAL CELLS
Madsen E.H.	-	TEST OF ASPIRIN RESISTANCE
	-	RESPONSE TO ASPIRIN AND CLOPIDOGREL IN HEALTHY MEN
Madsen E.M.	-	LMWH BRIDGING FOR ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
Madureira P.R.	-	SIMULTANEOUS BLEEDING AND THROMBOSIS AS THE INITIAL PRESENTATION OF SUPERWARFARIN POISONING
Mady E.	-	NOVEL RISK FACTORS FOR DEEP VEIN THROMBOSIS IN HOSPITALIZED PATIENTS
Maeda Y.	-	EVALUATION OF LASER-INDUCED THROMBOLYSIS IN THE RAT THROMBOSIS MODELS: A PULSED GREEN LASER TECHNIQUE
	-	A ROLE OF SURFACE-BOUND PLASMINOGEN IN THE LIVER REGENERATION IN RAT
Maekawa M.	-	PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS
Maekawa I.	-	HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AS A PLATELET SUBSTITUTE
	-	HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AND ENCAPSULATING ADENOSINE 5'-DIPHOSPHATE AS A PLATELET SUBSTITUTE
Maekawa M.	-	CLINICAL SIGNIFICANCE OF PLATELET-DERIVED MICROPARTICLE (PDMP) IN APS: PLASMA LEVELS OF PDMP WERE SIGNIFICANTLY ELEVATED IN APS PATIENTS WITH ARTERIAL THROMBOSES
Maertens B.	-	COMPARISON OF A HEPARIN-PLATELET FACTOR 4 (PF4)-ELISA FOR IGG, IGM AND IGA AND THE HEPARIN-INDUCED PLATELET ACTIVATION ASSAY (HIPA) WITH A HEPARIN-PF4-ELISA FOR IGG
Maerz W.	-	THE Y2561 ALLELE OF A COMMON POLYMORPHISM IN THE C1 DOMAIN OF VON WILLEBRAND FACTOR APPEARS AS A NOVEL RISK FACTOR FOR MYOCARDIAL INFARCTION
Maeso R.	-	BEMIPARIN THROMBOPROPHYLAXIS IN ELDERLY MEDICAL PATIENTS: THE "ANCIANOS" STUDY
Maffei F.H.A.	-	EFFECT OF THE IMPLEMENTATION OF A VENOUS THROMBOEMBOLISM PROPHYLAXIS GUIDELINE IN THE MANAGEMENT OF SURGICAL AND ORTHOPEDIC PATIENTS IN A PRIVATE TERTIARY HOSPITAL
Magagna A.	-	BETA-ADRENERGIC RECEPTORS MODULATION OF T-PA RELEASE VIA NO SYNTHASE-DEPENDENT PATHWAY IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS
	-	EPINEPHRINE INDUCES LOCAL T-PA RELEASE VIA A NITRIC OXIDE-DEPENDENT PATHWAY IN HUMAN FOREARM
Magalashvili G.E.	-	HEMOSTASIS DISORDERS MARKERS IN INTRACRACRANIAL MENONGIOMAS (IM) PATIENTS
Magana M.M.	-	HETEROZYGOUS FIBRINOGEN GAMMA-375 ARG-TRP MUTATION ASSOCIATED WITH EXCESSIVE SIALYLATION, PLASMIN RESISTANCE AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
	-	HETEROZYGOUS FIBRINOGEN GAMMA-114 TYR-HIS MUTATION ASSOCIATED WITH RESISTANCE TO TPA-MEDIATED FIBRINOLYSIS AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Magari Y.	-	USEFULNESS OF A D-DIMER KIT NEWLY DEVELOPED FOR STANDARDIZATION
Magdeleyns E.J.P.	-	ARGININE THERAPY TENDS TO REDUCE ENDOTHELIAL DAMAGE IN SEPSIS
Magdeleyns E.E.J.P.	-	FACTOR VA BOUND TO STORAGE INDUCED MICROPARTICLES HAVE REDUCED APC CATALYZED INACTIVATION
Magdolen V.	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Mager J.	-	MEASUREMENT OF THROMBIN GENERATION IN PATIENTS AT RISK FOR ATHEROTHROMBOSIS
	-	LIPIDS, MICROPARTICLES AND COAGULATION FACTORS AS DETERMINANTS OF LAG PHASE AND RATE OF THROMBIN GENERATION IN PLASMA
	-	MICROPARTICLES IN THROMBIN GENERATION - A SIGNIFICANT PARAMETER INFLUENCING PEAK THROMBIN LEVELS
Maghsoodlu M.	-	THROMBOTIC EVENTS IN PATIENTS WITH ELEVATED FVIII LEVEL
Magi A.	-	GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
	-	GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
	-	ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
Magliola R.	-	USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN
Magnacca S.	-	FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
	-	INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS
	-	ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
Magnaghi G.	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
Magnenat S.	-	REDUCED ATHEROSCLEROTIC LESIONS IN P2Y1/APOE DOUBLE KNOCKOUT MICE
Maguire P.B.	-	PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
	-	PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
Mahaney M.C.	-	GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
Mahdi F.	-	SCUPA OR FXII STIMULATE ERK1/2 OR AKT THROUGH UPAR AND BETA 1 INTEGRINS
Mahé I.	-	IS MODIFICATION OF DIET IN RENAL DISEASE (MDRD) FORMULA SIMILAR TO COCKCROFT-GAULT FORMULA TO ASSESS RENAL FUNCTION IN ELDERLY HOSPITALIZED PATIENTS TREATED WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)?
	-	HCAN CHANGES IN HEMOSTATIC PARAMETERS EXPLAIN THE INCREASED INCIDENCE OF DVT IN ELDERLY ?
	-	D-DIMER AND PROGNOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION
	-	SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
Mahesh U.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Mahieu-Caputo D.	-	SCREENING FOR THROMBOPHILIA IN A RETROSPECTIVE STUDY OF 320 WOMEN WITH PREGNANCY COMPLICATIONS
Mahjoub S.	-	THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Mahmoodi B.K.	-	HIGH ABSOLUTE RISKS AND PREDICTORS OF VENOUS AND ARTERIAL THROMBOEMBOLIC EVENTS IN PATIENTS WITH NEPHROTIC SYNDROME
Mahmoodi H.	-	CHILDHOOD GERM CELL TUMOR PRECEDING BY CHRONIC LONGSTANDING DIC
Mahmud S.A.	-	ENDOGENOUS PLATELET FACTOR 4 INCREASES ACTIVATED PROTEIN C GENERATION AND IMPROVES SURVIVAL AFTER LIPOPOLYSACCHARIDE CHALLENGE
Mahoney D.H.	-	ANTITHROMBOTIC THERAPY IN INFANTS WITH SVC SYNDROME: ADDITIONAL MODALITIES ARE REQUIRED
Mahony D.	-	POST-THROMBOTIC SYNDROME IN CHILDREN SURVIVING ACUTE LYMPHOBLASTIC LEUKEMIA
Maimets T.	-	IMMUNE RESPONSE TO ADMINISTRATION OF PLASMA-DERIVED COAGULATION FACTOR VIII IN FACTOR VIII-DEFICIENT MICE
Mainard D.	-	INFLUENCE OF INJECTION SITE ON PROPHYLACTIC DOSE ENOXAPARIN BIOAVAILABILITY IN OBESE PATIENTS
Maione A.	-	PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN
Maisnar V.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Maitra A.	-	POLYMORPHISMS IN THE IL6 GENE IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE (CAD) -INDIAN ATHEROSCLEROSIS RESEARCH STUDY
Majumdar S.R.	-	POST-THROMBOTIC SYNDROME (PTS) AFTER TOTAL HIP REPLACEMENT (THR): INCIDENCE AND CORRELATES
Majumdar S.	-	CHARACTERIZATION OF A NEW METHOD TO ASSESS PLATELET ACTIVATION AND ERYTHROCYTE LYSIS DURING EXPOSURE TO PATHOPHYSIOLOGICAL SHEAR STRESS
Makarova A.	-	DIRECT PROTECTIVE EFFECT OF ACTIVATED PROTEIN C ON MAST CELLS DEGRANULATION
Makarova A.M.	-	PAR1 AGONISTS ACCELERATE ULCER HEALING IN RATS
Makatsaria A.D.	-	INHERITED AND ACQUIRED THROMBOPHILIA IN PATIENTS WITH METABOLIC SYNDROME IN OBSTETRIC-GYNECOLOGIC PRACTICE
Makatsariya A.D.	-	PROPHYLAXIS OF RECURENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA
	-	PATHOGENETIC PROPHYLAXIS OF RECCURENT FETAL LOSS SYNDROME IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND GENETIC THROMBOPHILIA
	-	ANTIPHOSPHOLIPID ANTIBODIES SPECTRUM IN WOMEN WITH RECCURENT FETAL LOSS SYNDROME
	-	PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS IN PREGNANT WOMEN WITH THROMBOPHILIA
Makim A.	-	PHARMACOKINETIC PROFILES AND PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIP OF A VWF INHIBITORY APTAMER IN THE CYNOMOLGUS MONKEY
	-	DISCOVERY AND CHARACTERIZATION OF A POTENT NEUTRALIZING ANTI-VWF A1 DOMAIN SPECIFIC APTAMER
	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
	-	PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Makinodann K.	-	ALTERNATION OF VON WILLEBRAND FACTOR AND ADAMTS13 ACTIVITY AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
Makni S.	-	THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Makri L.P.	-	DIETARY EFFECT ON VITAMIN K-DEPENDED COAGULATION FACTORS AND ON PLATELETS' AGGREGATION
Makris M.P.	-	DIETARY EFFECT ON VITAMIN K-DEPENDED COAGULATION FACTORS AND ON PLATELETS' AGGREGATION
Makris P.E.	-	DIETARY EFFECT ON VITAMIN K-DEPENDED COAGULATION FACTORS AND ON PLATELETS' AGGREGATION
Makris M.	-	CHARACTERISATION OF THE MOLECULAR GENETIC DEFECTS UNDERLYING GLANZMANN'S THROMBASTHENIA IN JORDANIAN FAMILIES
	-	IN VITRO ASSESSMENT OF ANTICOAGULATION REVERSAL WITH ROTEM THROMBOELASTOMETRY
Makris P.E.	-	EVALUATION OF PRO-TIME MICROCOAGULLATION SUSTEM
Makris M.P.	-	EVALUATION OF PRO-TIME MICROCOAGULLATION SUSTEM
Makris M.	-	COMPARISON OF THROMBIN GENERATION WITH MODIFIED THROMBOELASTOMETRY IN HAEMOPHILIA A
	-	THROMBIN GENERATION TO MONITOR INHIBITOR BYPASS AGENTS REQUIRES LOW CONCENTRATIONS OF TISSUE FACTOR (TF)
	-	SIGNIFICANT VARIATION IN THROMBIN GENERATION POTENTIAL IN "ADEQUATELY" ANTICOAGULATED PATIENTS
	-	THE CHROMOGENIC FVIII:C ASSAY IS A SUITABLE ALTERNATIVE TO THE TWO-STAGE ASSAY IN DETECTION OF MILD HAEMOPHILIA A PATIENTS WITH ONE-STAGE, TWO-STAGE DISCREPANCY
	-	COMPARISON OF FIX CONCENTRATES BY CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY (CAT)
	-	FACTOR VIII ASSAY DISCREPANCY IN TYPE 2N VWD IS REAGENT DEPENDANT
	-	EVALUATION OF A NEW LATEX-BASED HOMOCYSTEINE ASSAY
Makris P.E.	-	TEN YEARS FOLLOW UP OF HEREDITARY HAEMORRHAGIC PARIENTS IN DENTAL PRACTICE
Makris S.P.	-	TEN YEARS FOLLOW UP OF HEREDITARY HAEMORRHAGIC PARIENTS IN DENTAL PRACTICE
Makris M.P.	-	TEN YEARS FOLLOW UP OF HEREDITARY HAEMORRHAGIC PARIENTS IN DENTAL PRACTICE
	-	COINHERITANCE OF FV-LEIDEN MUTATION AND FV-HR2
Makris P.E.	-	COINHERITANCE OF FV-LEIDEN MUTATION AND FV-HR2
Makris M.P.	-	EPIDEMIOLOGICAL STUDY: CAUSES OF DETHS IN PTOLEMAIDA CITY
Makris L.P.	-	EPIDEMIOLOGICAL STUDY: CAUSES OF DETHS IN PTOLEMAIDA CITY
Makris P.E.	-	EPIDEMIOLOGICAL STUDY: CAUSES OF DETHS IN PTOLEMAIDA CITY
Malacarne S.	-	RECOMBINANT ACTIVATED FACTOR VII IN THE TREATMENT OF ACUTE POST PARTUM HEMORRHAGE: THE ITALIAN REGISTRY
Malagutti P.	-	TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
Malan E.H.	-	A POTENTIAL SOURCE OF ERRONEOUS RESULTS ON AUTOMATED COAGULATION ANALYSERS - AN OBSERVATIONAL STUDY
Malara A.	-	VON WILLEBRAND FACTOR AND GPIB-IX-V REGULATE PROPLATELETS FORMATION BY HUMAN MEGAKARYOCYTES
Malatesta G.	-	INHIBITORY EFFECT OF COFFEE ON PLATELET AGGREGATION
Malato A.	-	THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE
	-	PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY
	-	VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS UNDERGOING CHEST SURGERY FOR LUNG OR PLEURAL MALIGNANT DISEASE
	-	ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
Malaver E.	-	ROLE OF PPAR-GAMMA ACTIVATION IN MEGAKARYOCYTOPOIESIS
	-	GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION
Male C.	-	MONITORING HEPARIN LEVELS IN CHILDREN DURING CARDIAC CATHETERIZATION: COMPARISON OF ACTIVATED CLOTTING TIME, ACTIVATED PARTIAL PROTHROMBIN TIME, AND ANTI-XA ACTIVITY
	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
Malek M.	-	EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
Malerba G.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Malhotra J.	-	ANTI-OXIDANTS IMPROVE FACTOR VIII FOLDING AND SECRETION AND REDUCE CELL TOXICITY AND INFLAMMATION IN VIVO IN MICE
Malhotra P.	-	INVESTIGATION OF THROMBOPHILIA DURING PREGNANCY AND PUERPERIUM: A STUDY FROM NORTH INDIA
Malhotra J.	-	ANTI-OXIDANTS IMPROVE FACTOR VIII FOLDING AND SECRETION AND REDUCE CELL TOXICITY AND INFLAMMATION IN VIVO IN MICE
Malikova I.	-	DECREASE OF SOLUBLE P-SELECTIN AND INHIBITION BOTH, ACTIVATED FACTOR XA AND THROMBIN AFTER I.V.ENOXAPARIN DURING PCI
Maliskova J.	-	AGGREGATION TEST FOR DETECTION CLOPIDOGREL RESISTANCE
Malissen M.	-	ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION
Malissen B.	-	ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION
Mallari C.	-	A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Malleier J.M.	-	REGULATION OF PROTEIN C INHIBITOR (PCI) ACTIVITY BY OXIDIZED AND NEGATIVELY CHARGED PHOSPHOLIPIDS
Mallett S.V.	-	POINT-OF-CARE ASSESSMENT OF PERI-OPERATIVE PLATELET FUNCTION USING THROMBOELASTOGRAPH PLATELET MAPPING
Mallick S.	-	NOVEL RISK FACTORS FOR DEEP VEIN THROMBOSIS IN HOSPITALIZED PATIENTS
Malmqvist K.	-	COMPARISON OF THREE DIFFERENT TAFI ASSAYS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Malmström A.	-	DALTEPARIN SHORTENS HUMAN LABOR
Malmström R.E.	-	NO EFFECT OF LIPID LOWERING BY SIMVASTATIN OR SIMVASTATIN AND EZETIMIBE ON PLATELET FUNCTION IN PATIENTS WITH TYPE 2 DIABETES OR IMPAIRED GLUCOSE TOLERANCE AND CORONARY ARTERY DISEASE
Malofeev V.N.	-	AIRWAY OBSTRUCTION CAUSED BY HEMORRHAGE IN PATIENTS (PTS) WITH INHIBITOR HEMOPHILIA
Malouf J.F.	-	ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE
Malowany J.I.	-	DIFFERENTIAL DOSING OF ENOXAPARIN (ENOX) IN TERM AND PRETERM NEONATES
Malush N.A.	-	STABILITY OF COAGULATION SYSTEM BASELINE STATE: A MATHEMATICAL MODEL
	-	STABILITY OF COAGULATION SYSTEM BASELINE STATE: A MATHEMATICAL MODEL
Maly J.	-	ACETYLSALICYLIC ACID (ASA) RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE (IHD) AS BIOINDICATOR OF THE TREATMENT STRATEGY
Maly R.	-	ACETYLSALICYLIC ACID (ASA) RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE (IHD) AS BIOINDICATOR OF THE TREATMENT STRATEGY
Maly J.	-	MODIFIED PLATELETS FUNCTION ANALYSIS TO RATIONALIZE CHOLESTEROL ELIMINATION PROCEDURE
	-	CONFIRMATION OF EFFICACY, SAFETY AND COST EFFECTIVENESS OF FRAXIPARINE FORTE IN THE OUTPATIENT TREATMENT OF DEEP VENOUS THROMBOSIS
Maly R.	-	CONFIRMATION OF EFFICACY, SAFETY AND COST EFFECTIVENESS OF FRAXIPARINE FORTE IN THE OUTPATIENT TREATMENT OF DEEP VENOUS THROMBOSIS
Maly J.J.M.	-	FREQUENCY OF F II20210A IN WOMEN WITH VENOUS THROMBOEMBOLISM IN ASSOCIATION WITH ORAL CONTRACEPTIVE USE
Maly R.	-	ASSOCIATION OF VENOUS THROMBOEMBOLISM AND OLANZAPINE
Malyszko J.	-	ADIPOCYTOKINES AND VASCULAR ENDOTHELIUM IN DIABETIC AND NON-DIABETIC PERITONEALLY DIALYZED PATIENTS
Malyszko J.S.	-	ADIPOCYTOKINES AND VASCULAR ENDOTHELIUM IN DIABETIC AND NON-DIABETIC PERITONEALLY DIALYZED PATIENTS
Malyszko J.	-	HEPCIDIN IN HEMODIALYZED AND PERITONEALLY DIALYZED PATIENTS: A LINK BETWEEN ANEMIA AND INFLAMMATION?
Malyszko J.S.	-	HEPCIDIN IN HEMODIALYZED AND PERITONEALLY DIALYZED PATIENTS: A LINK BETWEEN ANEMIA AND INFLAMMATION?
Mammarella A.	-	ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS
Mammo L.	-	THE 4G/5G INSERTION/DELETION POLYMORPHISM OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
Managhchi M.R.	-	EVALUATION OF THE USE OF RECOMBINANT FVIIA, NOVOSEVEN IN 28 GLANZMANN'S THROMBASTHENIA PATIENTS
Manara R.	-	EFFECTIVE TREATMENT OF INTRACRANIAL HEMORRHAGE IN A SEVERE HEMOPHILIA B PATIENT
Manarini S.	-	PHOSPHODIESTERASE-TYPE IV REGULATES PMN/PLATELET INTERACTION IN VITRO AND PMN ACCUMULATION AT THE SITE OF VASCULAR INJURY IN VIVO
	-	ANTI-INFLAMMATORY EFFECS OF CLOPIDOGREL IN THE MOUSE
	-	INHIBITION BY SOY ISOFLAVONES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION
	-	PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN
	-	GLYCOGEN SYNTHASE KINASE-3 NEGATIVELY REGULATES TISSUE FACTOR GENE EXPRESSION IN MONOCYTES INTERACTING WITH ACTIVATED PLATELETS
Manaster Y.	-	PLATELET GPIIBIIIA-FIBRINOGEN BINDING ACTIVITY IS INCREASED BY ALLICIN (A THIOL-REACTIVE REAGENT)
Mancini F.	-	EVIDENCE FOR THROMBIN-INDUCED PLATELET ACTIVATION INDEPENDENT OF PAR1, PAR4, AND GPIB-IX-V
Manco-Johnson M.	-	ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN THE THROMBOPHILIA PILOT PROJECT
Manco-Johnson M.J.	-	A THROMBOLYTIC REGIMEN FOR HIGH-RISK DEEP VENOUS THROMBOSIS MAY SUBSTANTIALLY REDUCE THE RISK OF POST-THROMBOTIC SYNDROME IN CHILDREN
Manco-Johnson M.	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: THROMBOPHILIA SCREENING IN CHILDREN
Manco-Johnson M.J.	-	CATHETER RELATED THROMBOSES IN INFANTS AND CHILDREN
Mancuso M.E.	-	EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
	-	PORT IS NOT A SAFE AND SUITABLE VENOUS ACCESS FOR IMMUNE TOLERANCE TREATMENT (ITT) IN HEMOPHILIC CHILDREN
Mancuso P.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Mancuso M.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Mancuso M.E.	-	ARTERIOVENOUS FISTULA (AVF) IS A SAFE AND SUITABLE VENOUS ACCESS FOR IMMUNE TOLERANCE TREATMENT (ITT) IN HEMOPHILIC CHILDREN
Mancuso G.	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
	-	FACTOR VIII (F8) GENE MUTATIONS AND IMMUNE TOLERANCE INDUCTION (ITI) IN HAEMOPHILIA A WITH INHIBITORS: DATA FROM THE ITALIAN ITI REGISTRY (THE PROFIT STUDY)
	-	FVIII/VWF CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN ITALIAN HAEMOPHILIACS WITH NEGATIVE PREDICTORS OF ITI RESPONSE
Mancuso M.E.	-	THROMBIN GENERATION IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Mancuso G.	-	HOME CLINICAL ASSISTANCE: SICILIAN SURVEY ON THE HCA SUPPORT FOR THE MANAGEMENT OF THE PROPHYLAXIS IN PAEDIATRIC HAEMOPHILIAC PATIENTS
	-	IMMUNOGLOBULINE ANTI-D (WINRHO) IN CRHONIC CHILDOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), ANALYSIS OF "IMMATURE PLATELET FRACTION (I.P.F.)" AND ASYMPTOMATIC THROMBOCYTOPENIA
Mancuso M.E.	-	IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY
	-	GYNAECOLOGICAL AND OBSTETRICAL PROBLEMS IN WOMEN AFFECTED WITH INHERITED BLEEDING DISORDERS
Mandeliev A.	-	CLINICAL EXPERIENCE WITH FACTOR VIII/VON-WILLEBRAND-FACTOR CONCENTRATE HAEMATE P RESULTS ON EFFICACY AND SAFETY IN A SINGLE CENTRE REGISTRY
Mandic V.	-	THE USE OF HAEMOSTASIS TESTS IN THE FOLOW UP OF A PATIENT WITH ANTITHROMBIN DEFICIENCY DURING THE PREGNANCY AND AFTER DELIVERY
Maneyro A.	-	COMPARISON BETWEEN CONVENTIONAL AND AUTOMATED METHODS OF RISTOCETIN COFACTOR ACTIVITY AND VON WILLEBRAND FACTOR ANTIGEN
Manfredi E.	-	SUBCLINICAL HYPOTHYROIDISM AND DEEP VENOUS THROMBOSIS. A PILOT CROSS-SECTIONAL STUDY
Manfredi A.	-	PLATELET P-SELECTIN IS ASSOCIATED WITH CIRCULATING NEUTROPHIL ACTIVATION AT THE VERY ONSET OF MYOCARDIAL INFARCTION
Mangge H.	-	THROMBIN GENERATION IN OBESE CHILDREN AFTER WEIGHT REDUCTION
Mangin P.	-	MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
	-	THE NON-CATALYTIC SIGNALLING FUNCTION OF PI 3-KINASE P110GAMMA PROMOTES PLATELET ACTIVATION AND THROMBUS FORMATION
	-	A MONOCLONAL ANTIBODY AGAINST PLATELET GPIBBETA INHIBITS GPIB-V-IX-DEPENDENT SIGNALLING, PROCOAGULANT ACTIVITY AND THROMBUS FORMATION UNDER FLOW PERFUSION
	-	THE GPIB-V-IX COMPLEX FACILITATES PLATELET PROCOAGULANT ACTIVITY INDEPENDENTLY OF THE GPIB ALPHA NH2 TERMINAL DOMAIN
Mani H.	-	ALTERNATIVE ANTICOAGULATION WITH FONDAPARINUX IN PREGNANT PATIENTS WITH HEPARIN-INTOLERANCE
	-	NON-RESPONSE TO CLOPIDOGREL IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
	-	DETERMINATION OF CLOPIDOGREL MAIN METABOLITE IN PLASMA USEFUL TOOL FOR THERAPY MONITORING ?
	-	NON-RESPONSE TO ASPIRIN (ASA) IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
Manigrasso M.	-	ASSOCIATION BETWEEN ENHANCED SOLUBLE CD40 LIGAND AND PLATELET ACTIVATION IN HYPERTENSIVES WITH MICROALBUMINURIA
Mann K.	-	ASSOCIATION BETWEEN ASPIRIN RESISTANCE AND INCREASED THROMBIN GENERATION AT THE SITE OF MICROVASCULAR INJURY: THE EFFECT OF SIMVASTATIN
Mann K.G.	-	ANTAGONISM OF INTRINSIC PATHWAY INHIBITS TISSUE FACTOR (TF)-INITIATED COAGULATION IN A PLATELET-DEPENDENT WHOLE BLOOD FLOW ASSAY
	-	THROMBIN GENERATION PROFILES IN PATIENTS WITH ACUTE CORONARY SYNDROME AND STABLE CORONARY ARTERY DISEASE: A COMPUTATIONAL ANALYSIS
	-	FACTOR XIA (FXIA) AND TISSUE FACTOR (TF) ACTIVITY IN PLASMA OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD)
Mann J.	-	SIGNIFICANT REDUCTION OF VASCULAR GRAFT OCCLUSIONS IN CHRONIC HEMODIALYSIS PATIENTS WITH PEG-HIRUDIN (SPP200)
Mann K.G.	-	THE INFLUENCE OF VON WILLEBRAND FACTOR (VWF) ON FACTOR VIII (FVIII) ACTIVITY IN PLASMA
Mannhalter C.	-	P-SELECTIN (P-SEL) GENE HAPLOTYPES MODULATE SOLUBLE (S) P-SEL LEVELS AND INCREASE THE RISK OF VENOUS THROMBOEMBOLISM (VTE)
	-	RISK OF RECURRENCE AFTER A FIRST VENOUS THROMBOEMBOLIC EVENT IN YOUNG WOMEN
	-	ANGIOTENSIN-CONVERTING ENZYME (ACE) INSERTION/DELETION (I/D) POLYMORPHISM AND SERUM LEVELS OF ACE IN VENOUS THROMBOEMBOLISM (VTE)
Manning S.L.	-	AN ENU MUTAGENESIS SCREEN FOR DOMINANT GENETIC MODIFIERS OF THROMBOSIS IN THE FACTOR 5 LEIDEN MOUSE
Mannini L.	-	LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
	-	RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
	-	HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
	-	HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
Manno C.	-	INFERIOR VENA CAVA FILTERS IN PEDIATRIC PATIENTS
	-	THROMBOPROPHYLAXIS IN HIGH-RISK ADOLESCENT INPATIENTS
Manns J.M.	-	ELEVATED PLASMA LEVELS OF THROMBOSPONDIN-1 (TSP1) ARE ASSOCIATED WITH INCREASED LEVELS OF TGF-BETA AND PRO-INFLAMMATORY CYTOKINES IN RHEUMATOID ARTHRITIS PATIENTS
	-	THROMBOSPONDIN-1 (TSP1) PROMOTES THROMBIN GENERATION ON THE SURFACE OF FIBROBLASTS (HS-68) AND INDUCES UPREGULATION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE AND PROTEIN EXPRESSION
Mannucci P.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Mannucci P.M.	-	NEW INSIGHTS IN ADAMTS13 PHYSIOLOGY BY MEASURING ACTIVITY OVER ANTIGEN RATIO
	-	THE INTERNATIONAL NORMALIZED RATIO TO PRIORITIZE PATIENTS FOR LIVER TRANSPLANTATION. PROBLEMS AND SOLUTIONS
	-	PHENOTYPIC ANALYSIS OF THREE MUTATIONS CAUSING GLANZMANN THROMBASTHENIA
	-	PORT IS NOT A SAFE AND SUITABLE VENOUS ACCESS FOR IMMUNE TOLERANCE TREATMENT (ITT) IN HEMOPHILIC CHILDREN
	-	EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
	-	A RANDOMIZED, CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF LMWH ON PREGNANCY OUTCOME OF WOMEN WITH PREVIOUS PREGNANCY COMPLICATIONS. H.A.P.P.Y. STUDY
	-	ARTERIOVENOUS FISTULA (AVF) IS A SAFE AND SUITABLE VENOUS ACCESS FOR IMMUNE TOLERANCE TREATMENT (ITT) IN HEMOPHILIC CHILDREN
Mannucci P.	-	EFFECT OF PH AND TEMPERATURE ON ADAMTS-13 CATALYSIS
Mannucci P.M.	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
	-	DETERMINATION OF ANTI-ADAMTS13 AUTOANTIBODIES IN THROMBOTIC TROMBOCITOPENIC PURPURA (TTP) PATIENTS: COMPARISON OF TWO DIFFERENT METHODS
	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
	-	INTERFERENCE OF FACTOR V LEIDEN ON PROTEIN S ACTIVITY. EVALUATION OF A NEW PROTHROMBIN TIME-BASED ASSAY
	-	THROMBOSIS AND BLEEDING DISORDERS OUTSIDE WESTERN COUNTRIES
	-	THROMBIN GENERATION IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
	-	GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN
	-	THE ENDOGENOUS THROMBIN POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM
	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
	-	PLATELET ADAMTS13 AND IN VITRO EXPRESSION STUDY OF A PATIENT AFFECTED BY CONGENITAL TTP
Manolopoulos P.	-	PLATELET EP3 RECEPTORS AS TARGETS FOR ANTITHROMBOTIC AGENTS - COMPARISON OF DG-041 WITH ASPIRIN AND AR-C69931
Manolova N.	-	EVALUATION OF THE BEHAVIOR OF (QUATERNIZED) POLY[(2-DIMETHYLAMINO)ETHYL METHACRYLATE] AND (CROSSLINKED) N-CARBOXYETHYLCHITOSAN AND THEIR COMPLEXES IN CONTACT WITH BLOOD
Mansour A.	-	PROGNOSTIC SIGNIFICANCE OF MRD (MINIMAL RESIDUAL DISEASE) QUANTIFICATION BY PCR IN CHILDHOOD ACUTE LEUKEMIA
Mansouri Taleghani B.	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
Mansouri Torghabe H.	-	PATTERN OF FACTOR VIII INHIBITOR IN PATIENTS WITH HEMOPHILIA A
Mansueto M.	-	HOME CLINICAL ASSISTANCE: SICILIAN SURVEY ON THE HCA SUPPORT FOR THE MANAGEMENT OF THE PROPHYLAXIS IN PAEDIATRIC HAEMOPHILIAC PATIENTS
Mant M.J.	-	POST-THROMBOTIC SYNDROME (PTS) AFTER TOTAL HIP REPLACEMENT (THR): INCIDENCE AND CORRELATES
Mantero F.	-	POLYMORPHISMS OF VON WILLEBRAND FACTOR (VWF) GENE PROMOTER MODULATE THE CORTICOSTEROID-MEDIATED INCREASE IN VWF LEVELS IN CUSHING'S SYNDROME: A POTENTIAL MODEL OF TRANSCRIPTIONAL REGULATION AND A NEW THROMBOTIC MARKER
Mantilla J.	-	NATIONAL STUDY OF INHIBITOR KINETICS AND TREATMENT RESPONSE IN HEMOPHILIA A AND B MEXICAN PATIENTS
Mantovani L.	-	PREFERENCES TOWARDS COAGULATION FACTOR CONCENTRATES USED TO TREAT HEMOPHILIC PATIENTS WITH INHIBITORS: THE PATIENTS', PHYSICIANS' AND PHARMACISTS' PERSPECTIVE
Manukyan D.	-	BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION
	-	PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY
Mao Y.	-	RHOA/P160ROCK PLAYS AN IMPORTANT ROLE IN THE DENSE GRANULE RELEASE OF PLATELETS
Mao G.	-	NF-B REGULATES PLATELET PLC-2 EXPRESSION: STUDIES IN HUMAN PLATELET PLC-2 DEFICIENCY
Mapara S.	-	LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Maraveyas A.	-	CHEMOANTICOAGULATION VERSUS CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): RESULTS OF THE INTERIM ANALYSIS OF THE FRAGEM TRIAL
Marchese P.	-	THE ROLE OF PLATELET GLYCOPROTEIN VI IN ARTERIAL THROMBOSIS
	-	KLF4, A MODIFIER GENE IN GP6-NULL MICE
Marchesini E.	-	RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
	-	HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY
	-	ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS
Marchesoni D.	-	SAFETY AND EFFICACY OF NADROPARIN FOR THE MANAGEMENT OF VENOUS THROMBOEMBOLISM OR THROMBOPHILIA IN PREGNANCY
Marchetti G.	-	VITAMIN K-INDUCED VARIATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY
Marchetti M.	-	ACQUIRED RESISTANCE TO ACTIVATED PROTEIN C (APC) IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) DALTEPARIN REDUCES THE PROTHROMBOTIC AND PROANGIOGENIC POTENTIAL OF MICROVASCULAR ENDOTHELIAL CELLS ELICITED BY TUMOR CELLS
Marchetti G.	-	COAGULATION FACTOR XI LEVELS AND THE LDL RECEPTOR-RELATED PROTEIN (LRP) GENOTYPE
Marchetti M.	-	PROGNOSTIC SIGNIFICANCE FOR VENOUS THROMBOEMBOLISM (VTE) OF HEMOSTATIC MARKERS IN PATIENTS WITH MULTIPLE MYELOMA (MM) RECEIVING THALIDOMIDE
	-	DIFFERENTIAL EFFECTS OF RETINOIDS ON THE PROCOAGULANT ACTIVITY (PCA) AND CYTO-DIFFERENTIATION OF LEUKEMIC CELLS FRESHLY ISOLATED FROM ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS
	-	ALL-TRANS RETINOIC ACID (ATRA) INHIBITS ENDOTHELIAL ANGIOGENESIS INDUCED BY TUMOR CELLS AND STANDARD FACTORS
	-	THROMBIN GENERATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
Marchi R.C.	-	EFFECT OF HOMOCYSTEINE ON CLOT STRUCTURE AND FIBRINOLYSIS
Marchi S.	-	WHOLE-BLOOD CLOTTING FOR EVALUATING THROMBIN GENERATION IN CHRONIC LIVER FAILURE
Marchiori A.	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AMONG HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN OR PROTHROMBIN G20210A MUTATION. A SYSTEMATIC REVIEW OF PROSPECTIVE STUDIES
Marchioro P.	-	INFLUENCE OF HAEMATOCRIT ON ROTEM PARAMETERS
Marco P.	-	GENETIC THROMBOPHILIA AND THROMBOSIS OF CEREBRAL VENOUS SINUSES
	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) GENE POLYMORPHISM AND RISK FOR VENOUS THROMBOSIS DISEASE (VTD)
Marco A.	-	CLINICAL MANAGEMENT USING LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) IN PREGNANT WOMEN WITH THROMBOPHILIA, THROMBOEMBOLIC DISEASE (DVT) OR THROMBOPHILIA-RELATED MATERNOPLACENTAL SYNDROME: EXPERIENCE IN ONE CENTER
Marcos P.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Marcos-Contreras O.A.	-	PARTIAL FIBRIN ADHESION AND DIFFUSION SUGGESTED RETEPLASE AS THE THERAPEUTIC CHOICE FOR CATHETER DRIVEN THROMBOLYSIS
Marcucci R.	-	EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
	-	POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
	-	MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS
	-	B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
	-	PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
	-	DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS?
	-	LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
	-	HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
	-	PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
	-	ALTERED ULTRALARGE VON WILLEBRAND FACTOR LEVELS AND ADAMTS-13 ACTIVITY AFFECT RESIDUAL PLATELET REACTIVITY IN HIGH RISK VASCULAR PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
	-	CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
	-	THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
	-	GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS
	-	QUALITY OF OAT AND VTE RECURRENCE
	-	CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
	-	LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
	-	VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
Mardari R.	-	EFFECTIVE TREATMENT OF INTRACRANIAL HEMORRHAGE IN A SEVERE HEMOPHILIA B PATIENT
Marder V.	-	A PHASE I TRIAL OF LOCALLY-DELIVERED HUMAN PLASMIN TO EVALUATE SAFETY AND THROMBOLYTIC EFFICACY IN PATIENTS WITH HEMODIALYSIS GRAFT OCCLUSION (HGO)
Marder V.J.	-	THE PRIORITY TRIAL: PLASMIN REVASCULARIZATION OF ACUTE LOWER EXTREMITY NATIVE ARTERY OR BYPASS GRAFT OCCLUSIONPHASE I/II PROTOCOL DESIGN
	-	A NEW ANIMAL MODEL OF CATHETER-SELECTIVE MIDDLE CEREBRAL ARTERY THROMBO-OCCLUSIVE STROKE: DEMONSTRATION OF RAPID REPERFUSION BY LOCAL PLASMIN INFUSION
	-	FACTORS INFLUENCING THE ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODY (ANTI-PF4/H AB) IMMUNE RESPONSE: AN ANALYSIS OF FOUR RANDOMIZED CONTROLLED TRIALS (RCT'S) COMPARING ENOXAPARIN (ENOX) TO FONDAPARINUX (FONDA)
Maréchal C.	-	EVALUATION OF THROMBOPHILIA SCREENING IN WOMEN WITH OBSTETRICAL COMPLICATIONS: A "REAL WORLD" EXPERIENCE
Marenzi G.	-	DIFFERENT PATTERN OF TF EXPRESSION IN PLATELETS, LEUKOCYTES AND AGGREGATES OF CAD PATIENTS
Marès P.	-	ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
	-	THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
Margaglione M.	-	EFFICACY OF ENOXAPARIN IN PREVENTING ADVERSE FETO-MATERNAL OUTCOMES IN CARRIERS OF ANTICOAGULANTS DEFICIENCY
	-	THE G20210A PROTHROMBIN VARIANT (PT-G20210A) AND THE RISK OF THROMBOEMBOLISM AND FOETAL LOSS IN PREGNANT WOMEN
	-	COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS
Margaglione M.M.M.	-	A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS
Margaglione M.	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
	-	PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY
	-	FACTOR VIII (F8) GENE MUTATIONS AND IMMUNE TOLERANCE INDUCTION (ITI) IN HAEMOPHILIA A WITH INHIBITORS: DATA FROM THE ITALIAN ITI REGISTRY (THE PROFIT STUDY)
	-	A NEW MUTATION WITHIN PROTEIN Z GENE IS ASSOCIATED WITH VERY LOW PROTEIN LEVELS IN WOMEN WITH FETAL LOSS
	-	PHENOTYPIC ANALYSIS OF THREE MUTATIONS CAUSING GLANZMANN THROMBASTHENIA
	-	TF EXPRESSION IN HUMAN PLACENTA IS SIGNIFICANTLY ASSOCIATED WITH VEGF EXPRESSION
	-	A RAPID METHOD FOR THE QUANTIFICATION OF THE ENANTIOMERS OF WARFARIN, PHENPROCOUMON AND ACENOCOUMAROL BY TWO DIMENSIONAL-ENANTIOSELECTIVE LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY
Margeli A.	-	CIRCULATING LEVELS OF ADHESION MOLECULES AND MARKERS OF ENDOTHELIAL DYSFUNCTION IN ACUTE INFLAMMATION INDUCED BY PROLONGED BRISK EXERCISE: RAPID ENDOTHELIAL RECOVERY AND POTENTIAL BENEFICIAL EFFECTS
	-	LONGITUDINAL COURSE AND CLINICAL SIGNIFICANCE OF TGF-B1, SL- AND SE-SELECTINS AND SICAM-1 LEVELS DURING SEVERE ACUTE STRESS IN CHILDREN
Margit S.	-	HEMOSTATIC EXPRESSION OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN
Mari D.	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
Mariani G.	-	VITAMIN K-INDUCED VARIATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY
	-	U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
	-	SUCCESSFUL MANAGEMENT OF BLEEDING WITH A PASTEURIZED FVIII/VWF CONCENTRATE IN A WOMAN AFFECTED BY TYPE 2A VON WILLEBRAND DISEASE UNDERGOING UTERINE CERVIX CONIZATION
	-	GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY
	-	INHIBITOR OF FVII IN CONGENITAL SEVERE FACTOR VII DEFICIENCY
Marie J.P.	-	ENDOTHELIAL IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Marilda F.	-	807C/T POLYMORPHISM IN THE PLATELET GLYCOPROTEIN IA GENE IN PATIENTS WITH RETINAL VEIN OCCLUSION
Marin F.	-	INFLUENCE OF FACTOR VII 323 DEL/INS POLYMORPHISM IN THE PROTHROMBOTIC STATE AND ISCHAEMIC STROKE RISK IN ATRIAL FIBRILLATION
Marin S.	-	THROMBIN GENERATION TEST IN THE MONITORING OF PROTHROMBIN COMPLEX CONCENTRATES
Marin I.	-	CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES
Marín D.M.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Marin F.	-	ROLE OF TISSUE REMODELLING IN HYPERTROPHIC MYOCARDIOPATHY
	-	TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 1 (TIMP-1) PREDICTS RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN END STAGE SYSTOLIC HEART FAILURE
	-	ANNEXIN A5 1 C/T POLYMORPHISM DISPLAYS A BETTER OUTCOME IN A LONG TERM FOLLOW-UP AFTER PREMATURE MYOCARDIAL INFARCTION
Marin E.	-	DEEP VEIN THROMBOSIS AND THE RISK OF RECURRENT PULMONARY EMBOLISM
Marini M.	-	GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
Mariz M.	-	MASSIVE VENOUS THROMBOEMBOLISM IN A PEDIATRIC PATIENT: A CASE REPORT
	-	SEVERE GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIA IN A PATIENT WITH GLANZMANN THROMBASTHENIA
	-	SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS
Marjamäki A.	-	PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
Markakis K.	-	PRELIMINARY RESULTS ON EFFECTIVENESS AND SAFETY OF COMBINED ANTICOAGULANT AND ANTIPLATELET THERAPY
	-	DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS
Markov A.	-	THE VITAMIN K EPOXIDE REDUCTASE GENE POLYMORPHISMS AND PHARMACOGENETICS OF WARFARIN
Marková M.	-	MAJOR ABDOMINAL SURGERY IN A PATIENT WITH SEVERE HAEMOPHILIA A AND HIGH INHIBITOR TITRE
Marks R.S.	-	RISK FACTORS FOR VENOUS THROMBOEMBOLISM (VTE) AMONG ACTIVE CANCER PATIENTS: A POPULATION-BASED CASE-CONTROL STUDY
Marlar R.	-	THROMBOPATH KIT HAS INCREASED SENSITIVITY TO PROTHROMBOTIC LUPUS ANTICOAGULANTS
Marlu R.	-	TAFI ACTIVITY LEVELS AND RECURRENT VENOUS THROMBOEMBOLIC DISEASE
Marmur J.D.	-	THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Marongiu F.	-	ANTIPHOSPHOLIPID SYNDROME AND PORTABLE COAGULOMETERS
	-	PERIODICAL LABORATORY EVALUATION OF PORTABLE COAGULOMETERS
Marosi A.	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
Marotta S.	-	CAMP-INDUCED INHIBITION OF CA2+ MOBILIZATION IS REVERSED BY TYROSINE PHOSPHORYLATION OF IP3R IN PLATELETS
Marotta H.	-	MARKERS OF ENDOTHELIAL CELL ACTIVITY BEFORE AND AFTER BOSENTAN THERAPY IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION DUE TO CONNECTIVE TISSUE DISEASE
Marques L.	-	RFVIIA IN THE TREATMENT OF GLANZMANN'S THROMBASTHENIA - CASE REPORT
Marquès-Verdier A.	-	SECONDARY PROPHYLAXIS WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A SEVERE HAEMOPHILIA A PATIENT WITH ANTI-FACTOR VIII INHIBITORS
Marquez J.M.	-	EVALUATION OF LIPOPROTEIN (A) IN ARGENTINIAN WOMEN WITH ADVERSED PREGNANCY OUTCOME
Marr H.	-	WHICH PATIENTS WITH VENOUS THROMBOSIS DO NOT REQUIRE SCREENING FOR MALIGNANCY? A PREDICTIVE MODEL TO IDENTIFY PATIENTS WITH VTE AT MINIMAL RISK OF MALIGNANCY
Marrel A.	-	MULTINATIONAL DEVELOPMENT OF A QUESTIONNAIRE ASSESSING PATIENT SATISFACTION WITH ANTI-COAGULANT TREATMENT
Mar[scaron]ál K.	-	FACTOR V LEIDEN AND PLACENTAL PATHOLOGY
Marschalek R.	-	A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
Marsden K.	-	2B OR NOT 2B? DISPARATE DISCRIMINATION OF FUNCTIONAL VWF DISCORDANCE USING DIFFERENT ASSAYS OR METHODOLOGIES FOR VWF LEADS TO SUCCESS OR FAILURE IN THE EARLY IDENTIFICATION OF TYPE 2B VWD
Marsh J.J.	-	HETEROZYGOUS FIBRINOGEN GAMMA-114 TYR-HIS MUTATION ASSOCIATED WITH RESISTANCE TO TPA-MEDIATED FIBRINOLYSIS AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
	-	HETEROZYGOUS FIBRINOGEN GAMMA-375 ARG-TRP MUTATION ASSOCIATED WITH EXCESSIVE SIALYLATION, PLASMIN RESISTANCE AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Marsh H.	-	INHIBITION OF PLATELET FUNCTION BY THE ANTI-VON WILLEBRAND FACTOR APTAMER, ARC1779
Marsh H.N.	-	DISCOVERY AND CHARACTERIZATION OF A POTENT NEUTRALIZING ANTI-VWF A1 DOMAIN SPECIFIC APTAMER
	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
Marson P.	-	THE MANAGEMENT OF HIGH RISK PREGNANT PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME
Marta R.F.	-	INVOLVEMENT OF THE TPO/MPL PATHWAY IN THE PATHOGENESIS OF INHERITED THROMBOCYTOPENIAS
Martageix C.	-	NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO RARE PLATELET ALLOANTIGENS
Martchenke J.	-	ABNORMAL PLATELET FUNCTION IS COMMON IN PEDIATRIC CONGENITAL CARDIAC SURGERY PATIENTS
Martel F.	-	MRNA ANALYSIS IN A SEVERE HAEMOPHILIA A PATIENT: DETECTION OF AN EXON 6 SKIPPING
Martel N.	-	VERY LOW FREQUENCY OF HEPARIN INDUCED THROMBOCYTOPENIA (HIT) IN A TERTIARY CARE HOSPITAL
Martelli N.	-	ANTI-INFLAMMATORY EFFECS OF CLOPIDOGREL IN THE MOUSE
	-	PHOSPHODIESTERASE-TYPE IV REGULATES PMN/PLATELET INTERACTION IN VITRO AND PMN ACCUMULATION AT THE SITE OF VASCULAR INJURY IN VIVO
	-	INHIBITION BY SOY ISOFLAVONES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION
	-	GLYCOGEN SYNTHASE KINASE-3 NEGATIVELY REGULATES TISSUE FACTOR GENE EXPRESSION IN MONOCYTES INTERACTING WITH ACTIVATED PLATELETS
Marti-Fabregas J.	-	MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
Martin J.	-	THROMBOPHILIA IN PAEDIATRIC CYSTIC FIBROSIS PATIENTS
Martin P.	-	DOES TRANEXAMIC ACID DECREASE ERYTHROCYTE TRANSFUSION IN PATIENTS UNDERGOING HIP FRACTURE SURGERY WITH FONDAPARINUX FOR PREVENTION OF VENOUS THROMBOEMBOLISM ?
Martin J.	-	RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) EXPRESSED ON HEK293 CELLS BINDS OXIDIZED LOW DENSITY LIPOPROTEINS (OXLDL)
Martín A.	-	IMPACT OF FVIII PRODUCT CHANGE IN SEVERE HAEMOPHILIA A PATIENTS PREVIOUSLY TREATED WITH PLASMA-DERIVED FVIII
Martin M.	-	IMMUNE TOLERANCE INDUCTION WITH VIII-CONTAINING FACTOR VWF
Martin C.	-	PURIFIED A2 DOMAIN OF VWF BINDS TO THE ACTIVE CONFORMATION OF VWF AND BLOCKS THE INTERACTION WITH PLATELET GPIB; A NOVEL A2 DOMAIN-DERIVED PEPTIDE INHIBITS VWF-GPIB INTERACTION UNDER HIGH FLOW CONDITIONS
Martin K.	-	DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE
Martin J.	-	ACUTE EFFECT OF STATINS ON THE REGULATION AND EXPRESSION OF CANDIDATE GENES (CD36, MMP-9 AND IL-8) IN ATHEROSCLEROSIS IN HIV-INFECTED PATIENTS
Martin E.J.	-	EFFECT OF RECOMBINANT FACTOR VIIA VARIANT (NN1731) ON PLATELET FUNCTION, CLOT STRUCTURE AND FORCE ONSET TIME IN BLOOD FROM HEALTHY VOLUNTEERS AND HEMOPHILIA PATIENTS
Martín Mateos M.	-	LONG TERM ANTICOAGULATION WITH FONDAPARINUX FOR DIALYSIS DEPENDENT PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Martinas G.	-	RISK FACTORS PREDICTIVE OF CARDIOVASCULAR EVENTS IN AN INCIDENT DIALYSIS COHORT: A ROLE FOR HOMOCYSTEINEMIA AND ITS MTHFR GENOTYPE
Martinelle K.	-	A NOVEL RECOMBINANT B-DOMAIN-DELETED FACTOR VIII EXPRESSED IN A HUMAN CELL LINE
Martinelli I.	-	A RANDOMIZED, CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF LMWH ON PREGNANCY OUTCOME OF WOMEN WITH PREVIOUS PREGNANCY COMPLICATIONS. H.A.P.P.Y. STUDY
Martinelli T.	-	ADDITION OF PRION REDUCTION FACTORS FROM SINGLE STEP EXPERIMENTS MAY OVERESTIMATE MANUFACTURING PROCESS CLEARANCE CAPABILITY
Martinelli I.	-	MODERATE HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH REDUCED PLASMA FIBRINOLYTIC CAPACITY AND INCREASED TAFI LEVELS
	-	THE ENDOGENOUS THROMBIN POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM
	-	THE G20210A PROTHROMBIN VARIANT (PT-G20210A) AND THE RISK OF THROMBOEMBOLISM AND FOETAL LOSS IN PREGNANT WOMEN
Martinelli T.	-	THE STABILITY OF A PLASMA-DERIVED FACTOR VIII PRODUCT DURING SIMULATED CONTINUOUS INFUSION
Martinelli N.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Martinelli I.	-	THE RISK OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN DOUBLE CARRIERS OF FACTOR V LEIDEN AND PROTHROMBIN G20210A
	-	HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH APC RESISTANCE
Martinez M.	-	COMPARATIVE "IN VITRO" CHARACTERIZATION OF DIFFERENT PROTHROMBIN COMPLEX CONCENTRATES
Martinez J.	-	TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 1 (TIMP-1) PREDICTS RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN END STAGE SYSTOLIC HEART FAILURE
Martínez C.	-	BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN
Martinez P.A.	-	THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY
	-	FREE PROTEIN S LEVELS DURING PREGNANCY
Martínez C.	-	FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA
	-	TISSUE FACTOR-DEPENDENT COAGULANT ACTIVITY OF PLATELET-MONOCYTE COMPLEXES IN CHRONIC RENAL FAILURE (CRF). ASSOCIATION WITH HEMOSTATIC ACTIVITY, INFLAMMATION, OXIDATIVE DAMAGE AND ENDOTHELIAL DYSFUNCTION
Martinez C.	-	JAK2 V617F MUTATION IS ASSOCIATED WITH THE LEUKOCYTE COUNT AND BONE MARROW CD34+ CELLS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
Martínez C.	-	INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
	-	PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION
Martínez Sales V.	-	INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND ANGIOGENIC ACTIVITY IN STABLE HEART FAILURE PATIENTS
	-	DYSFUNCTION ENDOTHELIAL AND ANGIOGENIC ACTIVITY IN CHRONIC HEART FAILURE: ROLE OF ORAL ANTICOAGULANT THERAPY
Martínez-González J.	-	THROMBOPROPHYLAXIS WITH BEMIPARIN STARTED 6 HOURS AFTER HIP OR KNEE REPLACEMENT SURGERY: REVIEW OF CLINICAL AND POSTMARKETING EXPERIENCE
	-	BEMIPARIN THROMBOPROPHYLAXIS IN ELDERLY MEDICAL PATIENTS: THE "ANCIANOS" STUDY
	-	CLINICAL OUTCOMES DURING BEMIPARIN POST-MARKETING OBSERVATIONAL STUDIES ON PROPHYLAXIS OF VENOUS THROMBOEMBOLISM
Martínez-Sales V.	-	ATORVASTATIN NEUTRALIZED THE UP-REGULATION OF THROMBOSPONDIN INDUCED BY THROMBIN IN ENDOTHELIAL CELLS
Martini W.Z.	-	THE DIFFERENTIAL EFFECTS OF ACIDOSIS ON FIBRINOGEN SYNTHESIS AND DEGRADATION IN PIGS
Martini F.	-	RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION
	-	ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS
Martini W.Z.	-	CHANGES IN THROMBIN GENERATION KINETICS FOLLOWING HEMORRHAGIC SHOCK AND RESUSCITATION IN PIGS
Martini A.	-	EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN
Martinka J.	-	TORPID CLINICAL COURSE OF THROMBOTIC THROMBOCYTOPENIC PURPURA
Martin-McNulty B.	-	A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Martino L.	-	A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY)
Martino F.	-	EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN
Martino E.	-	EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN
Martino S.	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Martinova K.	-	HOSPITALISATION FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD- IS IT ALWAYS NECESSARY?
	-	A RARE CONGENITAL BLEEDING DISORDER: F.VII DEFICIENCY (CASE REPORT)
Martinovitz U.	-	INTRA-SUBJECT VARIABILITY OF THROMBOELASTOGRAPHIC PARAMETERS FOLLOWING RFVIIA IN VIVO ADMINISTRATION IN HAEMOPHILIA PATIENTS: A MULTI-CENTRE, RANDOMIZED TRIAL
Martinowitz U.	-	CAN THROMBIN GENERATION (TG) BE USED TO MONITOR RFVIIA TREATMENT: IN VIVO "MINI-PK" STUDY IN HEMOPHILIA A PATIENTS
	-	A RECOMBINANT FACTOR VIIA ANALOGUE WITH ENHANCED POTENCY, EXPRESSED BY THROMBIN GENERATION, AND PHOSPHOLIPIDS DEPENDENCY: AN IN VITRO STUDY
	-	COMPARISON OF PEGYLATED LIPOSOMAL FVIII INFUSION RATES IN HEMOPHILIA A
	-	The contribution of phospholipids (PL) to thrombin generation (TG) induced by factor eight inhibitor bypassing activity (FEIBA) and recombinant factor VIIa (rFVIIa)
Martin-Toutain I.	-	COMPARISON OF TWO WHOLE BLOOD PLATELET FUNCTION ASSAYS: PFA-100 AND A NEW MULTIPLE ELECTRODE AGGREGOMETRY (MULTIPLATE) FOR CONTROL OF ASPIRIN AND/OR CLOPIDOGREL EFFECT
Martinuzzo M.	-	EFFECTS OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FROM APL PATIENTS WITH APS OR WITH LEPROSY IN AN IN VIVO MODEL OF APS
	-	THROMBOPHILIA IN HIV-INFECTED PATIENTS WITH OSTEONECROSIS: IS THERE A REAL CONNECTION? THE FIRST CASE-CONTROL STUDY
Martinuzzo M.E.	-	CORRELATION BETWEEN DIFFERENT FIBRINOLYTIC TESTS IN PATIENTS WITH OBSTETRIC COMPLICATIONS
	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION
Marti-Vilalta J.	-	MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
Martucci M.	-	THROMBOPROPHYLAXIS IN HIGH-RISK ADOLESCENT INPATIENTS
Maruhn-Debowski B.	-	RISK STRATIFICATION OF RECURRENT VENOUS THROMBOEMBOLISM
Marutsuka K.	-	PLATELET IS AN IMPORTANT FACTOR IN VENOUS THROMBOEMBOLISM: INTERACTION OF VON WILLEBRAND FACTOR AND PLATELET GPIB PROMOTES VENOUS THROMBUS GROWTH
Maruyama I.	-	HIGH-MOBILITY GROUP BOX 1 PROTEIN PROMOTES DEVELOPMENT OF MICROVASCULAR THROMBOSIS IN RATS
	-	HMGB1 PLAYS A CENTRAL ROLE IN ATHEROTHROMBOSIS
Marx G.	-	EXCESS THROMBIN GENERATION IN PATIENTS AFTER ON-PUMP CARDIAC SURGERY
Marx P.F.	-	UNRAVELING THE MECHANISM OF INACTIVATION OF ACTIVATED TAFI
Marx I.	-	A MURINE MODEL TO ASSESS VON WILLEBRAND FACTOR FUNCTION IN VIVO
Marx P.F.	-	NOVEL ROLE FOR TAFI IN THE MODULATION OF HOST RESPONSES BY STREPTOCOCCI?
Marx G.	-	THE VALUE OF ROTEM THROMBOLELASTOMETRY TO DETECT DISTURBED HAEMOSTASIS AND BLEEDING RISK IN ON-PUMP CARDIAC SURGERY
Marx P.F.	-	EFFECT OF GLYCATED TAFI AND PLASMINOGEN ON FIBRINOLYSIS
Maryanoff B.	-	EFFECTS OF JNJ-28045446 ON P2Y12 ADP RECEPTOR FUNCTION IN VITRO AND IN VIVO
März W.	-	ENDOGENOUS THROMBIN POTENTIAL IN 3183 PARTICIPANTS OF THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
	-	LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
Marzec U.M.	-	HIGH SENSITIVITY THROMBOGENIC MARKER DETECTION IN THE INTRALUMINAL BOUNDARY LAYER
	-	PROTEIN C ACTIVATOR (PCA) INTERRUPTION OF THROMBUS PROPAGATION WITHOUT ANTIHEMOSTATIC SIDE EFFECT IN PRIMATES
Marzec U.	-	IN VIVO ANTITHROMBOTIC ACTIVITY OF PROTEIN S (PS) THAT IS INDEPENDENT OF APC
Marzolo M.	-	INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY
Marzot F.	-	THROMBOPHILIA IN PATIENTS WITH CRYPTOGENETIC STROKE AND PATENT FORAMEN OVALE
	-	D-DIMER TESTING AND RECURRENT VENOUS THROMBOEMBOLISM AFTER UNPROVOKED PULMONARY EMBOLISM
	-	LOW-INTENSITY (INR TARGET 1,8) VERSUS STANDARD ANTICOAGULATION FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION: A RANDOMIZED SINGLE CENTRE STUDY IN ELDERLY PATIENTS
Masaun R.	-	VENOUS THROMBOEMBOLISM PROPHYLAXIS IN CRITICALLY-ILL SURGICAL PATIENTS
Mascaretti G.	-	SUCCESSFUL MANAGEMENT OF BLEEDING WITH A PASTEURIZED FVIII/VWF CONCENTRATE IN A WOMAN AFFECTED BY TYPE 2A VON WILLEBRAND DISEASE UNDERGOING UTERINE CERVIX CONIZATION
Masciarelli S.	-	MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES
Masenko V.P.	-	THE INCREASE OF INFLAMMATORY MARKERS IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IS NOT AFFECTED BY GLYCOPROTEIN IIB-IIIA ANTAGONIST EPTIFIBATIDE
Masereel B.	-	THROMBIN ACTIVITY PROFILE: A POWERFUL EX VIVO SCREENING TEST FOR THE DEVELOPMENT OF ANTICOAGULANT DRUGS
Maseri A.	-	EVALUATION OF THE EFFICACY OF DUAL ANTITHROMBOTIC THERAPY WITH TWO MARKERS OF PLATELET ACTIVATION
	-	PLATELET P-SELECTIN IS ASSOCIATED WITH CIRCULATING NEUTROPHIL ACTIVATION AT THE VERY ONSET OF MYOCARDIAL INFARCTION
Masiero L.	-	THROMBOPHILIA AS A PREDICTOR OF RESIDUAL VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
Masin V.	-	MODIFIED PLATELETS FUNCTION ANALYSIS TO RATIONALIZE CHOLESTEROL ELIMINATION PROCEDURE
Maslac A.	-	THE USE OF HAEMOSTASIS TESTS IN THE FOLOW UP OF A PATIENT WITH ANTITHROMBIN DEFICIENCY DURING THE PREGNANCY AND AFTER DELIVERY
	-	PREVALENCE OF THROMBOPHILIA IN WOMEN WITH RECURRENT PREGNANCY LOSS SERBIAN EXPERIENCE
	-	HAEMOPHILIA TREATMENT IN SERBIA FROM 2000 TO 2006 HOW TO REACH ONE UNIT PER CAPITA IN LOW ECONOMIC CAPACITY COUNTRY
Mason K.D.	-	PROGRAMMED ANUCLEAR CELL DEATH DELIMITS PLATELET LIFE SPAN
Mason M.J.	-	A ROLE FOR DENSE GRANULE SECRETION IN POTENTIATION OF STORE-OPERATED CALCIUM ENTRY IN HUMAN PLATELETS
Mason III L.L.	-	THROMBOSPONDIN-1 (TSP1) PROMOTES THROMBIN GENERATION ON THE SURFACE OF FIBROBLASTS (HS-68) AND INDUCES UPREGULATION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE AND PROTEIN EXPRESSION
Masopust J.	-	ASSOCIATION OF VENOUS THROMBOEMBOLISM AND OLANZAPINE
Masotti L.	-	HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) AND THE RISK OF FIRST EVER ISCHEMIC STROKE IN HEALTHY PEOPLE
	-	APPLICABILITY OF D-DIMER IN RULING OUT VENOUS THROMBOEMBOLISM (VTE) IN ELDERLY MEDICAL PATIENTS: COMPARISON BETWEEN IMMUNOTURBIDIMETRIC AND ELISA (ELFA) METHODS
Massarani G.	-	IMMUNO-MAGNETIC ENRICHMENT FOLLOWED BY MULTI-PARAMETER FLOW CYTOMETRY: A NEW APPROACH TO COUNT CIRCULATING ENDOTHELIAL CELLS
Massaro M.	-	THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE (DHA) REDUCES CYCLOOXYGENASE(COX)-2 INDUCTION BY INHIBITING NADP(H) OXIDASE AND PKC: POSSIBLE INVOLVEMENT OF 15-LIPOXIGENASE(LO)-1
	-	THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR(PPAR)GAMMA AGONIST ROSIGLITAZONE (RSG) INHIBITS CYCLOOXYGENASE(COX)-2 EXPRESSION BY SUPPRESSING PKCAPLHA AND CREB ACTIVATION
	-	HOMOCYSTEINE INDUCES VCAM-1 GENE EXPRESSION THROUGH NF-KB AND NAD(P)H OXIDASE ACTIVATION: PROTECTIVE ROLE OF MEDITERRANEAN DIET POLYPHENOLIC ANTIOXIDANTS
	-	HYDROXYTYROSOL, THE MAJOR OLIVE OIL PHENOLIC ANTIOXIDANT, REGULATES EXPRESSION AND ACTIVITY OF MATRIX METALLOPROTEINASE(MMP)-9 IN HUMAN MONOCYTOID CELLS - POSSIBLE CONTRIBUTION TO PLAQUE STABILITY
Massberg S.	-	INCREASED EXPRESSION OF AND ENHANCED PLATELET REACTIVITY TO FRACTALKINE IN TYPE-II DIABETIC ZDF-RATS
	-	PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY
	-	IN VIVO ASSESSMENT OF EXPERIMENTAL MELANOMA METASTASIS BY INTRAVITAL MICROSCOPY REVEALS A CRITICAL ROLE OF PLATELETS AND GLYCOPROTEIN IIB
	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
	-	THE CHEMOKINE FRACTALKINE MEDIATES LEUKOCYTE RECRUITMENT TO INFLAMMATORY ENDOTHELIUM AT ARTERIAL SHEAR RATES IN VIVO AND IN VITRO
Massey G.	-	U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Massicotte M.	-	KNOWLEDGE RETENTION IMPROVES OUTCOMES FOR CHILDREN REQUIRING VITAMIN K ANTAGONISTS
	-	ACCURACY OF THE COAGUCHEK XS FOR POC INR IN CHILDREN REQUIRING WARFARIN
Massicotte P.	-	DOES INCREASING THE STARTING DOSE OF ENOXAPARIN RESULT IN BETTER TREATMENT OF CHILDREN REQUIRING THROMBOPROPHYLAXIS? A RETROSPECTIVE COHORT STUDY
	-	DIFFERENTIAL DOSING OF ENOXAPARIN (ENOX) IN TERM AND PRETERM NEONATES
	-	POST-THROMBOTIC SYNDROME IN CHILDREN SURVIVING ACUTE LYMPHOBLASTIC LEUKEMIA
	-	PHARMACOKINETICS AND DOSE-FINDING OF FRAGMIN IN PEDIATRIC PATIENTS AT RISK FOR THROMBOEMBOLIC EVENTS
Massicotte M.	-	KIDCLOT: KIDS INFORMED DECREASE COMPLICATIONS; LEARNING ON THROMBOSIS-CHILD FOCUSED EDUCATION TO FACILITATE ADHERENCE
	-	POINT OF CARE INR MONITORING IN CHILDREN WITH VENTRICULAR ASSIST DEVICES
Masszi T.	-	HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
Mastrogiacomo O.	-	D-DIMER AS PREDICTIVE FACTOR FOR VENOUS THROMBOEMBOLISM IN CANCER PATIENTS BEFORE CHEMOTHERAPY
Masurat S.	-	PHYSICAL EXAMINATION IN PATIENTS WITH SEVERE HEMOPHILIA UNDER PROPHYLACTIC TREATMENT - EFFICACY OF AN EARLY LONG-TERM PROPHYLAXIS?
Mata R.	-	RISK FACTOR PROFILE ASSOCIATED WITH ICD IN SPANISH POPULATION
Matayoshi T.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Mateo J.	-	WHAT IS THE CLINICAL IMPACT OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) DEFICIENCY?
	-	CONTRIBUTION OF C46T MUTATION IN F12 GENE TO THROMBOTIC RISK IN THROMBOPHILIC FAMILIES WITH FACTOR V LEIDEN MUTATION
	-	CLINICAL MANAGEMENT USING LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) IN PREGNANT WOMEN WITH THROMBOPHILIA, THROMBOEMBOLIC DISEASE (DVT) OR THROMBOPHILIA-RELATED MATERNOPLACENTAL SYNDROME: EXPERIENCE IN ONE CENTER
	-	IGM ANTI PROTEIN S ANTIBODIES AS A RISK FACTOR OF VENOUS THROMBOSIS
	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
	-	MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
Matetzky S.	-	RESPONSIVENESS TO CLOPIDOGREL AND ASPIRIN AMONG PATIENTS WITH ACUTE CORONARY SYNDROME AS ASSESSED BY THE IMPACT-R [CONE AND PLATE(LET) ANALYZER]
	-	CLOPIDOGREL UNRESPONSIVENESS OVERCOME BY RELOADING: ASSESSEMENT BY PLATELET AGGREGOMETRY AND IMPACT-R [CONE AND PLATE(LET) ANALYZER]
Mather T.	-	CRYSTAL STRUCTURE OF THE HPC-4 FAB IN COMPLEX WITH PROTEIN C EPITOPE PEPTIDE
Mathew P.	-	FIRST INTERIM ANALYSIS OF SEVEN BLEEP REGISTRY FOCUSED ON EFFICACY AND SAFETY OF THE TREATMENT WITH RFVIIA IN MASSIVE HAEMORRHAGE IN CHILDREN
Mathews V.	-	POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B
	-	MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
	-	NINE NOVEL MUTATIONS IDENTIFIED IN GLYCOPROTEINS (GP) IB AND IX GENES AMONG 13 UNRELATED PATIENTS WITH BERNARD SOULIER SYNDROME IN INDIA
	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY IN INDIA - A SERIES OF 31 PATIENTS
Mathias G.	-	IMMUNE-TOLERANCE IN HAEMOPHILIA A USING PLASMA-DERIVED FACTOR VIII CONCENTRATE FANHDI
Mathias M.C.	-	PLATELET FUNCTION TESTING IN CHILDREN UNDER 1 YEAR
Mathiesen E.B.	-	MEAN PLATELET VOLUME (MPV) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
	-	FAMILY HISTORY OF MYOCARDIAL INFARCTION (MI) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
Mathijssen N.C.J.	-	TWO NOVEL MUTATIONS AND FOUR NOVEL POLYMORPHISMS IN THE FACTOR VII GENE
	-	IN VIVO AND IN VITRO EFFECTS OF RECOMBINANT ACTIVATED FACTOR VII ON THE PLATELET PROTEOME
Mathonnet F.T.	-	FIBRIN MONOMER BY A QUANTITATIVE ASSAY IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
	-	CUTANEOUS REACTION TO LOW MOLECULAR WEIGHT HEPARIN AND HOMOZYGOUSIS FOR FACTOR V LEIDEN MUTATION DURING PREGNANCY: A CASE REPORT
Maticki M.	-	PROPHYLACTIC APPROACH TO WOMEN WITH THROMBOPHILIA AND REPEATED SPONTANEOUS ABORTIONS
Matijevic N.	-	PLATELET AND MONOCYTE ACTIVATION IN PATIENTS UNDERGOING CIRCULATORY SUPPORT WITH LEFT VENTRICULAR ASSIST DEVICES (LVAD)
Matingou M.	-	IMMUNE TOLERANCE IN AN ADULT AFTER A LONG TERM HISTORY OF I,HIBITOR
Matos R.	-	MASSIVE VENOUS THROMBOEMBOLISM IN A PEDIATRIC PATIENT: A CASE REPORT
	-	SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS
Matsubara Y.	-	GENETIC FACTORS FOR DETERMINATION OF PLASMA VWF LEVELS IN A GENERAL POPULATION
	-	EFFECT OF HUMAN TERT TRANSFECTION ON GENE EXPRESSION PROFILING IN NORMAL HUMAN CORONARY ARTERY ENDOTHELIAL CELLS
	-	ULTRASTRUCTURAL ANALYSIS OF CULTURED MEGAKARYOCYTES GROWN FROM BONE MARROW MONONUCLEAR CELLS OF A NEWLY DIAGNOSED JAPANESE PATIENT WITH GRAY PLATELET SYNDROME
Matsuda J.	-	INCREASED THROMBIN GENERATION CAPACITY IN SEPTIC PATIENTS WITH DIC
	-	INCREASED LEVELS OF D-DIMER IN PATIENTS WITH MYOCARDIAL INFARCTION
	-	CIRCADIAN VARIATIONS IN COAGULATION AND FIBRINOLYTIC FACTORS AMONG FOUR STRAINS OF MICE
Matsuda S.	-	MECHANISMS OF THROMBUS FORMATION DIFFER BETWEEN ATHEROSCLEROTIC AND NORMAL ARTERIES IN HYPERCHOLESTEROLEMIC RABBITS
Matsui H.	-	SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
Matsui K.	-	PLATELET VOLUME IN CORD BLOOD
Matsui T.	-	IMMUNO-PURIFICATION OF PLASMA ADAMTS13 AND ITS PHYSICO-CHEMICAL CHARACTERIZATION
Matsui H.	-	Pharmacokinetics of a mixture of FVIIa and FX in rats
	-	IMMUNE TOLERANCE INDUCTION TO FVIII IN HEMOPHILIA A MICE USING SUBCUTANEOUSLY IMPLANTED FVIII GENE-MODIFIED ENDOTHELIAL PROGENITOR CELLS
Matsumoto S.	-	CLUSTERING OF SURFACE-BOUND BETA2-GLYCOPROTEIN I
Matsumoto Y.	-	AN ULTRA SENSITIVE ASSAY FOR THE QUANTIFICATION OF GPVI SHEDDING IN HUMAN PLASMA
Matsumoto M.	-	IMMUNO-PURIFICATION OF PLASMA ADAMTS13 AND ITS PHYSICO-CHEMICAL CHARACTERIZATION
	-	ANALYSIS OF ADAMTS13 IN PATIENTS WITH COLLAGEN DISEASE-ASSOCIATED TMAS
Matsumoto Y.	-	EVALUATION OF LASER-INDUCED THROMBOLYSIS IN THE RAT THROMBOSIS MODELS: A PULSED GREEN LASER TECHNIQUE
	-	FUNCTIONAL ANALYSIS OF ANTI-GPVI MONOCLONAL ANTIBODIES WITH DISTINCT BINDING SITES
Matsumoto T.	-	ELEVATED D-DIMER LEVELS IN PATIENTS WITH DEEP VEIN THROMBOSIS
Matsumoto S.	-	IDENTIFICATION OF MULTIPLE SPLICE VARIANTS OF PHOSPHOLIPID SCRAMBLASE 1
Matsumoto L.A.	-	THROMBOSIS IN PRETERM INFANTS: A REPORT OF FIVE CASES TREATED WITH HIGH DOSE OF TISSUE PLASMINOGEN ACTIVATOR (R-TPA)
Matsumoto Y.	-	MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
Matsumoto M.	-	ALTERNATION OF VON WILLEBRAND FACTOR AND ADAMTS13 ACTIVITY AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
Matsumoto T.	-	ADAMTS13 RELATED MARKERS IN PLASMA FROM PATIENTS WITH TTP
Matsumoto Y.	-	THE EFFECTS OF BLOCKING P2Y12 RECEPTOR IN ARTEROSCLEROSIS PRODUCED BY MURINE ALLO-TRANSPALANTATION
Matsunaga Y.	-	MOLECULAR AND FUNCTIONAL DIVERSITY OF SNAKE VENOM VEGFS
Matsuno H.	-	2-AG PLAY A ROLE ON ASPIRIN RESISTANCE IN TYPE 2 DIABETES
	-	EFFECT OF SYNTHETIC PEPTIDES DERIVED FROM STAPHYLOKINASE ON THE ACTIVATION OF PLASMINOGEN
Matsuo O.	-	EFFECT OF SYNTHETIC PEPTIDES DERIVED FROM STAPHYLOKINASE ON THE ACTIVATION OF PLASMINOGEN
Matsuo M.	-	NEW LATEX-ENHANCED IMMUNOTURBIDIMETRY ASSAY WITH UNIQUE MONOCLONAL ANTIBODY TO SPECIFIC EPITOPES MEASURES SOLUBLE FIBRIN
Matsuo N.	-	A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS
Matsushita T.	-	FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
	-	DIFFERENTIAL DETECTION OF WILD-TYPE AND MUTANT MYH9 MRNA AND NMMHC-IIA POLYPEPTIDE REVEALS DOMINANT-NEGATIVE EFFECT IN GRANULOCYTES AND HAPLOINSUFFICIENCY IN PLATELETS IN PATIENTS WITH MYH9 DISORDERS
Matsushita H.	-	NEW LATEX-ENHANCED IMMUNOTURBIDIMETRY ASSAY WITH UNIQUE MONOCLONAL ANTIBODY TO SPECIFIC EPITOPES MEASURES SOLUBLE FIBRIN
Matsushita T.	-	MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
	-	IDENTIFICATION OF AMINO ACID RESIDUES RESPONSIBLE FOR VON WILLEBRAND FACTOR BINDING TO SULFATIDES BY CHARGED TO ALANINE SCANNING MUTAGENESIS
	-	THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
	-	PARATOPE AND EPITOPE MAPPING OF THE ANTITHROMBOTIC ANTIBODY 6B4 IN COMPLEX WITH PLATELET GLYCOPROTEIN IBALPHA
Matsuura E.	-	CLUSTERING OF SURFACE-BOUND BETA2-GLYCOPROTEIN I
	-	REDUCTION OF DIABETES-RELATED LIPID OXIDATIVE STRESS BY STATIN THERAPY AS MONITORED BY SERUM OXIDIZED LDL/B2GPI COMPLEX LEVELS
	-	ASSOCIATION OF IGG ANTI-OXLDL/B2GPI AND B2GPI-DEPENDENT ANTI-CARDIOLIPIN (ACL) ANTIBODIES WITH VASCULAR THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS)
	-	ARE ANTIPHOSPHOLIPID ANTIBODIES RISK FACTORS FOR CORONARY ARTERY DISEASE?
Matsuyama T.	-	ANALYSIS OF ADAMTS13 IN PATIENTS WITH COLLAGEN DISEASE-ASSOCIATED TMAS
Matsuzawa A.	-	BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF KDN-7438, A NOVEL SYNTHETIC TISSUE FACTOR/FACTOR VIIA INHIBITOR
Mattarozzi S.	-	DIFFERENT CUT-OFF VALUES OF THREE D-DIMER (DD) TESTS TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER A VENOUS THROMBOEMBOLISM (VTE)
	-	HIGHER FIBRIN MONOMERS (FM) LEVELS AFTER ORAL ANTICOAGULATION (OAT) WITHDRAWAL ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
	-	INNOVANCE D-DIMER ASSAY TO ASSESS THE INDIVIDUAL RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE AFTER ANTICOAGULATION (OAT) WITHDRAWAL
	-	EFFECTS OF AGE AND DIFFERENT CUT-OFF VALUES ON USE OF D-DIMER (DD) TESTING TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER VENOUS THROMBOEMBOLISM (VTE)
Matte D.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Mattei J.	-	HIGH DOSES OF RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A HEMOPHILIA A PATIENT WITH INHIBITOR
Matthiessen H.P.	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
Mattiello T.	-	EVIDENCE OF ASPIRIN EXCRETION FROM PLATELET BY MRP4 TRANSPORT RESPONSIBLE FOR REDUCED DRUG ACTIVITY IN PATIENTS AT 5 DAYS CABS
Mattson J.C.	-	ARGATROBAN DOSE REQUIREMENTS IN INTENSIVE CARE UNIT PATIENTS
	-	AN EVALUATION OF AN ARGATROBAN DOSE TITRATION NOMOGRAM
Mattsson C.	-	CHARACTERISATION OF THE ACTIVE FORM OF THE NOVEL ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN COAGULATION ASSAYS
Matus V.	-	TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
	-	PLASMA PROCPU (TAFI) AND CLOT LYSIS TIME ARE CORRELATED WITH CLOTTING FACTOR LEVELS AND THROMBIN GENERATION: A NOVEL APPROACH TO ASSESS THROMBOSIS RISK?
	-	INDUCTION OF TISSUE FACTOR ACTIVITY IN STIMULATED PLATELETS
	-	PLASMA LEVELS OF CLOTTING FACTORS ARE POSITIVELY CORRELATED IN HEALTHY POPULATION: A COMPREHENSIVE PERSPECTIVE TO ASSESS THROMBOTIC RISK?
Matysiak M.	-	HAEMOTHORAX IN A BOY WITH SEVERE HAEMOPHILIA AND FACTOR VIII INHIBITOR
	-	CLINICAL EXPERIENCE WITH A HIGH PURITY FACTOR IX CONCENTRATE IN YOUNG CHILDREN
	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
Matyskova M.	-	ACQUIRED FACTOR VIII INHIBITOR: REPORT FROM THE REGIONAL HAEMOPHILIA CENTRE
	-	EFFECT OF THE FIRST DOSE SIZE OF RECOMBINANT FACTOR VIIa ON TREATMENT EFFICACY OF FREQUENT JOINT BLEEDS IN PATIENT WITH HAEMOPHILIA A AND INHIBITOR
Matyugicheva U.	-	PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
Maugeri N.	-	DIFFERENTIAL ANALYSIS BY 2-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS (2D-DIGE) OF HUMAN PLATELET PROTEINS RELEASED FOLLOWING THROMBIN ACTIVATION: IDENTIFICATION OF LAMIN A, A NOVEL PLATELET PROTEIN
	-	PLATELET P-SELECTIN IS ASSOCIATED WITH CIRCULATING NEUTROPHIL ACTIVATION AT THE VERY ONSET OF MYOCARDIAL INFARCTION
Maurelli M.	-	EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
Maurer M.C.	-	ROLE OF INDIVIDUAL AMINO ACID POSITIONS IN THE BINDING AND HYDROLYSIS OF GLUTAMINE-CONTAINING SUBSTRATES TO FACTOR XIIIA
Maurer G.	-	CORONARY INSTENT RESTENOSIS OF DRUG-ELUTING STENTS IS ASSOCIATED WITH SERUM LEVELS OF MMP-9
Maurer-Spurej E.	-	ANOMALOUS BEHAVIOR OF PLATELETS IN RESPONSE TO TEMPERATURE
Maurice P.	-	TYPE III COLLAGEN BINDING PROTEIN (TIIICBP) IS IDENTICAL TO KINDLIN-3, A PROTEIN BELONGING TO A NOVEL FAMILY OF FOCAL ADHESION PROTEINS
Maurissen L.	-	PROTEIN S-C4BP COMPLEX STIMULATES ACTIVATED PROTEIN C-MEDIATED INACTIVATION AT R306 BUT INHIBITS INACTIVATION AT R506 IN FACTOR VA
Maurone D.	-	A SUCCESSFUL IMMUNOMODULATION-ITI RESCUE IN SEVERE HAEMOPHILIA A WITH HIGH RESPONDER INHIBITOR
Mavri A.	-	QUALITY OF ANTICOAGULANT MANAGEMENT: A 4-YEAR ANALYSIS OF TREATMENT AND COMPLICATIONS IN ANTICOAGULATION SERVICE IN LJUBLJANA
Mavrikiou M.	-	LONGITUDINAL COURSE AND CLINICAL SIGNIFICANCE OF TGF-B1, SL- AND SE-SELECTINS AND SICAM-1 LEVELS DURING SEVERE ACUTE STRESS IN CHILDREN
Max J.P.	-	AGE-DEPENDENT INCREASED ARTERIAL STIFFNESS IS ASSOCIATED WITH COMPOSITE CHANGES IN PRO- AND ANTI-COAGULANT REACTIONS IN SUBCLINICAL ATHEROSCLEROSIS
	-	PLATELET ACTIVATION REINFORCES THE PROCOAGULANT PHENOTYPE INDUCED BY MURINE MONOCLONAL ANTI-PHOSPHOLIPID ANTIBODIES
	-	INFLUENCE OF PHOSPHOLIPID SURFACE AND CONCENTRATION IN THROMBOGRAPHY
May F.	-	RAC1 IS AN EFFECTOR OF THE GPVI SIGNALING CASCADE IN PLATELETS
May J.A.	-	MEASUREMENT OF ENDOTHELIAL MICROPARTICLES IN BLOOD IS IMPAIRED IF CHYLOMICRONS ARE PRESENT AFTER A FATTY MEAL
	-	EFFECTS OF A FLAVANOL-RICH COCOA BEVERAGE ON PLATELET AND LEUCOCYTE FUNCTION IN MAN
	-	HETEROCLITIN D, A COMPONENT OF PLANTS OF THE KADSURA SPECIES INHIBITS PAF-INDUCED PLATELET AGGREGATION, P-SELECTIN EXPRESSION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
Mayer G.	-	DESIGN AND IN VITRO CHARACTERIZATION OF A PHOTODYNAMIC ANTICOAGULANT
Mayer J.	-	ACQUIRED FACTOR VIII INHIBITOR: REPORT FROM THE REGIONAL HAEMOPHILIA CENTRE
Mayer S.A.	-	LATE BREAKING CLINICAL TRIAL: RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE III STUDY TO ASSESS RFVIIA EFFICACY IN ACUTE INTRACEREBRAL HEMORRHAGE: THE FAST TRIAL
Mayer B.	-	ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY
Mayet J.	-	CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Mayne E.S.	-	A STUDY OF THE UTILITY OF THROMBOELASTOGRAPHY IN THE MONITORING OF ASPIRIN THERAPY
Mayr F.B.	-	EFFECTS OF LOW DOSE ENDOTOXEMIA ON ENDOTHELIAL PROGENITOR CELLS IN HUMANS
	-	ETHNIC DIFFERENCES IN A HUMAN MODEL OF TISSUE FACTOR- TRIGGERED COAGULATION
	-	EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT LOW DOSE ENDOTOXEMIA ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS
	-	THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
Mayumi T.	-	THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Mazaev A.A.	-	THE INCREASE OF INFLAMMATORY MARKERS IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IS NOT AFFECTED BY GLYCOPROTEIN IIB-IIIA ANTAGONIST EPTIFIBATIDE
Mazet M.	-	ASSESSMENT OF A METHOD BASED ON LUMINESCENCE DETECTION FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Mazet B.	-	PULMONARY EMBOLISM DIAGNOSTIC TOOLS IN FRENCH EMERGENCY DEPARTMENTS: AVAILABILITY INCREASES BUT PHYSICIAN KNOWLEDGE REMAINS POOR
Mazharian A.	-	PAR4 INDUCES FULL PLATELET SPREADING ON A FIBRINOGEN MATRIX: INVOLVEMENT OF ERK2 AND P38 AND CA2+ MOBILIZATION
	-	INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION
Mazurier C.	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
	-	IDENTIFICATION AND EXPRESSION OF R763G MUTATION ABOLISHING THE CLEAVAGE OF VON WILLEBRAND FACTOR PROPEPTIDE, AT THE HETEROZYGOUS AND HOMOZYGOUS STATE
	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
Mazurov A.V.	-	THE INCREASE OF INFLAMMATORY MARKERS IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IS NOT AFFECTED BY GLYCOPROTEIN IIB-IIIA ANTAGONIST EPTIFIBATIDE
	-	VARIATIONS OF PLATELET GLYCOPROTEIN IIB-IIIA QUANTITY AFFECTS PLATELET AGGREGATION AND SENSITIVITY TO GLYCOPROTEIN IIB-IIIA ANTAGONISTS
Mazzanti B.	-	ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
Mazzara R.	-	ENDOTHELIAL DYSFUNCTION IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Mazzolari M.	-	EVALUATION OF A NEW INR PORTABLE MONITOR
Mazzucato M.	-	ALTERED BINDING OF PURIFIED TYPE 2M VICENZA VON WILLEBRAND FACTOR TO PLATELET RECEPTOR ALPHAIIBBETA3 AND GPIB-V-IX COMPLEX
	-	SPATIO-TEMPORAL CALCIUM SIGNALING ELICITED BY INTEGRIN ALPHA2-BETA1 AND GLICOPROTEIN VI UNDER FLOW
Mazzucconi M.	-	PHARMACOKINETICS OF THE REFORMULATED B-DOMAIN DELETED RECOMBINANT FACTOR VIII (BDD-RFVIII) CONCENTRATE USING CHROMOGENIC AND ONE-STAGE ASSAYS WITH POOLED NORMAL PLASMA (PNP) AND REFACTO LABORATORY STANDARD (RLS)
Mazzucconi M.G.	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
McBride E.R.	-	USE OF A CLINICAL ALGORITHM IN THE DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA
McCabe C.H.	-	TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
McCarty O.J.T.	-	FACTOR XI MEDIATES PLATELET LAMELLIPODIA FORMATION AND TETHERING AND ROLLING UNDER SHEAR CONDITIONS
McCarty O.T.J.	-	PROTEIN C ACTIVATOR (PCA) INTERRUPTION OF THROMBUS PROPAGATION WITHOUT ANTIHEMOSTATIC SIDE EFFECT IN PRIMATES
McCarty O.J.T.	-	THE LEECH PRODUCT SARATIN IS A POTENT INHIBITOR OF PLATELET INTEGRIN ALPHA2BETA1 AND VWF BINDING TO COLLAGEN
	-	GLYCOPROTEIN Ib MEDIATES PLATELET RECRUITMENT, ACTIVATION AND AGGREGATION ON IMMOBILIZED PROTEIN C AND ACTIVATED PROTEIN C UNDER SHEAR
	-	THE THROMBIN MUTANT W215A/E217A ACTS AS A PLATELET ANTAGONIST THROUGH INHIBITION OF THROMBIN ACTIVATION AND GPIB BINDING TO VWF
McCauley T.	-	PHARMACOKINETIC PROFILES AND PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIP OF A VWF INHIBITORY APTAMER IN THE CYNOMOLGUS MONKEY
	-	PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
McClintock R.A.	-	BIOMECHANICAL PROPERTIES OF VON WILLEBRAND FACTOR BINDING TO PLATELET GLYCOPROTEIN IB RECAPITULATED BY THE DIMERIC A1 DOMAIN
McClintock R.	-	GLYCOPROTEIN IB ALPHA BINDS THROMBIN VIA TO BOTH EXOSITE I AND II OF THROMBIN
McColl M.D.	-	PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
McConville D.	-	HEPARIN EYE DROPS ARE EFFECTIVE AS LONG TERM THERAPY FOR LIGNEOUS CONJUNCTIVITIS
McCormick J.C.	-	Prospective Evaluation of a Quantitative D-dimer for Pulmonary Embolism: is Structured Pretest Probability Assessment Always Needed?
McCourt P.A.G.	-	ROLE OF LIVER SINUSOIDAL ENDOTHELIAL CELLS IN ELIMINATION OF HEPARIN
McCraken F.	-	RECOMBINANT ACTIVATED FACTOR VII VS. ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE AS ON-DEMAND TREATMENT OF JOINT BLEEDS IN HEMOPHILIACS WITH INHIBITORS: A SYSTEMATIC LITERATURE REVIEW
McCubbin T.R.	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
McCusker P.	-	DIFFERENTIAL DOSING OF ENOXAPARIN (ENOX) IN TERM AND PRETERM NEONATES
McDermott-Roe C.	-	RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) EXPRESSED ON HEK293 CELLS BINDS OXIDIZED LOW DENSITY LIPOPROTEINS (OXLDL)
McDonald A.G.	-	RESTORING INITIAL THROMBIN GENERATION DOES NOT NORMALIZE CUTANEOUS WOUND HEALING IN HEMOPHILIA B
	-	TISSUE FACTOR AROUND DERMAL VESSELS HAS BOUND FACTOR VII IN THE ABSENCE OF INJURY
	-	LOW INTENSITY LASER THERAPY SPEEDS WOUND HEALING IN HEMOPHILIA B MICE
Mcewan P.	-	MOLECULAR MODEL OF THE PREKALLEKREIN STRUCTURE
McEwen N.	-	COMPARISON OF THE ASSERACHROM VON WILLEBRAND FACTOR ANTIGEN ASSAY AND THE LIATEST VWF ASSAY AUTOMATED ON THE AMAX 200 COAGULATION ANALYZER IN HUMAN AND CANINE PLASMA SAMPLES
McGahan L.	-	ECONOMIC EVALUATION OF POINT-OF-CARE MONITORING DEVICES FOR LONG-TERM ORAL ANTICOAGULATION THERAPY
McGarrigle S.A.	-	HOMOCYSTEINE AND ITS THIOLACTONE DERIVATIVE ACTIVATE THE PLATELET INTEGRIN ALPHA IIB BETA 3
McGeehan E.	-	DIFFERENTIAL EFFECTS OF FXA INHIBITORS AND HEPARINS IN SIMULATED ARTERIAL AND VENOUS THROMBOSIS
	-	RELATIVE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARINS IN HUMAN AND FELINE BLOOD PLASMA. POTENTIAL THERAPEUTIC IMPLICATIONS
	-	THE PHARMACOKINETICS OF DEFIBROTIDE IN NON-HUMAN PRIMATES IS DOSE DEPENDENT
McGlade J.	-	A GADS-INDEPENDENT PATHWAY OF PLCGAMMA2 REGULATION DOWNSTREAM OF THE COLLAGEN RECEPTOR, GPVI
McGlasson D.L.	-	COMPARISON OF SINGLE AND SEVEN-DAY ASPIRIN PLATELET RESPONSE REVEALS DOSAGE EFFECT AT 81 AND 325 MG
	-	COMPARISON OF TWO ANTI-XA ASSAYS USING A SINGLE CALIBRATION CURVE FOR MONITORING HEPARIN ANTICOAGULATION
McGrath J.	-	COMPARISON OF THE ASSERACHROM VON WILLEBRAND FACTOR ANTIGEN ASSAY AND THE LIATEST VWF ASSAY AUTOMATED ON THE AMAX 200 COAGULATION ANALYZER IN HUMAN AND CANINE PLASMA SAMPLES
McGregor J.	-	ACUTE EFFECT OF STATINS ON THE REGULATION AND EXPRESSION OF CANDIDATE GENES (CD36, MMP-9 AND IL-8) IN ATHEROSCLEROSIS IN HIV-INFECTED PATIENTS
McGregor J.L.	-	CD36 AND SRA GENE EXPRESSION IN HUMAN CAROTID ENDARTERECTOMY LESIONS
McGregor J.	-	RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) EXPRESSED ON HEK293 CELLS BINDS OXIDIZED LOW DENSITY LIPOPROTEINS (OXLDL)
McGuire J.M.	-	STRATEGIES FOR CHARACTERIZING THE PHOSPHO- AND GLYCOPROTEOMES OF MICROPARTICLES DERIVED FROM INTERLEUKIN-1BETA STIMULATED PANCREATIC BETA-CELLS
Mckay I.	-	PLATELET ACTIVATION INCREASES WITH THE SEVERITY OF PERIPHERAL ARTERIAL DISEASE: IMPLICATIONS FOR CLINICAL MANAGEMENT
McKenzie S.C.	-	AN ASSESSMENT OF THE EFFECTIVENESS OF INFERIOR VENA CAVA FILTERS IN PREVENTION OF PULMONARY EMBOLISM BASED UPON DEMONSTRATION OF TRAPPED EMBOLUS AT THE TIME OF FILTER RETRIEVAL
	-	AN AUSTRALIAN EXPERIENCE OF RETRIEVABLE INFERIOR VENA CAVA FILTERS IN PATIENTS WITH INCREASED RISK OF THROMBOEMBOLIC DISEASE
McKenzie L.	-	HFE GENE MUTATIONS DO NOT SHOW ASSOCIATIONS WITH HEMOPHILIC ARTHROPATHY
McKinnon T.A.J.	-	N-LINKED GLYCOSYLATION OF VWF MODULATES THE INTERACTION WITH ADAMTS13
McLane M.A.	-	DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
McLean L.	-	THE ASSOCIATION OF DEPRESSION WITH PLATELET ACTIVATION: EVIDENCE FOR A TREATMENT EFFECT
McMahon A.D.	-	PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
McMahon G.	-	TRANSIENT REVERSAL OF THE ANTI-PLATELET EFFECT OF ASPIRIN AFTER ADMINISTRATION OF UNFRACTIONATED HEPARIN IN HEALTHY SUBJECTS
McManus A.	-	VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
McManus C.	-	NGR; A NOVEL FIBRINOGEN ADHESION MOTIF ENHANCING PLATELET ACTIVATION
McMullen B.	-	GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
McNamara H.	-	INHERITED THROMBOPHILIA AND PREECLAMPSIA WITHIN A COHORT OF 5337 WOMEN: RESULTS OF THE MONTREAL PREECLAMPSIA STUDY
McNamee R.A.	-	PLATELET DENSE GRANULE SECRETION ACCELERATES THE DEVELOPMENT OF ARTERIOSCLEROSIS AFTER VASCULAR INJURY
McNeil J.	-	THE HAEMOSTASIS REGISTRY AUSTRALIAN AND NEW ZEALAND EXPERIENCE WITH RFVIIA
McNulty O.	-	RECURRENCE OF THE FACTOR VIII GENE R531H MUTATION IN 13 IRISH FAMILIES: EVIDENCE FOR A FOUNDER EFFECT
	-	THE USE OF THE WARKENTIN ET AL 4T CLINICAL SCORING SYSTEM TO DETERMINE PROSPECTIVELY THE APPROPRIATENESS OF HIT ANTIBODY TESTING AT THE REGIONAL HAEMOSTASIS LABORATORY, BELFAST CITY HOSPITAL, N IRELAND
McRae S.J.	-	EVALUATION OF A PRE-TEST CLINICAL SCORE FOR THE DIAGNOSIS OF HIT
McVey J.H.	-	NEOINTIMAL CELLS IN WIRE-INJURED ARTERIES HAVE A MIXED ENDOTHELIAL CELL (EC)/VASCULAR SMOOTH MUSCLE CELL (VSMC) PHENOTYPE WHICH IS THROMBIN-DEPENDENT
	-	THROMBIN PROMOTES ANOMALOUS DIFFERENTIATION OF VASCULAR PROGENITOR CELLS DURING NEOINTIMAL HYPERPLASIA AFTER WIRE-INDUCED INJURY
	-	NK CELL AND MACROPHAGE INFILTRATION INTO ORGAN XENOGRAFTS IS DEPENDENT ON THROMBIN-MEDIATED PRODUCTION OF MONOCYTE CHEMOTACTIC PROTEIN-1(MCP-1) THROUGH PAR-1
	-	HEPATIC TARGETING OF ADENOVIRUS MEDIATED BY COAGULATION FACTOR X
Meade G.	-	MOLECULAR AND CELLULAR DYNAMICS OF MOESIN IN VASCULAR CELLS VIA MECHANO-TRANSDUCTION
	-	A NOVEL ROLE FOR CADHERIN 6 IN PLATELET FUNCTION
	-	A NOVEL GPIB ALPHA BINDING PROTEIN ON STREPTOCOCCUS GORDONII INDUCES PLATELET ROLLING AT LOW SHEAR
Meade M.	-	DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY
Meade G.	-	CONFORMATION-SPECIFIC BLOCKADE OF THE INTEGRIN GPIIB/IIIA): IN VITRO AND IN VIVO RESULTS DEMONSTRATING A SELECTIVE PLATELET BLOCKADE WITH LESS ADVERSE EFFECTS
	-	STAPHYLOCOCCUS AUREUS FIBRONECTIN BINDING PROTEINS DO NOT PLAY A ROLE IN THROMBUS FORMATION
	-	THE MECHANO-REGULATION OF LASP-1 IN THE PATHOGENESIS OF CARDIOVASCULAR DISEASE
Mechmeche R.	-	ASSOCIATION OF HYPERHOMOCYSTEINEMIA WITH RESTENOSIS
Meckley L.M.	-	THE RELATIVE EFFECTS OF VKORC1 AND CYP2C9 VARIANTS ON CLINICAL OUTCOMES IN WARFARIN PATIENTS
Medcalf R.L.	-	FIBRINOLYSIS, INFLAMMATION, AND REGULATION OF THE PLASMINOGEN ACTIVATING SYSTEM
	-	DESMOTEPLASE-MEDIATED PLASMINOGEN ACTIVATION AND CLOT LYSIS ARE ANTAGONIZED BY THE LYSINE ANALOGUE TRANEXAMIC ACID
Medina M.	-	SEVERE GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIA IN A PATIENT WITH GLANZMANN THROMBASTHENIA
Medina P.	-	PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION
Medina M.	-	MASSIVE VENOUS THROMBOEMBOLISM IN A PEDIATRIC PATIENT: A CASE REPORT
Medina P.	-	FUNCTIONAL ANALYSIS OF SNPS SPECIFIC FOR HAPLOTYPE 1 (H1) OF THE GENE CODING FOR THE ENDOTHELIAL PROTEIN C RECEPTOR (EPCR)
	-	INCREASED GENERATION OF ACTIVATED PROTEIN C ASSOCIATED WITH OBESITY. WEIGHT LOSS INFLUENCE
	-	ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION
Medved L.	-	DIRECT EVIDENCE OF SPECIFIC INTERACTIONS OF FIBRINOGEN ALPHA C REGIONS WITH THE CENTRAL E REGION AND WITH EACH OTHER
	-	IDENTIFICATION OF A NOVEL ENDOTHELIAL CELL RECEPTOR FOR FIBRIN
Medvedeff G.	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
Meeks S.L.	-	FUNCTIONAL CHARACTERIZATION OF STRUCTURAL EPITOPES IN THE C2 DOMAIN OF FACTOR VIII
Meems H.	-	LYSINE RESIDUES 2065 AND 2092 OF THE FACTOR VIII C1 DOMAIN CONTRIBUTE TO BINDING LRP AND LDL RECEPTOR, BUT ARE NOT INVOLVED IN BINDING FACTOR IXA
	-	THE FACTOR VIII C1 DOMAIN CONTRIBUTES TO EFFICIENT LRP/LDL RECEPTOR BINDING
Mefleh R.	-	CHARACTERISATION OF THE MOLECULAR GENETIC DEFECTS UNDERLYING GLANZMANN'S THROMBASTHENIA IN JORDANIAN FAMILIES
Megarbane A.	-	DETECTION OF 23 NOVEL MUTATIONS IN LEBANESE HEMOPHILIA PATIENTS
Megens R.T.A.	-	VISUALIZATION OF THROMBUS FORMATION ON ACUTELY RUPTURED PLAQUES IN VIVO
Mehran R.	-	MAJOR BLEEDING IN ACUTE CORONARY SYNDROME PATIENTS IS ASSOCIATED WITH A MAKED PRO-INFLAMMATORY RESPONSE: RESULTS FROM THE ACUITY INFLAMMATORY BIOMARKER SUB-STUDY
Mehta H.	-	PLATELET DENSE GRANULE SECRETION ACCELERATES THE DEVELOPMENT OF ARTERIOSCLEROSIS AFTER VASCULAR INJURY
Mehta S.R.	-	MORTALITY BENEFIT OF FONDAPARINUX VERSUS ENOXAPARIN IN DIABETIC PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES (NSTE-ACS): A SUBANALYSIS OF OASIS-5
	-	FONDAPARINUX IS SAFER THAN ENOXAPARIN IN ELDERLY PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES: A SUBANALYSIS OF OASIS-5
	-	FONDAPARINUX REDUCED MAJOR BLEEDING VERSUS ENOXAPARIN IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING EARLY INVASIVE MANAGEMENT EVEN IN THE CONTEXT OF TRANS-RADIAL CORONARY INTERVENTION: INSIGHTS FROM OASIS-5
	-	BENEFIT OF FONDAPARINUX IN THE LONG-TERM PREVENTION OF ISCHEMIC EVENTS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES IN THE OASIS-5 TRIAL
	-	IMPACT OF RENAL FUNCTION ON THE BENEFIT-RISK RATIO OF FONDAPARINUX IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES IN THE OASIS-5 TRIAL
	-	BENEFIT-RISK RATIO OF FONDAPARINUX IN DIABETIC PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION (STEMI): A SUBANALYSIS OF OASIS-6
	-	EARLY SAFETY BENEFIT OF FONDAPARINUX VERSUS ENOXAPARIN IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES: A SECONDARY ANALYSIS OF THE OASIS-5 TRIAL
Mehta Z.	-	LOW LEVELS OF PROTEIN Z ARE ASSOCIATED WITH AN INCREASED RISK OF RECURRENT VASCULAR EVENTS: A POPULATION-BASED STUDY
Mehus M.	-	NT-PROBNP, AND NOT TF, FM, PAPP-A, MPO OR CD40 LIGAND, PREDICTS RECURRENT TROPONIN-T POSITIVE CARDIAC EVENTS FOLLOWING AN ACUTE MYOCARDIAL INFARCTION
Mei B.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
	-	PEGYLATION PROTECTS FACTOR VIII FROM THE INHIBITION OF ANTIBODY INHIBITORS
	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
Meijer P.	-	EXTERNAL QUALITY CONTROL FOR THE COAGUCHEK INR MEASUREMENT IMPORTANT TO CONTROL TEST STRIP QUALITY: EVIDENCE FOR LIMITED PROPORTIONAL DIFFERENCES
	-	A NATIONAL FIELD STUDY OF QUALITY ASSESSMENT (QA) OF COAGUCHEK MONITORS
Meijer A.B.	-	LYSINE RESIDUES 2065 AND 2092 OF THE FACTOR VIII C1 DOMAIN CONTRIBUTE TO BINDING LRP AND LDL RECEPTOR, BUT ARE NOT INVOLVED IN BINDING FACTOR IXA
Meijer P.	-	LIPIDS, MICROPARTICLES AND COAGULATION FACTORS AS DETERMINANTS OF LAG PHASE AND RATE OF THROMBIN GENERATION IN PLASMA
	-	QUALITY ASSESSMENT OF COAGUCHEK MONITORS: COMPARATIVE ANALYSIS OF THE ECAA AND CONVENTIONAL EXTERNAL QA
	-	INTER-LABORATORY VARIATION AND THE EFFECT OF THE TYPE OF FLUORIMETER ON THE RESULTS OF THE TECHNOTHROMBIN THROMBIN GENERATION ASSAY
	-	QUANTIFICATION OF THE MEASUREMENT UNCERTAINTY FOR D-DIMER ASSAY RESULTS AROUND THE CUT-OFF LEVEL: IMPROVED DECISION RULES REQUIRED?
	-	THE THROMBIN GENERATION TEST NEEDS TO BE SUPPLEMENTED WITH ADDITIONAL TESTS TO FULLY DOCUMENT THE EFFECTS OF THROMBIN INHIBITORS: EVALUATION FOR MELAGATRAN
Meijer A.B.	-	THE FACTOR VIII C1 DOMAIN CONTRIBUTES TO EFFICIENT LRP/LDL RECEPTOR BINDING
Meijer P.	-	PERFORMANCE OF BETHESDA ASSAY AND NIJMEGEN VARIANT IN EXTERNAL QUALITY ASSESSMENT (ECAT) OF FACTOR VIII INHIBITOR ASSAYS
	-	RECOMBINANT HUMAN PLASMIN PRODUCED IN LEMNA MINOR
Meijers J.C.M.	-	NOVEL ROLE FOR TAFI IN THE MODULATION OF HOST RESPONSES BY STREPTOCOCCI?
	-	DETERMINANTS OF THE ENDOGENOUS THROMBIN POTENTIAL IN A DUTCH THROMBOPHILIC FAMILY
	-	EFFECT OF GLYCATED TAFI AND PLASMINOGEN ON FIBRINOLYSIS
	-	FLUID LOSS, COAGULATION ACTIVATION AND AIR TRAVEL
	-	UNRAVELING THE MECHANISM OF INACTIVATION OF ACTIVATED TAFI
Meiring M.	-	CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS
Meiring M.S.	-	IDENTIFICATION OF TYPE 2M VON WILLEBRAND DISEASE BY DENSITOMETRIC ANALYSIS OF VON WILLEBRAND FACTOR MULTIMER PATTERNS
Meiring M.	-	THE HUMANIZED ANTI-GPIB MONOCLONAL ANTIBODY 6B4-FAB ABOLISHES THROMBUS FORMATION IN A MODIFIED FOLTS' MODEL IN BABOONS
Meiring M.S.	-	CHARACTERISATION OF AN INHIBITORY ANTIBODY FRAGMENT TO HUMAN TISSUE FACTOR
Meiring S.M.	-	A NOVEL COMPLETE HIGH SHEAR RATE ARTERIAL THROMBOSIS AND BLEEDING MODEL IN BABOONS
Meiring M.S.	-	PERFORMANCE AND UTILITY OF A COST-EFFECTIVE COLLAGEN BINDING ASSAY USING TYPE III COLLAGEN
Meissner A.	-	A PROSPECTIVE EFFICACY AND SAFETY STUDY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED FACTOR VIII ADMINISTERED BY CONTINUOUS INTRAVENOUS INFUSION IN SEVERE HAEMOPHILIA A PATIENTS UNDERGOING MAJOR SURGICAL PROCEDURES (PERFACT STUDY)
Meixner S.C.	-	PROTEOLYTIC CONVERSION OF CLOTTING FACTOR XA INTO A FIBRINOLYSIS ACCELERATOR
Mejia-Carvajal C.	-	THE IMPACT OF JOINT BLEEDING AND SYNOVITIS ON PHYSICAL ABILITY AND JOINT FUNCTION
Melchor J.	-	FIBRIN DEPOSITION ACCELERATES NEUROVASCULAR DAMAGE AND NEUROINFLAMMATION IN MOUSE MODELS OF ALZHEIMER'S DISEASE
Meley R.	-	INR STANDARDIZATION: FRENCH EXPERIENCE OF AN EXTERNAL QUALITY ASSESSMENT PROGRAM
Melgar M.	-	EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT
Melikian C.N.	-	POINT-OF-CARE ASSESSMENT OF PERI-OPERATIVE PLATELET FUNCTION USING THROMBOELASTOGRAPH PLATELET MAPPING
Melinte I.A.	-	FACTOR XI MEDIATES PLATELET LAMELLIPODIA FORMATION AND TETHERING AND ROLLING UNDER SHEAR CONDITIONS
Melnikova G.N.	-	ANTITHROMBIN III IN COMPARISON WITH FRESH FROZEN PLASMA IN THE TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION ACCOMPANIED BY ANTITHROMBIN III DEFICIENCY
Meloni A.	-	INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
Melot C.	-	USEFULNESS OF PERFUSION LUNG SCAN COMBINED WITH CLINICAL ASSESSMENT TO RULE OUT PULMONARY EMBOLISM
	-	IS D-DIMER TESTING COST-EFFECTIVE IN ELDERLY PATIENTS CLINICALLY SUSPECTED OF DEEP VEIN THROMBOSIS?
Melton III L.J.	-	IMPACT OF VENOUS THROMBOEMBOLISM, VENOUS STASIS SYNDROME, VENOUS OUTFLOW OBSTRUCTION AND VENOUS VALVULAR INCOMPETENCE ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING: A POPULATION-BASED CASE-CONTROL STUDY
	-	RISK FACTORS FOR VENOUS THROMBOEMBOLISM (VTE) AMONG ACTIVE CANCER PATIENTS: A POPULATION-BASED CASE-CONTROL STUDY
Meltzer M.E.	-	SYNERGISTIC EFFECTS OF HYPOFIBRINOLYSIS AND GENETIC AND ACQUIRED RISK FACTORS IN VENOUS THROMBOSIS
	-	HYPOFIBRINOLYSIS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MEN
Meluzinova I.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Membre A.	-	AGE-DEPENDENT INCREASED ARTERIAL STIFFNESS IS ASSOCIATED WITH COMPOSITE CHANGES IN PRO- AND ANTI-COAGULANT REACTIONS IN SUBCLINICAL ATHEROSCLEROSIS
	-	PLATELET ACTIVATION REINFORCES THE PROCOAGULANT PHENOTYPE INDUCED BY MURINE MONOCLONAL ANTI-PHOSPHOLIPID ANTIBODIES
	-	INFLUENCE OF PHOSPHOLIPID SURFACE AND CONCENTRATION IN THROMBOGRAPHY
Menard J.	-	ORAL OR VAGINAL ADMINISTRATION OF ETHINYL ESTRADIOL HAS A SIMILAR IMPACT ON LIVER PROTEINS AND COAGULATION MARKERS: RESULTS OF A RANDOMIZED, CROSS-OVER STUDY
Mencarelli S.	-	BETA-N-ACETYLHEXOSAMINIDASE (BETA-HEX), A PLATELET LYSOSOMAL ENZYME, POTENTIATES THROMBIN-INDUCED PLATELET ACTIVATION BY ACTING ON GPV
Menchen L.	-	CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES
Menchini U.	-	VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
Mendez T.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Mendieta C.	-	MODIFIED CRP ENHANCES PLATELET ADHESION AND THROMBUS GROWTH ON COLLAGEN
Mendolicchio L.	-	EVALUATION OF THE EFFICACY OF DUAL ANTITHROMBOTIC THERAPY WITH TWO MARKERS OF PLATELET ACTIVATION
	-	PROTEOLYSIS-INDEPENDENT ENHANCEMENT OF ARTERIAL THROMBOSIS MEDIATED BY THROMBIN BINDING TO GLYCOPROTEIN IB AND VON WILLEBRAND FACTOR
Mendoza G.	-	BISBUDIAME, AN ESTROGEN DERIVATIVE WITH AN ANTITHROMBOTIC EFFECT
Menegatti M.	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
	-	KINETICS STUDIES OF A NATURALLY OCCURRING MUTATION ON FACTOR X (FX) GENE (G222D)
Mengozzi G.	-	ANTIPHOSPHOLIPID ANTIBODY TESTING IN PIEMONTE AND VALLE D'AOSTA: A MULTILABORATORY EXTERNAL QUALITY ASSURANCE (EQA) PROGRAM
Meo A.	-	THE HYPERCOAGULABILITY AND VASCULAR ENDOTHELIUM ABNORMAL CYTOKINES' RELEASE MAY INFLUENCE THE PROGRESSION OF THE OSTEOPATHY IN HOMOZYGOUS B-THALASSEMIA PATIENTS
Meral A.	-	LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE
Mercier E.	-	ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
Mercier B.	-	VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY
Mercier E.	-	THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
Merhi F.	-	THIOSULFINATES MODULATE PLATELET ACTIVATION AND MONOCYTE FUNCTION BY REACTION WITH SURFACE FREE SULFHYDRYLS AND INTERNAL THIOL-CONTAINING PROTEINS
Merli G.	-	RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD?
Merlino P.G.	-	INHIBITION OF PLATELET FUNCTION BY THE ANTI-VON WILLEBRAND FACTOR APTAMER, ARC1779
	-	DISCOVERY AND CHARACTERIZATION OF A POTENT NEUTRALIZING ANTI-VWF A1 DOMAIN SPECIFIC APTAMER
Merlino P.	-	PHARMACOKINETIC PROFILES AND PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIP OF A VWF INHIBITORY APTAMER IN THE CYNOMOLGUS MONKEY
Meroni P.	-	EFFECTS OF A TOLL-LIKE RECEPTOR ANTAGONIST AND ANTI-ANNEXIN A2 ANTIBODIES ON BINDING AND ACTIVATION OF DECIDUAL CELLS BY ANTIBETA2GLYCOPROTEIN I ANTIBODIES
Meroni P.L.	-	DETECTION OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES: THE INFLUENCE OF DIFFERENT ANTIGEN PREPARATIONS
Meroni P.	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
Merricks E.	-	RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD
	-	EFFECT OF RFVIIA AND NN1731 (RFVIIA ANALOGUE) ON THROMBOELASTOGRAPHY (TEG) IN WHOLE BLOOD OBTAINED FROM HAEMOPHILIA A DOGS
	-	PHARMACOKINETICS (PK) OF RVWF IN DOGS AND MICE WITH SEVERE VWD
Mertens K.	-	THE FACTOR VIII C1 DOMAIN CONTRIBUTES TO EFFICIENT LRP/LDL RECEPTOR BINDING
	-	THE MARBURG-1 MUTATION REDUCES THE AUTOCATALYTIC ACTIVITY OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP)
	-	CORRELATION BETWEEN THE POTENCY OF A BETA2-GLYCOPROTEIN I DEPENDENT LUPUS ANTICOAGULANT AND THE LEVEL OF RESISTANCE TO ACTIVATED PROTEIN C
	-	LYSINE RESIDUES 2065 AND 2092 OF THE FACTOR VIII C1 DOMAIN CONTRIBUTE TO BINDING LRP AND LDL RECEPTOR, BUT ARE NOT INVOLVED IN BINDING FACTOR IXA
Merz M.	-	ARGATROBAN IN PATIENTS AFTER CARDIOVASCULAR SURGERY: INFLUENCE ON A THROMBIN GENERATION ASSAY
Meschengieser S.S.	-	FACTOR XIII DEFICIENCY: SYMPTOMS, DIAGNOSIS AND LONG-TERM REPLACEMENT THERAPY
	-	LOW MOLECULAR THIOLS, PRO-COAGULANT STATE AND NATURAL ANTIOXIDANT SYSTEM IN HEMODIALYSIS PATIENTS
	-	HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
	-	D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
	-	ANTITHROMBIN (AT): A CONFORMATIONAL VARIANT?
	-	THROMBOPHILIA TESTING IN A DEVELOPING COUNTRY REFERRAL CENTER: A 3-YEAR OBSERVATIONAL STUDY
	-	BIOLOGICAL AND CLINICAL RESPONSE TO DESMOPRESSIN IN CHILDREN WITH VON WILLEBRAND DISEASE
	-	POISONING WITH SUPERWARFARIN
	-	MANAGEMENT OF SERIOUS HEMATOMAS IN PATIENTS ON CHRONIC ORAL ANTICOAGULATION: BALANCE BETWEEN IMMEDIATE AND LONG-TERM RISKS
	-	DIAGNOSIS AND FOLLOW UP OF FACTOR XIII DEFICIENCY: COMPARISON OF DIFFERENT CLOT-SOLUBILITY TESTS
	-	COMPARISON BETWEEN CONVENTIONAL AND AUTOMATED METHODS OF RISTOCETIN COFACTOR ACTIVITY AND VON WILLEBRAND FACTOR ANTIGEN
Meshkani R.	-	THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Mesli M.N.	-	SEVERE HYPOFIBRINOGENEMIA ASSOCIATED WITH MIDDLE CEREBRAL ARTERIAL THROMBOSIS
Mespouille L.	-	EVALUATION OF THE BEHAVIOR OF (QUATERNIZED) POLY[(2-DIMETHYLAMINO)ETHYL METHACRYLATE] AND (CROSSLINKED) N-CARBOXYETHYLCHITOSAN AND THEIR COMPLEXES IN CONTACT WITH BLOOD
Mesquita B.	-	ROLE OF PLATELET GLYCOPROTEIN IB-ALPHA POLYMORPHISM IN PLATELET REACTIVITY
Messadek J.	-	BETAINE (TRIMETHYLGLYCINE), A NOVEL ORAL ANTICOAGULANT WITH COMBINED NITRIC OXIDE AND TISSUE FACTOR PATHWAY INHIBITOR RELEASE POTENTIAL. IMPLICATIONS IN THE MANAGEMENT OF VASCULAR DISEASES
	-	SHORT TERM BETAINE ADMINISTRATION IN PATIENTS WITH COLLAGEN VASCULAR DISEASE-MEDIATED SEVERE PULMONARY ARTERIAL HYPERTENSION
Messmore H.L.	-	DEFIBROTIDE AND ITS MOLECULAR FRACTIONS DO NOT CROSS-REACT WITH HIT ANTIBODIES. IMPLICATIONS IN THE MANAGEMENT OF HIT
Messmore H.	-	POTENTIAL OF THE FACTOR XA INHIBITOR RIVAROXABAN FOR THE ANTICOAGULATION MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
Messmore H.L.	-	UPREGULATION OF MICROPARTICLES IN HEPARIN INDUCED THROMBOCYTOPENIA (HIT) AND IT'S MODULATION BY ARGATROBAN
Mesters R.M.	-	CIRCULATING ANGIOPOIETIN-2 IS A STRONG PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA
Meta A.	-	HIGH-YIELD PRODUCTION AND CHARACTERIZATION OF RECOMBINANT APROTININ IN SACCHAROMYCES CEREVISIAE
Metcalf D.	-	PROGRAMMED ANUCLEAR CELL DEATH DELIMITS PLATELET LIFE SPAN
Metzler H.	-	EFFECTS OF FIBRINOGEN LEVELS AND CLOT STRENGTH IN THE PRESENCE OF THROMBOCYTOPENIA
Metzner H.J.	-	CHARACTERIZATION OF COMMERCIALLY AVAILABLE VWF-CONTAINING FVIII CONCENTRATES BY VWF MULTIMER ANALYSIS
Meunier S.	-	CONTRIBUTION OF GENETIC ANALYSIS FOR DIAGNOSIS OF VON WILLEBRAND DISEASE TYPE 2B
Meurs I.	-	EFFECT OF SR-BI DEFICIENCY ON PLATELET AGGREGATION AND SUSCEPTIBILITY TO THROMBOSIS
Mewhort-Buist T.	-	CHEMOTHERAPY AFFECTS ACTIVATED PROTEIN C GENERATION TO A GREATER DEGREE IN NEWBORN THAN IN ADULT PLASMA
Meye A.	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Meyer S.C.	-	A ROLE OF THE ADAMTS13 GENE IN ACUTE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Meyer G.	-	MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL
Meyer D.	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Meyer G.	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) AND CANCER SURVIVAL. A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS IN PATIENTS WITH AND WITHOUT VTE
	-	PULMONARY EMBOLISM DIAGNOSTIC TOOLS IN FRENCH EMERGENCY DEPARTMENTS: AVAILABILITY INCREASES BUT PHYSICIAN KNOWLEDGE REMAINS POOR
	-	RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD?
Meyer D.	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
Meyer T.	-	THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Meyer G.	-	RISK FACTORS AND CLINICAL SIGNIFICANCE OF RESIDUAL PERFUSION DEFECTS AFTER SYMPTOMATIC PULMONARY EMBOLISM
	-	LONG-TERM PROGNOSIS OF PULMONARY EMBOLISM
Meyer T.V.	-	PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Meyer G.	-	A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY)
Meyer D.	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
Meyer Dos Santos S.	-	FRACTALKINE RECEPTOR CX3CR1 EXPRESSION IN PLATELETS FROM PATIENTS WITH CARDIOVASCULAR DISEASE
Mezzano D.	-	INDUCTION OF TISSUE FACTOR ACTIVITY IN STIMULATED PLATELETS
	-	PLASMA PROCPU (TAFI) AND CLOT LYSIS TIME ARE CORRELATED WITH CLOTTING FACTOR LEVELS AND THROMBIN GENERATION: A NOVEL APPROACH TO ASSESS THROMBOSIS RISK?
	-	TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
	-	TISSUE FACTOR-DEPENDENT COAGULANT ACTIVITY OF PLATELET-MONOCYTE COMPLEXES IN CHRONIC RENAL FAILURE (CRF). ASSOCIATION WITH HEMOSTATIC ACTIVITY, INFLAMMATION, OXIDATIVE DAMAGE AND ENDOTHELIAL DYSFUNCTION
	-	PLASMA LEVELS OF CLOTTING FACTORS ARE POSITIVELY CORRELATED IN HEALTHY POPULATION: A COMPREHENSIVE PERSPECTIVE TO ASSESS THROMBOTIC RISK?
Mezzasoma A.	-	LABORATORY DIAGNOSIS AND MONITORING OF DDAVP TREATMENT OF VON WILLEBRAND DISEASE BY FLOW CYTOMETRY
	-	A NEW CASE OF ACQUIRED GLANZMANN'S THROMBASTHENIA: COMPARATIVE EVALUATION OF THE DIAGNOSTIC VALUE OF DIFFERENT PLATELET FUNCTION TESTS
	-	PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENT A NORMAL ENDOTHELIAL FUNCTION
Miao H.	-	ANTI-OXIDANTS IMPROVE FACTOR VIII FOLDING AND SECRETION AND REDUCE CELL TOXICITY AND INFLAMMATION IN VIVO IN MICE
Miao C.H.	-	ANTI-ICOS IMMUNOTHERAPY PREVENTED INHIBITORY ANTIBODY FORMATION AGAINST FACTOR VIII FOLLOWING NONVIRAL GENE TRANSFER IN HEMOPHILIA A MICE
Miao H.Z.	-	EFFICIENT SECRETION OF BIOENGINEERED COAGULATION FACTOR VIII INTO THE MILK OF TRANSGENIC ANIMALS
	-	ANTI-OXIDANTS IMPROVE FACTOR VIII FOLDING AND SECRETION AND REDUCE CELL TOXICITY AND INFLAMMATION IN VIVO IN MICE
Michaels L.	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: THROMBOPHILIA SCREENING IN CHILDREN
Michalski C.	-	ANALYZE OF THE CO-PURIFIED PROTEINS WITH A HIGHLY PURIFIED PLASMA-DERIVED FACTOR VIII: FVIII-SD-35-15
Michalsky C.	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
Michel J.	-	INCREASED PLASMA MARKERS OF PLATELET AND PROTHROMBIN ACTIVATION IN PATIENTS WITH THORACIC ASCENDING AORTIC ANEURYSM
Michelson A.D.	-	CYSTIC FIBROSIS HETEROZYGOTES DO NOT HAVE INCREASED PLATELET ACTIVATION
	-	TARGETED INHIBITION OF THE SEROTONIN 5-HT2A RECEPTOR ATTENUATES RECURRENT PLATELET-MEDIATED THROMBOSIS IN AN IN VIVO MODEL MIMICKING UNSTABLE ANGINA
Michelucci A.	-	CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
Michielsen P.	-	THE AUTOMATED ENDOGENOUS THROMBIN POTENTIAL (ETP) TEST TO REFLECT COAGULATION CHANGES IN PATIENTS WITH CIRRHOSIS OF THE LIVER
Micic D.	-	RISK FACTORS FOR THROMBOSIS IN CHILDREN
Micò C.	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
Middeldorp S.	-	HYPERHOMOCYSTEINEMIA IS NOT A RISK FACTOR FOR VENOUS AND ARTERIAL THROMBOSIS, BUT AN EPIPHENOMENON: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY
	-	THROMBOPHILIC RISK FACTORS FOR FIRST VENOUS THROMBOEMBOLISM, RECURRENCE AND ITS IMPLICATIONS: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
	-	JAK2-V617F IS A RISK FACTOR FOR VENOUS THROMBOEMBOLISM
	-	DETERMINANTS OF THE ENDOGENOUS THROMBIN POTENTIAL IN A DUTCH THROMBOPHILIC FAMILY
	-	THROMBOPHILIA AND PREGNANCY COMPLICATIONS: CAUSE OR ASSOCIATION?
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY
	-	NECESSITY OF SCREENING FOR THROMBOPHILIA AT DIAGNOSIS OF VENOUS THROMBOEMBOLISM: OUTLINE OF THE NOSTRADAMUS INTERVENTION TRIAL
	-	THE ABSOLUTE RISK OF VENOUS THROMBOSIS AFTER AIR TRAVEL: EFFECT OF RISK FACTORS AND BEHAVIOUR DURING FLIGHTS
	-	DOES THE PRESENCE OF MULTIPLE INHERITED THROMBOPHILIC DEFECTS EXPLAIN THE INCREASED RISK OF ARTERIAL THROMBOTIC EVENTS IN PATIENTS WITH PRIOR VENOUS THROMBOEMBOLISM?
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY
	-	INFLUENCE OF TESTING FOR INHERITED THROMBOPHILIA ON RECURRENCE OF VENOUS THROMBOEMBOLISM
	-	AIR TRAVEL AND VENOUS THROMBOSIS: A SYSTEMATIC REVIEW
Middleton S.M.	-	DESIGN OF A PLATELET SUBSTITUTE UTILISING HOST FIBRINOGEN TO ENHANCE HAEMOSTASIS
Miesbach W.	-	THE TYPE OF MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME IN RELATION TO THE AGE OF THE PATIENTS
	-	RAPID INCREASE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HAEMOPHILIA AND CHRONIC HCV- INFECTION
Mietner S.	-	ANALYSIS OF THE INTERACTOME IN HUMAN PLATELETS
Migliacci R.	-	PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENT A NORMAL ENDOTHELIAL FUNCTION
Migliaresi P.	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Migliorini A.	-	LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
Mihailov D.	-	HEMOSTATIC EXPRESSION OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN
Mihaly J.	-	UROKINASE (UPA) INDUCES ENDOTHELIAL CELL SURVIVAL VIA THE X-LINKED INHIBITOR OF APOPTOSIS PROTEIN (XIAP)
Mikhailenko I.	-	IDENTIFICATION OF A NOVEL ENDOTHELIAL CELL RECEPTOR FOR FIBRIN
Mikheeva J.A.	-	INFLUENCE OF CYP2C9 GENETIC POLYMORPHISMS ON METABOLIC CLEARANCE, WARFARIN MAINTENANCE DOSE AND BLEEDING COMPLICATIONS IN RUSSIAN PATIENTS
Mikita J.	-	COULD HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS BE A RARE MANIFESTATION OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME?
Mikovic D.	-	THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION
	-	THE USE OF HAEMOSTASIS TESTS IN THE FOLOW UP OF A PATIENT WITH ANTITHROMBIN DEFICIENCY DURING THE PREGNANCY AND AFTER DELIVERY
Mikovic Z.	-	THE USE OF HAEMOSTASIS TESTS IN THE FOLOW UP OF A PATIENT WITH ANTITHROMBIN DEFICIENCY DURING THE PREGNANCY AND AFTER DELIVERY
Mikovic D.	-	PREVALENCE OF THROMBOPHILIA IN WOMEN WITH RECURRENT PREGNANCY LOSS SERBIAN EXPERIENCE
	-	INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
	-	HAEMOPHILIA TREATMENT IN SERBIA FROM 2000 TO 2006 HOW TO REACH ONE UNIT PER CAPITA IN LOW ECONOMIC CAPACITY COUNTRY
Mikulenkova D.	-	Detection of nonmuscle myosin-IIA, inclusions in neutrophils, D-variant of fibulin-1 and mutations within MYH9 gene in patients with MYH9-ralated disorders
Mikulska M.	-	BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
Milan R.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Milani M.	-	D-DIMER AS PREDICTIVE FACTOR FOR VENOUS THROMBOEMBOLISM IN CANCER PATIENTS BEFORE CHEMOTHERAPY
Mildh L.	-	FRESH FROZEN PLASMA DOES NOT ATTENUATE COAGULATION ACTIVATION AFTER NEONATAL CARDIOPULMONARY BYPASS
Milewicz D.M.	-	DYSREGULATION OF ALTERNATIVE SPLICING OF COAGULATION FACTOR V RESULTS IN BLEEDING DISORDER, EAST TEXAS TYPE (OMIM 605913)
Miljic P.S.	-	MOLECULAR MARKERS OF BLOOD HYPERCOAGULABILITY IN HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN MUTATION
Miljic P.	-	PROCARBOXYPEPTIDASE U (TAFI) PLASMA LEVELS IN PATIENTS WITH HEREDITARY THROMBOPHILIA
	-	THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION
Millanvoye-Van Brussel E.	-	THE THROMBIN ENDOTHELIAL RECEPTORS, THROMBOMODULIN AND PAR-1, ACTIVATE EGF RECEPTOR THROUGH DISTINCT SIGNALLING
Millar C.M.	-	CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME PRESENTING WITH ISOLATED ANTI-BETA2 GLYCOPROTEIN I ANTIBODY POSITIVITY
Miller T.N.	-	FACTOR XIA RESIDUES TYR143, GLU98, AND LYS192 ARE IMPORTANT FOR SUBSTRATE FACTOR IX (FIX) AND S-2366 CATALYSIS
Miller D.D.	-	THE PLAQUE LIPID LYSOPHOSPHATIDIC ACID STIMULATES PLATELETS NOT THROUGH THE LPA1, LPA2 AND LPA3 RECEPTOR
Miller C.H.	-	LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
	-	QUALITY OF LIFE (QOL) EVALUATION IN WOMEN WITH MENORRHAGIA AND ABNORMAL HEMOSTASIS TESTING PARTICIPATING IN A CROSS-OVER STUDY OF INTRANASAL DESMOPRESSIN AND ORAL TRANEXAMIC ACID
	-	THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY
Miller C.M.	-	SMOOTH MUSCLE-DERIVED TISSUE FACTOR IS CRITICAL FOR ARTERIAL THROMBOSIS AFTER FECL3 INJURY
Miller C.H.	-	ASSESSMENT OF PLATELET FUNCTION IN NORMAL ADULTS: RISTOCETIN-INDUCED PLATELET AGGREGATION (RIPA)
Miller J.L.	-	RISTOCETIN-INDUCED AGGREGATION OF HUMAN GPIBALPHA TRANSGENIC MICE IS INHIBITED BY ANTI-HUMAN GPIBALPHA ANTIBODIES IN THE PRESENCE OF HUMAN PLASMA
Miller C.H.	-	U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Miller J.L.	-	FUNCTIONAL ELISA OF VON WILLEBRAND FACTOR (VWF) ACTIVITY USING HIS-TAGGED INCREASE-OF-FUNCTION RECOMBINANT GPIB BOUND TO NICKEL CHELATE PLATES
Miller J.D.	-	REVERSAL OF HYPERCHOLESTEROLEMIA PROTECTS AGAINST ARTERIAL THROMBOSIS IN ATHEROSCLEROTIC MICE
Millet L.	-	SYNTHESIS AND PROPERTIES OF BIOTINYLATED ANTITHROMBOTIC OLIGOSACCHARIDES
	-	IN VITRO AND EX VIVO PROPERTIES OF LONG-ACTING REVERSIBLE OLIGOSACCHARIDES
	-	REVERSIBLE BIOTINYLATED OLIGOSACCHARIDES: A NEW APPROACH FOR A BETTER MANAGEMENT OF THE ANTICOAGULANT THERAPY
	-	ANTITHROMBOTIC ACTIVITIES IN PHARMACOLOGICAL MODELS OF A LONG-ACTING REVERSIBLE SYNTHETIC OLIGOSACCHARIDE
Milne A.	-	AUDIT OF SCREENING FOR VON WILLEBRANDS DISEASE AND PLATELET FUNCTION ABNORMALITIES USING THE PFA-100
Milne A.E.	-	EFFECT OF VITAMIN K FOR WARFARIN REVERSAL ON ELEMENTS OF THE TISSUE FACTOR PATHWAY
Milne A.	-	THE EFFECT OF THE SUGARBAKER PROCEDURE ON HAEMOSTASIS
Milner M.	-	ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
Milos M.	-	ACL TOP PERFORMANCE IN ROUTINE COAGULATION TESTING
	-	SENSITIVITY OF THE PLATELET FUNCTION ANALYZER (PFA-100) AS A SCREENING TEST FOR LABORATORY DIAGNOSIS OF VON WILLEBRAND DISEASE
Milosevic Jovcic N.M.	-	EFFEKT OF PARAPROTEINS ON PLATELET AGGREGATION
Mimuro J.	-	SILENCING OF A TARGETED PROTEIN IN IN VIVO PLATELETS USING A LENTIVIRAL VECTOR DELIVERING SHORT HAIRPIN RNA SEQUENCE
	-	INDUCTION OF FACTOR VIII SPECIFIC UNRESPONSIVENESS BY INTRATHYMIC FACTOR VIII INJECTION IN MURINE HEMOPHILIA A
Miñano A.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
	-	IN VIVO EFFECTS OF HYPERTHERMIA ON THE FUNCTIONAL AND CONFORMATIONAL CHARACTERISTICS OF ANTITHROMBIN
	-	BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS
	-	HEPARIN PROTECTS THE NATIVE CONFORMATION OF ANTITHROMBIN
	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Mingot M.E.	-	ACQUIRED HEMOPHILIA IN AN HIV PATIENT
	-	NON-CATHETER SUPERIOR CAVA VEIN THROMBOSIS IN A PATIENT WITH HEMOPHILIA B AND HIGH TITRE INHIBITOR
	-	IMPACT OF FVIII PRODUCT CHANGE IN SEVERE HAEMOPHILIA A PATIENTS PREVIOUSLY TREATED WITH PLASMA-DERIVED FVIII
Mingozzi F.	-	PROTEASE-ACTIVATED RECEPTOR 2 (PAR-2) A NOVEL TARGET TO PREVENT FIX INHIBITOR FORMATION
Minoldo S.	-	ANTICOAGULATION IN A PATIENT WITH SEVERE PREECLAMPSIA, POSITIVE ANTIBETA2-GLYCOPROTEIN I ANTIBODIES AND HOMOZIGOSITY FOR PAI-1 AND MTHFR
	-	PAI-1 GENE 4G/5G GENOTYPE AS AN ADDITIONAL RISK FACTOR IN PATIENTS WITH THROMBOSIS: A RETROSPECTIVE COHORT STUDY
Minucci D.	-	THE MANAGEMENT OF HIGH RISK PREGNANT PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME
Minullina I.	-	GENERATION AND CHARACTERIZATION OF A RECOMBINANT BLOCKING ANTI-GLYCOPROTEIN VI SINGLE CHAIN ANTIBODY FRAGMENT
	-	COORDINATED ACTION OF GPVI AND FCRGAMMA CYTOPLASMIC DOMAINS IN SIGNALLING
Miquet M.	-	DOES TRANEXAMIC ACID DECREASE ERYTHROCYTE TRANSFUSION IN PATIENTS UNDERGOING HIP FRACTURE SURGERY WITH FONDAPARINUX FOR PREVENTION OF VENOUS THROMBOEMBOLISM ?
Mir M.	-	CORONARY ARTERY BYPASS GRAFTING (CABG) IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA (ITP)
Mira Y.	-	ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION
	-	PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION
Miranda M.	-	SEVERE GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIA IN A PATIENT WITH GLANZMANN THROMBASTHENIA
Miranda A.L.P.	-	NEW THIENYLACYLHYDRAZONE DERIVATIVES AS CYCLIC NUCLEOTIDES MODULATORS AND PLATELET AGGREGATION INHIBITORS
Mirella F.	-	THE NATURAL HISTORY OF D-DIMER LEVELS IN SUBJECTS WITH NEGATIVE D-DIMER AFTER SUSPENSION OF ORAL ANTICOAGULATION FOR A FIRST EPISODE OF VENOUS THROMBOEMBOLISM: THE PROSPECTIVE OBSERVATIONAL PROLONG II STUDY
Mirkhani F.	-	FACTOR XI DEFICIENCY: THREE NOVEL MUTATIONS IN IRANIAN PATIENTS
Miron M.	-	PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP
Mirshahi S.	-	UP-REGULATION OF ACTIVATED PROTEIN-C RECEPTOR ON HUMAN ENDOTHELIAL CELLS BY ALDOSTERONE
Mirshahi M.	-	UP-REGULATION OF ACTIVATED PROTEIN-C RECEPTOR ON HUMAN ENDOTHELIAL CELLS BY ALDOSTERONE
Mirshahi S.S.	-	HUMAN MALIGNANT CELLS EXPRESS FUNCTIONALLY ACTIVE ENDOTHELIAL PROTEIN C RECEPTOR
Mirshahi M.	-	HUMAN MALIGNANT CELLS EXPRESS FUNCTIONALLY ACTIVE ENDOTHELIAL PROTEIN C RECEPTOR
Mirshahi S.S.	-	CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY
Mirshahi P.	-	CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY
	-	PLASMA ANGIOGENIC ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS
Mirshahi M.	-	PLASMA ANGIOGENIC ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS
Mirshahi S.	-	BASAL EXPRESSION OF ENDOTHELIAL CELL PROTEIN C RECEPTOR IS REGULATED BY ENDOGENOUS ALDOSTERONE, PRODUCED VIA ALDOSTERONE SYNTHASE
Mirshahi M.	-	BASAL EXPRESSION OF ENDOTHELIAL CELL PROTEIN C RECEPTOR IS REGULATED BY ENDOGENOUS ALDOSTERONE, PRODUCED VIA ALDOSTERONE SYNTHASE
Misenheimer T.M.	-	THE HEPARIN-BINDING EXOSITE IS CRITICAL TO ALLOSTERIC ACTIVATION OF FACTOR IXA IN THE INTRINSIC TENASE COMPLEX:
Miserus R.J.	-	MOLECULAR IMAGING OF THROMBI USING A BIMODAL A2-ANTIPLASMIN-BASED CONTRAST AGENT
Mishal Z.	-	CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY
Mishima K.	-	CLEC-2, A NOVEL PLATELET ACTIVATION RECEPTOR, IS INVOLVED IN PODOPLANIN-MEDIATED PLATELET ACTIVATION BY CANCER CELLS
Mishra M.N.	-	Common thrombophilias in 85 Indian patients with arterial thrombosis
Mismetti P.	-	RETRIEVABLE VENA CAVA FILTERS FOR SECONDARY PREVENTION OF PULMONARY EMBOLISM IN ORTHOPAEDIC SURGERY
	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) AND CANCER SURVIVAL. A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS IN PATIENTS WITH AND WITHOUT VTE
	-	IN VITRO EFFECTS OF LEPIRUDINE, DANAPAROID AND FONDAPARINUX ON THROMBIN GENERATION IN HIT PLASMAS
	-	THROMBOPROPHYLAXIS IN ACUTELLY ILL MEDICAL PATIENTS: WHO, WHEN AND HOW
	-	DOES TRANEXAMIC ACID DECREASE ERYTHROCYTE TRANSFUSION IN PATIENTS UNDERGOING HIP FRACTURE SURGERY WITH FONDAPARINUX FOR PREVENTION OF VENOUS THROMBOEMBOLISM ?
	-	RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD?
	-	LATE BREAKING CLINICAL TRIAL: ANTICOAGULANT CLINICS-BASED SHARED-CARE VERSUS GENERAL PRACTITIONERS MANAGEMENT OF ORAL ANTICOAGULANTS: A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY
	-	ENOXAPARIN 40 MG VERSUS NADROPARIN 0.3 ML IN THE PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) IN COLORECTAL CANCER SURGERY ACCORDING TO AGE AND CREATININE CLEARANCE (CRCL)
Misselwitz F.	-	LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING
	-	PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF RIVAROXABAN: A COMPARISON OF ONCE- AND TWICE-DAILY DOSING IN PATIENTS UNDERGOING TOTAL HIP REPLACEMENT (THR)
	-	POTENTIAL OF THE FACTOR XA INHIBITOR RIVAROXABAN FOR THE ANTICOAGULATION MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
Missere M.	-	THROMBOCYTOPENIA AND CONGENITAL RADIAL DYSPLASIA: A CONTINUUM SPECTRUM OF DISEASES. CASE REPORT
Mister R.	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
Mistrik M.	-	BLEEDING AND THROMBOTIC MANIFESTATION IN 58 PATIENTS WITH CONGENITAL DYSFIBRINOGENEMIA
	-	TORPID CLINICAL COURSE OF THROMBOTIC THROMBOCYTOPENIC PURPURA
Mitchell M.	-	PROTEOMIC ANALYSIS OF PLASMA FROM HAEMOPHILIA A PATIENTS AFTER FACTOR VIII CONCENTRATE INFUSION
Mitchell L.	-	DOES INCREASING THE STARTING DOSE OF ENOXAPARIN RESULT IN BETTER TREATMENT OF CHILDREN REQUIRING THROMBOPROPHYLAXIS? A RETROSPECTIVE COHORT STUDY
Mitchell S.J.	-	URINARY EXCRETION OF VITAMIN K METABOLITES IN TERM AND PRETERM INFANTS
Mitchell S.	-	HEPARIN EYE DROPS ARE EFFECTIVE AS LONG TERM THERAPY FOR LIGNEOUS CONJUNCTIVITIS
Mitchell L.G.	-	RISK FACTORS AND OUTCOME OF THROMBOEMBOLIC EVENTS IN CHILDREN UNDERGOING CARDIAC SURGERY
Mitchell V.	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
Mitchell M.J.	-	THE FIRST CAUSATIVE MUTATION OF HAEMOPHILIA A IDENTIFIED IN THE PROMOTER REGION OF THE FACTOR VIII GENE (F8)
Mitchell M.	-	THE SIGNIFICANCE OF BREAKPOINT DELINEATION IN LARGE DELETIONS IN THE F8 GENE
Mitchell L.G.	-	FIBRINOLYTIC CAPACITY OF CORD PLASMA COMPARED TO ADULT OVER VARIOUS CONCENTRATIONS OF TPA
	-	POST-THROMBOTIC SYNDROME IN CHILDREN SURVIVING ACUTE LYMPHOBLASTIC LEUKEMIA
	-	PHARMACOKINETICS AND DOSE-FINDING OF FRAGMIN IN PEDIATRIC PATIENTS AT RISK FOR THROMBOEMBOLIC EVENTS
Mitchell A.M.	-	DECLINING RATE OF VENOUS THROMBOEMBOLISM IN PATIENTS EVALUATED FOR PULMONARY EMBOLISM IN TWO UNITED STATES EMERGENCY DEPARTMENTS AND LOW RATE OF EMPIRIC ANTICOAGULATION
	-	TANDEM MEASUREMENT OF D DIMER AND MYELOPEROXIDASE DECREASES UNNECESSARY PULMONARY VASCULAR IMAGING IN EMERGENCY DEPARTMENT PATIENTS EVALUATED FOR PULMONARY EMBOLISM
	-	EVALUATION OF 50 POTENTIAL MARKERS OF PULMONARY EMBOLISM FOR USE IN THE EMERGENCY DEPARTMENT
Mitchell L.	-	POINT OF CARE INR MONITORING IN CHILDREN WITH VENTRICULAR ASSIST DEVICES
Miteva M.M.	-	DISCOVERY OF COMPOUNDS THAT INHIBIT FACTOR VA-MEMBRANE INTERACTION BY IN SILICO SCREENING
Mitic G.	-	PROPHYLACTIC APPROACH TO WOMEN WITH THROMBOPHILIA AND REPEATED SPONTANEOUS ABORTIONS
Mitsiakos G.	-	HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
Mitsuya H.	-	ACTIVATED PROTEIN C INCREASES TISSUE FACTOR EXPRESSION ON HUMAN UMBILICAL ENDOTHELIAL CELL BY EPCR-DEPENDENT BUT PAR-1-INDEPENDENT MANNER
Mitterer A.	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
Miura M.	-	BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF KDN-7438, A NOVEL SYNTHETIC TISSUE FACTOR/FACTOR VIIA INHIBITOR
Miyata S.	-	THE DISTAL CARBOXYL-TERMINAL DOMAINS OF ADAMTS13 ARE REQUIRED IN VIVO FOR EFFICIENT CLEAVAGE OF VON WILLEBRAND FACTOR UNDER PROTHROMBOTIC CONDITIONS
Miyata T.	-	THE DISTAL CARBOXYL-TERMINAL DOMAINS OF ADAMTS13 ARE REQUIRED IN VIVO FOR EFFICIENT CLEAVAGE OF VON WILLEBRAND FACTOR UNDER PROTHROMBOTIC CONDITIONS
	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
	-	AGE- AND GENDER-RELATED DIFFERENCES OF PLASMA PROTHROMBIN ACTIVITY LEVELS
	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
	-	THE GENETIC ANALYSIS OF DEEP VEIN THROMBOSIS DURING PREGNANCY AND PERINATAL ASSOCIATED DISORDERS IN JAPANESE
	-	ACTIVITIES AND POLYMORPHISMS OF ADAMTS13 IN THE JAPANESE GENERAL POPULATION
Miyazaki K.	-	LOCALIZATION AND EXPRESSION OF MYOSIN VI IN HUMAN HAEMATOPOIETIC CELLS INCLUDING PLATELETS
Miyazaki H.	-	Pharmacokinetics of a mixture of FVIIa and FX in rats
Miyazaki O.	-	NEW LATEX-ENHANCED IMMUNOTURBIDIMETRY ASSAY WITH UNIQUE MONOCLONAL ANTIBODY TO SPECIFIC EPITOPES MEASURES SOLUBLE FIBRIN
Miyazawa Y.	-	INCREASED LEVELS OF D-DIMER IN PATIENTS WITH MYOCARDIAL INFARCTION
	-	INCREASED THROMBIN GENERATION CAPACITY IN SEPTIC PATIENTS WITH DIC
Mize G.J.	-	FUNCTIONAL CHARACTERIZATION OF PROLINE-RICH GLA PROTEINS (PRGPS) 1 AND 2
Mladenov M.	-	FUNCTIONAL COAGULATION ANALYSIS IN PATIENTS WITH BLOOD COAGULATION DISORDERS OR HYPERCOAGULABILITY: SIGNIFICANCE OF WHOLE BLOOD ROTATION THROMBELASTOGRAPHY IN COMPARISON WITH CONVENTIONAL BLOOD COAGULATION ANALYSIS
Moafi A.	-	EVALUATION FOR HYPERCOAGULOPATHY IN THALASSEMIA MAJOR PATIENTS IN ISFAHAN
Moake J.	-	SHEAR-INDUCED DISULFIDE BOND FORMATION REGULATES ADHESION ACTIVITY OF VON WILLEBRAND FACTOR
	-	STRUCTURAL AND THERMODYNAMIC EFFECTS OF TYPE 2M AND TYPE 2B VWD MUTATIONS IN THE A1 DOMAIN OF VWF
Moatti D.	-	INHIBITORY ACTIVITY OF TISSUE FACTOR PATHWAY INHIBITOR BETA EXPRESSED BY E COLI AND EXPRESSION IN NORMAL HUMAN TISSUE
Mobarrez F.	-	PREANALYTICAL CONDITIONS INFLUENCING FLOW CYTOMETRIC DETERMINATION OF PLATELET-DERIVED MICROPARTICLES (PDMP)
	-	INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION
Modaresi A.	-	PATTERN OF FACTOR VIII INHIBITOR IN PATIENTS WITH HEMOPHILIA A
Moeller N.	-	CLINICAL EXPERIENCE WITH FACTOR VIII/VON-WILLEBRAND-FACTOR CONCENTRATE HAEMATE P RESULTS ON EFFICACY AND SAFETY IN A SINGLE CENTRE REGISTRY
Moessmer G.	-	THROMBELASTOGRAPHY MAY NOT ALWAYS DETECT CLINICALLY RELEVANT FACTOR XIII DEFICIENCY
Moffat K.A.	-	NASCOLA SURVEY OF HIT TESTING IN NORTH AMERICA
Moffat K.	-	HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
Moffat K.A.	-	GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
Mogami H.	-	MODIFICATION BY PAI-1 OF SLOW EXOCYTOTIC DYNAMICS OF TISSUE PLASMINOGEN ACTIVATOR (TPA) AND ITS ACTIVITY ON VASCULAR ENDOTHELIAL CELLS (VECS)
Moghaddam L.	-	THROMBIN GENERATION & ROTEM TESTS IN PREGNANCY: POTENTIAL FOR MONITORING ADEQUACY OF LOW MOLECULAR WEIGHT HEPARIN ADMINISTRATION
Mogielnicki A.	-	N-METHYLNICOTINAMIDE INHIBITS ARTERIAL THROMBOSIS IN HYPERTENSIVE RATS
	-	PLASMIN SYSTEM REGULATION IN OVA-SENSITIZED RAT MODEL OF ASTHMA
	-	THE PROTHROMBOTIC AND HYPERTENSIVE EFFECTS OF ANGIOTENSIN(1-9) IN RATS MAY BE MEDIATED BY ANGIOTENSIN II
Moharir M.	-	OCCIPITAL BONE COMPRESSION OF THE SUPERIOR SAGITTAL SINUS AS A CONTRIBUTORY FACTOR IN NEONATAL CEREBRAL SINOVENOUS THROMBOSIS
Mohr H.	-	STERILIZATION OF PLATELET CONCENTRATES BY IRRADIATION WITH SHORT-WAVE ULTRAVIOLET LIGHT
Mohri H.	-	LOCALIZATION AND EXPRESSION OF MYOSIN VI IN HUMAN HAEMATOPOIETIC CELLS INCLUDING PLATELETS
Mohsin M.	-	CLINICAL OUTCOMES OF POINT-OF-CARE INR MONITORING FOR ANTICOAGULATION IN PRIMARY CARE PRACTICE
Moia M.	-	DELAY IN STARTING ORAL ANTICOAGULATION IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM (VTE): ANALYSIS FROM THE MASTER REGISTRY
	-	CLINICAL CHARACTERISTICS OF CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: FINDINGS FROM THE MASTER REGISTRY
	-	INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY
	-	ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY
	-	PREVALENCE OF UNPROVOKED VENOUS THROMBOEMBOLISM AND OF TRANSIENT AND PERMANENT RISK FACTORS IN DIFFERENT AGE GROUPS: RESULTS OF THE MASTER REGISTRY
Moix I.	-	DETECTION OF 23 NOVEL MUTATIONS IN LEBANESE HEMOPHILIA PATIENTS
Mokhtar S.	-	PROTHROMBIN AND FACTOR V LEIDEN GENE POLYMORPHISM IN PATIENTS WITH DVT
Molad Y.	-	ANTI-CD 20 MONOCLONAL ANTIBODY (RITUXIMAB) AS AN OPTIONAL TREATMENT FOR INTRACTABLE ACQUIRED GLANZMANN THROMBASTHENIA
Molderings G.J.	-	HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
Molina M.Q.	-	PROPHYLAXIS WITH RECOMBINANT FVIIA
	-	PRIMARY PROPHYLAXIS WITH RECOMBINANT FACTOR VIIA IN A PATIENT WITH HAEMOPHILIA A AND INHIBITOR
	-	NEW THERAPEUTIC APPROACH IN ACQUIRED HEMOFILIA
	-	SEVERE FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A PROTOCOL FOR LABOUR MANAGEMENT WITH FACTOR XI CONCENTRATE
Molinas F.C.	-	INVOLVEMENT OF THE TPO/MPL PATHWAY IN THE PATHOGENESIS OF INHERITED THROMBOCYTOPENIAS
	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Molins B.	-	BENEFICIAL EFFECTS OF DAILY OLIVE OIL CONSUMPTION IN THROMBOSIS. STUDIES IN NORMOLIPEMIC PIGS
	-	MODIFIED CRP ENHANCES PLATELET ADHESION AND THROMBUS GROWTH ON COLLAGEN
Molkentin J.D.	-	REDUNDANT AND NON-REDUNDANT ROLES FOR CLASSICAL PKC ISOFORMS IN THE REGULATION OF PLATELET FUNCTION
	-	CRITICAL ROLE FOR CYCLOPHILIN D (CYPD) AND THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP) IN THE REGULATION OF PLATELET ACTIVATION AND THROMBOSIS
Møller Sørensen T.	-	EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF A RAPID-ACTING RECOMBINANT FVII ANALOGUE, NN1731, IN HEALTHY MALE SUBJECTS
Molliex S.	-	DOES TRANEXAMIC ACID DECREASE ERYTHROCYTE TRANSFUSION IN PATIENTS UNDERGOING HIP FRACTURE SURGERY WITH FONDAPARINUX FOR PREVENTION OF VENOUS THROMBOEMBOLISM ?
Mombelli G.	-	CANOLA OIL, BUT NOT SUNFLOWER OIL, DECREASES CHOLESTEROL AND IMPROVES ENDOTHELIAL FUNCTION IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE: A DOUBLE-BLIND, RANDOMIZED INTERVENTIONAL STUDY
Momeux L.	-	BIOLOGICAL ASSAY OF ASPIRIN-RESISTANCE: ULTRASTRUCTURE OF PLATELET GLYCOPROTEIN REDISTRIBUTION AFTER ARACHIDONIC ACID ACTIVATION AND ASPIRIN INHIBITION, AND COMPARISON WITH USUAL LABORATORY TESTS
Momi S.	-	NCX-6550, A NITRIC OXIDE-DONATING DERIVATIVE OF PRAVASTATIN, EXERTS ANTI-INFLAMMATORY ACTIVITY IN HYPERCHOLESTEROLEMIC MICE
	-	PLATELET-DERIVED NITRIC OXIDE CONTRIBUTE TO THE REGULATION OF BLOOD PRESSURE IN MICE
Monagle P.	-	REFERENCE VALUES FOR THROMBOELASTOGRAPHY IN HEALTHY CHILDREN
	-	RANDOMISED TRIAL OF ANTICOAGULATION VERSUS ANTIPLATELET THERAPY AS PRIMARY THROMBOPROPHYLAXIS FOLLOWING FONTAN SURGERY IN CHILDREN.THE FONTAN A STUDY
	-	UFH PHARMACOLOGY IN CHILDREN
	-	AGE-RELATED REFERENCE RANGES FOR NEOPLASTINE R (PT) AND CEPHASCREEN (APTT) IN HEALTHY CHILDREN
	-	BLEEDING AND THROMBOTIC COMPLICATIONS OF LIVER TRANSPLANTATION IN CHILDREN
	-	POTENTIAL USE OF AUTOMATED THROMBIN CLOTTING TIME (TCT) ASSAY FOR MONITORING UFH THERAPY
Monagle P.T.	-	IN VITRO PLATELET AGGREGATION OF PAPUAN SNAKE VENOMS
Monagle P.	-	CLINICAL EFFICACY OF ANTI-VENOM TREATMENT IN PAPUAN NEW GUINEA SNAKE-BITE PATIENTS
	-	AGE-RELATED REFERENCE RANGES FOR TAFI AND FIBRIN MONOMERS IN HEALTHY CHILDREN
	-	MEASURES OF THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS (CPB) IN
	-	THE DIFFERENCES OF PLATELET RESPONSE TO SNAKE VENOMS: COMPARATIVE STUDY OF CHILDREN AND ADULTS
Monagle P.T.	-	MONITORING OF ORAL ANTICOAGULANT THERAPY IN CHILDREN: COMPARISON OF COAGUCHEK XS WITH VENOUS INR
Monagle P.	-	IDIOPATHIC FETAL GROWTH RESTRICTION (FGR) IS ASSOCIATED WITH DECREASED ANTICOAGULANT PROTEOGLYCAN DECORIN EXPRESSION IN HUMAN PLACENTA
	-	ENDOGENOUS THROMBIN POTENTIAL: FUNCTIONAL ROLE OF ALPHA-2-MACROGLOBULIN
Monagle P.T.	-	ANTICOAGULANT EFFECT OF DANAPAROID, FONDAPARINUX, AND LEPIRUDIN IN CHILDREN COMPARED TO ADULTS
Monagle P.	-	UNFRACTIONATED HEPARIN (UFH) PHARMACOKINETICS IN CHILDREN
	-	HEPARIN EYE DROPS ARE EFFECTIVE AS LONG TERM THERAPY FOR LIGNEOUS CONJUNCTIVITIS
	-	CHANGES IN HAEMOSTATIC FACTORS DURING AND AFTER LIVER TRANSPLANTATION IN CHILDREN
Monahan P.E.	-	FACTOR IX CONCENTRATED IN THE JOINT SPACE PROTECTS HEMOPHILIA B MICE FROM BLEEDING-INDUCED JOINT DETERIORATION IN THE ABSENCE OF CIRCULATING FACTOR IX
	-	LOCAL INTRAARTICULAR EXPRESSION OF FACTOR IX FROM ADENO-ASSOCIATED VIRUS (AAV) VECTORS PREVENTS DEVELOPMENT OF HEMOPHILIC ARTHROPATHY
Monard D.	-	INHIBITION OF PLATELET-DERIVED GROWTH FACTOR-BB (PDGF-BB) FUNCTION BY FACTOR VII ACTIVATING PROTEASE (FSAP): ROLE OF PROTEASE NEXIN-1 (PN-1) AND LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP)
Mondorf W.	-	TESTING FVIIA EFFICACY AS A POTENTIAL TREATMENT FOR PATIENTS WITH HERMANSKY-PUDLAK-SYNDROME TYPE 1 (HPS-1) WITH A THROMBIN GENERATION TEST (TGT) IN TWO CASES
	-	FINAL RESULTS OF A FEASIBILITY STUDY ON AN ELECTRONIC MONITORING SYSTEM IN HEMOPHILIA CARE
Mongkolwongroj P.	-	FIBRINOGEN THR312ALA BUT NOT FXIIIA VAL34LEU AND FXIIIB HIS95ARG POLYMORPHISMS ASSOCIATED WITH THAI DEEP VENOUS THROMBOSIS
Monopoli A.	-	NCX-6550, A NITRIC OXIDE-DONATING DERIVATIVE OF PRAVASTATIN, EXERTS ANTI-INFLAMMATORY ACTIVITY IN HYPERCHOLESTEROLEMIC MICE
Monraats P.S.	-	PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS
Monreal M.	-	LATE BREAKING CLINICAL TRIAL: EXTENDED-DURATION VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS WITH RECENT REDUCED MOBILITY: THE EXCLAIM STUDY
Monroe D.M.	-	HIGH DOSE FACTOR VIIA CORRECTS THROMBIN GENERATION IN A MODEL OF DILUTIONAL COAGULOPATHY
	-	RESTORING INITIAL THROMBIN GENERATION DOES NOT NORMALIZE CUTANEOUS WOUND HEALING IN HEMOPHILIA B
	-	LOW INTENSITY LASER THERAPY SPEEDS WOUND HEALING IN HEMOPHILIA B MICE
	-	TISSUE FACTOR AROUND DERMAL VESSELS HAS BOUND FACTOR VII IN THE ABSENCE OF INJURY
	-	RNA APTAMER-DIRECTED ANTICOAGULANT THERAPY
	-	GLYCOSYLATION OF THE ACTIVATION PEPTIDE OF FACTOR IX DETERMINES PLASMA HALF-LIFE
	-	N-GLYCAN SIALYLATION IS IMPORTANT FOR IN VIVO RECOVERY OF RECOMBINANT FACTOR IX
Montalescot G.	-	PROTEIN Z LEVEL AND GENE POLYMORPHISMS IN MYOCARDIAL INFARCTION IN THE YOUNG
	-	COMPARISON OF TWO WHOLE BLOOD PLATELET FUNCTION ASSAYS: PFA-100 AND A NEW MULTIPLE ELECTRODE AGGREGOMETRY (MULTIPLATE) FOR CONTROL OF ASPIRIN AND/OR CLOPIDOGREL EFFECT
Montalvao S.L.	-	SIMULTANEOUS BLEEDING AND THROMBOSIS AS THE INITIAL PRESENTATION OF SUPERWARFARIN POISONING
Montalvão S.A.L.	-	MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF FVIII MUTATIONS IN A FEMALE WITH SEVERE HEMOPHILIA A
Montaner J.	-	BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN
Montani N.	-	EFFICACY AND SAFETY OF HIGH DOSES OF FEIBA FOR MAJOR SURGERY IN A PATIENT WITH HAEMOPHILIA A AND HIGH-TITRE INHIBITOR
	-	CARDIOVASCULAR DISEASE, HYPERHOMOCYSTEINEMIA AND ATHEROTHROMBOTIC RISK FACTORS IN PSORIATIC PATIENTS
	-	THROMBOTIC MARKERS AND MITRAL VALVE PROLAPSE IN MIGRAINE WITH AND WITHOUT AURA AT CHILDHOOD ONSET
Montaruli B.	-	ANTIPHOSPHOLIPID ANTIBODY TESTING IN PIEMONTE AND VALLE D'AOSTA: A MULTILABORATORY EXTERNAL QUALITY ASSURANCE (EQA) PROGRAM
Monteagudo J.	-	THROMBIN GENERATION IN BEHET'S DISEASE: RELATIONSHIP WITH THROMBOSIS
	-	CANCER AND VENOUS THROMBOEMBOLISM: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
	-	VENOUS THROMBOEMBOLISM IN YOUNG PATIENTS: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
Monteagudo E.	-	EFFICACY OF FACTOR XIII SUBSTITUTION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
Monteagudo G.	-	BEMIPARIN THROMBOPROPHYLAXIS IN ELDERLY MEDICAL PATIENTS: THE "ANCIANOS" STUDY
Montebello E.	-	HIGH GLUCOSE INHIBITS NITRIC OXIDE PRODUCTION THROUGH AN HYPEROSMOLAR EFFECT, WITHOUT INDUCING ENDOTHELIAL CELL ADHESION SURFACE EXPRESSION IN HUMAN ENDOTHELIAL CELLS
Monteiro C.	-	PROTHROMBIN COMPLEX CONCENTRATE FOR REVERSAL OF ORAL ANTICOAGULATION THERAPY IN URGENT SITUATIONS. EXPERIENCE OF A SINGLE CENTER
Monteiro R.C.	-	COORDINATED ACTION OF GPVI AND FCRGAMMA CYTOPLASMIC DOMAINS IN SIGNALLING
Montequin J.F.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Montes R.	-	THROMBIN INDUCES MMP-10 IN HUMAN ENDOTHELIAL CELLS: PATHOPHYSIOLOGICAL IMPLICATIONS IN DISSEMINATED INTRAVASCULAR COAGULATION
	-	AUTO-ANTIBODIES AGAINST EPCR AND THE RISK OF A FIRST DEEP VENOUS THROMBOSIS
Montgomery R.R.	-	THE EFFECT OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR PROPEPTIDE LEVELS IN NORMAL INDIVIDUALS
Montgomery R.	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
Montgomery R.R.	-	TRANSPLANT BONE MARROW THAT IS GENETICALLY MODIFIED TO EXPRESS FVIII ONLY IN PLATELETS CAN RESTORE HEMOSTASIS TO HEMOPHILIA A MICE ON A STRONG INHIBITOR BACKGROUND
	-	A CALCIUM-DEPENDENT PROTEASE CLEAVES VWF73 AT THE PEPTIDE BOND CORRESPONDING TO V1607-T1608 IN THE A2 DOMAIN
Monti M.	-	FACTOR (F)XA STIMULATES FIBROPROLIFERATIVE RESPONSES IN FIBROBLASTS VIA PROTEASE ACTIVATED RECEPTOR (PAR)-2 ACTIVATION: IMPLICATIONS FOR TISSUE REMODELING
	-	CHARACTERIZATION OF PAR-MEDIATED SIGNALING CAPACITY OF COAGULATION FACTOR X MUTANTS
Montiel-Manzano G.	-	A DIMER OF B2GLYCOPROTEIN I (B2GPI) UPREGULATES TISSUE FACTOR (TF) AND IS THROMBOGENIC IN VIVO
	-	EFFECTS OF AN INHIBITOR OF NUCLEAR FACTOR-KAPPA B (NF-KB) ON THROMBOGENIC PROPERTIES OF ANTIPHOSPHOLIPID ANTIBODIES IN VIVO
Montori L.	-	EFFECT OF AGING ON PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION IN RAT TISSUES. POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND CARDIOVASCULAR RISK
Montoya M.M.	-	CRYOPRECIPITATE-REMOVED PLASMA AS A SOURCE OF FACTOR IX IN THE TREATMENT OF HEMOPHILIA B
Montserrat I.	-	IGM ANTI PROTEIN S ANTIBODIES AS A RISK FACTOR OF VENOUS THROMBOSIS
Monvoisin A.	-	EXPRESSION PATTERN OF PROTEIN S AND GAS6 IN THE RETINA
Moons K.G.M.	-	A DIAGNOSTIC TOOL TO SAFELY EXCLUDE DVT IN HIGH RISK GROUPS
	-	A DIAGNOSTIC TOOL TO SAFELY EXCLUDE DVT IN PRIMARY CARE: A VALIDATION STUDY
Moonsup Y.	-	THE USE OF RITUXIMAB AS AN ADJUVANT THERAPY TO INDUCE IMMUNE TOLERANCE IN CHILDREN WITH HEMOPHILIA A AND B
Moore K.	-	APIXABAN, AN ORAL DIRECT FACTOR XA INHIBITOR: MULTIPLE-DOSE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
Moore N.	-	STAPHYLOCOCCUS AUREUS FIBRONECTIN BINDING PROTEINS DO NOT PLAY A ROLE IN THROMBUS FORMATION
Moore J.C.	-	NASCOLA SURVEY OF HIT TESTING IN NORTH AMERICA
Moore G.W.	-	PLATELET GLYCOPROTEINS: PREDICTORS OR PROGRESSION MARKERS IN CARDIOVASCULAR DISEASE?
Moore C.L.	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Moosbauer C.	-	BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION
Morais S.	-	SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS
	-	SEVERE GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIA IN A PATIENT WITH GLANZMANN THROMBASTHENIA
Morais M.J.F.	-	PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS
Morais S.	-	MASSIVE VENOUS THROMBOEMBOLISM IN A PEDIATRIC PATIENT: A CASE REPORT
Moran B.	-	THE EFFECT OF THE SUGARBAKER PROCEDURE ON HAEMOSTASIS
Moran O.	-	HIGH PROPORTION OF MATERNAL THROMBOPHILIA AMONG PREVIOUSLY UNEXPLAINED STILLBIRTH CASES
Moran N.	-	SUB-CELLULAR LOCALIZATION REGULATES THE INTERACTION BETWEEN THE PLATELET INTEGRIN IIB3 AND ICLN
	-	A TAILOR-MADE PEPTIDE-AFFINITY COLUMN TO IDENTIFY NOVEL BINDING PARTNERS FOR A CYTOPLASMIC MOTIF OF THE PLATELET INTEGRIN ALPHA IIB
	-	A NOVEL ROLE FOR CADHERIN 6 IN PLATELET FUNCTION
	-	A ROLE FOR ADIPONENCTIN IN HUMAN PLATELET FUNCTION?
	-	S-NITROSYLATION OF THE PLATELET INTEGRIN ALPHA IIB BETA 3
	-	HOMOCYSTEINE AND ITS THIOLACTONE DERIVATIVE ACTIVATE THE PLATELET INTEGRIN ALPHA IIB BETA 3
Morandi V.	-	SYNDECAN-4 CONTRIBUTES TO ENDOTHELIAL TUBULOGENESIS THROUGH INTERACTIONS WITH TWO MOTIFS INSIDE THE PRO-ANGIOGENIC N-TERMINAL DOMAIN OF THROMBOSPONDIN-1
Morange P.E.	-	FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
Morange P.	-	CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Morange P.E.	-	PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY
	-	RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT
Morange S.	-	RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT
Morateck P.	-	THE EFFECT OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR PROPEPTIDE LEVELS IN NORMAL INDIVIDUALS
Moratti R.	-	EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
Morboeuf O.	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN 31 SUBJECTS BELONGING TO 7 FAMILIES WITH FVII DEFICIENCY
	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A NEW INSIGHT IN THE PATHOGENETIC MECHANISM
Mor-Cohen R.	-	PLATELET GPIIBIIIA-FIBRINOGEN BINDING ACTIVITY IS INCREASED BY ALLICIN (A THIOL-REACTIVE REAGENT)
	-	SPECIFIC CYSTEINE RESIDUES IN BETA3 ARE ESSENTIAL FOR DISULFIDE BOND EXCHANGE- DEPENDENT OR -INDEPENDENT PATHWAYS OF ALPHAIIBBETA3 ACTIVATION
Morcos H.H.	-	SOLUBLE P-SELECTIN RESPONSE IN PRE AND FULL-TERM NEWBORNS WITH SEPSIS
Mordillo C.	-	MAPPING QUANTITIVE TRAIT NUCLEOTIDES (QTN) IN THE F12 GENE REVEALED THAT THE C46T IS THE MAIN FUNCTIONAL VARIANT
Morel-Kopp M.C.	-	FIBRIN GENERATION IS NOT SUPPRESSED IN PATIENTS WARFARINISED FOR VENOUS THROMBOEMBOLISM (VTE)
	-	ANALYSIS OF THE SENSITIVITY OF THE OVERALL HAEMOSTATIC POTENTIAL (OHP) ASSAY TO COAGULATION FACTORS
	-	A COMPARATIVE STUDY OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) MONITORING BY ANTI-XA LEVELS, OVERALL HAEMOSTASIS POTENTIAL (OHP) AND CALIBRATED AUTOMATED THROMBOGRAM (CAT) ASSAYS
	-	THE ASSOCIATION OF DEPRESSION WITH PLATELET ACTIVATION: EVIDENCE FOR A TREATMENT EFFECT
Morelli B.	-	EVALUATION OF THE NEW KIT HEMOSIL D-DIMER HS ON SEVERAL INSTRUMENTS COMPARED TO OTHER TURBIDIMETRIC AND ELISA METHODS
Moreno V.P.	-	FIVE PROTHROMBOTIC POLYMORHISMS AND VENOUS THROMBOEMBOLISM
	-	THE T ALLELE OF THE FXII 46C/T GENE POLYMORPHISM IS RISK FACTOR FOR ICD IN SPANISH POPULATION
	-	RISK FACTOR PROFILE ASSOCIATED WITH ICD IN SPANISH POPULATION
Moreno M.J.	-	JAK2 V617F MUTATION IS ASSOCIATED WITH THE LEUKOCYTE COUNT AND BONE MARROW CD34+ CELLS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
	-	INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
	-	PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION
Moret A.	-	INFLUENCE OF ADDING 4% BSA IN THE BETHESDA ASSAY FOR FACTOR VIII INHIBITOR QUANTIFICATION
Moretó A.	-	RITUXIMAB TREATMENT FOR MILD HEMOPHILIA A WITH INHIBITORS
Moretti F.A.	-	PROTHROMBOTIC EFFECTS OF FIBRONECTIN ISOFORMS CONTAINING THE EDA DOMAIN
Morfini M.	-	THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES
	-	PRIMARY KNEE ARTHOPLASTY USING RECOMBINANT FACTOR VIIA (RFVIIA) AS FIRST-LINE THERAPY IN HAEMOPHILIA PATIENTS WITH HIGH RESPONDING INHIBITORS
	-	FACTOR VIII (F8) GENE MUTATIONS AND IMMUNE TOLERANCE INDUCTION (ITI) IN HAEMOPHILIA A WITH INHIBITORS: DATA FROM THE ITALIAN ITI REGISTRY (THE PROFIT STUDY)
	-	FVIII/VWF CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN ITALIAN HAEMOPHILIACS WITH NEGATIVE PREDICTORS OF ITI RESPONSE
Morgan L.	-	WARFARIN PHARMACOGENOMICS: A MULTIPLEX METHOD FOR CYP2C9 AND VKORC1 GENOTYPING
Mörgelin M.	-	NOVEL ROLE FOR TAFI IN THE MODULATION OF HOST RESPONSES BY STREPTOCOCCI?
	-	UNRAVELING THE MECHANISM OF INACTIVATION OF ACTIVATED TAFI
Morgenstern E.	-	BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION
Mori J.	-	PLATELET ITIM PROTEINS INHIBIT BASAL SIGNALLING BY YXXL-CONTAINING PLATELET ACTIVATION RECEPTORS
Moriarty R.D.	-	NGR; A NOVEL FIBRINOGEN ADHESION MOTIF ENHANCING PLATELET ACTIVATION
Moriguchi-Goto S.	-	ADAMTS-13 WITHIN THROMBUS DOWN-REGULATES THROMBUS FORMATION UNDER FLOW CONDITIONS
	-	FUNCTIONAL REGULATION OF VON WILLEBRAND FACTOR ON THE FORMATION OF PLATELET THROMBI UNDER BLOOD FLOW CONDITION BY ITS SPECIFIC CLEAVING PROTEASE OF ADAMTS13
	-	PLATELET IS AN IMPORTANT FACTOR IN VENOUS THROMBOEMBOLISM: INTERACTION OF VON WILLEBRAND FACTOR AND PLATELET GPIB PROMOTES VENOUS THROMBUS GROWTH
Morimoto T.	-	ASPIRIN EFFICACY: ANALYSIS OF WHOLE BLOOD-AGGREGATION USING THE SCREEN FILTRATION PRESSURE METHOD
Morin K.A.	-	EVALUATION OF A NEW, AUTOMATED QUANTITATIVE FACTOR XIII ASSAY
Morishima Y.	-	ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE, RECOMBINANT FACTOR VIII AND FACTOR IX REVERSE PROLONGED CLOTTING TIME INDUCED BY DU-176B, A DIRECT FACTOR XA INHIBITOR, IN HUMAN PLASMA
	-	COMPARISON OF ANTITHROMBOTIC PROPERTIES OF A DIRECT FXA INHIBITOR, DU-176B, WITH AN ANTITHROMBIN DEPENDENT FXA INHIBITOR, FONDAPARINUX, IN A CAPILLARY PERFUSION CHAMBER THROMBOSIS MODEL
	-	EFFECTS OF DU-176B, A NOVEL DIRECT FACTOR XA INHIBITOR, ON PROTHROMBINASE ACTIVITY AND PLATELET AGGREGATION IN VITRO
	-	EFFECT OF A FACTOR XA INHIBITOR DU-176B ON INTRACEREBRAL HEMORRHAGE IN RATS: A WIDER SAFETY MARGIN COMPARED WITH A THROMBIN INHIBITOR
Morishira E.	-	PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS
	-	CLINICAL SIGNIFICANCE OF PLATELET-DERIVED MICROPARTICLE (PDMP) IN APS: PLASMA LEVELS OF PDMP WERE SIGNIFICANTLY ELEVATED IN APS PATIENTS WITH ARTERIAL THROMBOSES
Morita T.	-	AGE- AND GENDER-RELATED DIFFERENCES OF PLASMA PROTHROMBIN ACTIVITY LEVELS
	-	AUGMENTATION OF VASCULAR PERMEABILITY OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IS ENHANCED BY VEGF RECEPTOR 2-BINDING PROTEINS
	-	MOLECULAR AND FUNCTIONAL DIVERSITY OF SNAKE VENOM VEGFS
	-	IDENTIFICATION OF VEGF RECEPTOR-BINDING SITES OF KDR-BINDING PROTEIN
Moritani Y.	-	BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF KDN-7438, A NOVEL SYNTHETIC TISSUE FACTOR/FACTOR VIIA INHIBITOR
Morken B.	-	BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD)
Moro C.	-	TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 1 (TIMP-1) PREDICTS RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN END STAGE SYSTOLIC HEART FAILURE
Moroi M.	-	VON WILLEBRAND FACTOR-GLYCOPROTEIN IB AND INTEGRIN ALPHA2BETA1-COLLAGEN INTERACTIONS MAKE COMPLEMENTARY, COLLAGEN-TYPESPECIFIC CONTRIBUTIONS TO ADHESION
Morra E.	-	FALSE UNCOAGULABLE PT-INR RESULTS
Morris T.A.	-	SENSITIVITY AND SAFETY OF PULMONARY EMBOLI IMAGING WITH RADIOLABELED ANTI-D-DIMER MONOCLONAL ANTIBODY FRAGMENTS
Morris M.A.	-	DETECTION OF 23 NOVEL MUTATIONS IN LEBANESE HEMOPHILIA PATIENTS
Morris T.A.	-	HETEROZYGOUS FIBRINOGEN GAMMA-114 TYR-HIS MUTATION ASSOCIATED WITH RESISTANCE TO TPA-MEDIATED FIBRINOLYSIS AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
	-	HETEROZYGOUS FIBRINOGEN GAMMA-375 ARG-TRP MUTATION ASSOCIATED WITH EXCESSIVE SIALYLATION, PLASMIN RESISTANCE AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Morrison W.	-	COAGULATION STUDIES IN PATIENTS PRESENTING WITH HYPOTHERMIA
Morrissey J.H.	-	NON-ANTICOAGULANT SULFATED POLYSACCHARIDES ENHANCE THROMBIN GENERATION BY ACCELERATING FACTOR V ACTIVATION
	-	THE TISSUE FACTOR CYTOPLASMIC DOMAIN REGULATES PROCOAGULANT RESPONSES IN MACROPHAGES
	-	PLATELET POLYPHOSPHATE MODULATES PLATELET COAGULATION PROTEIN RESPONSES
	-	ELEVATED PLASMA LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
	-	BLOOD COAGULATION REACTIONS ON NANOSCALE MEMBRANE SURFACES
	-	ELEVATED LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION
	-	POLYPHOSPHATE INTERACTS WITH THROMBIN EXOSITE II WITH HIGH AFFINITY
	-	POLYPHOSPHATE ENHANCES FACTOR XII ACTIVATION
Morrissey J.	-	ASSAY DEVELOPMENT FOR PLASMA FACTOR VIIA-ANTITHROMBIN COMPLEX (FVIIA-AT)
Morrissey J.H.	-	FACTOR VIIA-ANTITHROMBIN COMPLEXES IN HUMAN PLASMA
Morrone F.	-	EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN
Morser J.	-	A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Morser K.	-	RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) EXPRESSED ON HEK293 CELLS BINDS OXIDIZED LOW DENSITY LIPOPROTEINS (OXLDL)
Morstabilini G.	-	EVALUATION OF A NEW D-DIMER METHOD
	-	PT INR: COMPARISON BETWEEN TWO DIFFERENT POINT OF CARE SYSTEMS
	-	PROTHROMBIN TIME: COMPARISON BETWEEN DIFFERENT REAGENTS
	-	EVALUATION OF A NEW INR PORTABLE MONITOR
	-	ACCURACY AND COST EVALUATION OF A PORTABLE INR MONITOR
Mortazavi S.J.	-	THE CLINICAL RESULTS OF P32 RADIOSYNOVECTOMY IN HEMOPHILIC PATIENTS WITH CHRONIC SYNOVITIS
	-	ILIOPSOAS ABSCESS IN A 4-YEAR-OLD BOY WITH SEVERE HAEMOPHILIA
Mortensen E.	-	FREQUENCY AND TIME OF ONSET OF ACUTE MYOCARDIAL INFARCTION IN SUDDEN UNEXPECTED DEATHS IN A FORENSIC AUTOPSY MATERIAL
Mosberg H.I.	-	THROMBOSTATIN FM19 - A THROMBIN RECEPTOR ACTIVATION ANTAGONIST
Moscardo A.	-	EARLY TISSUE FACTOR-INDUCED THROMBIN GENERATION IN PLATELETS: INFLUENCE OF ASPIRIN AND ASPIRIN PLUS CLOPIDOGREL
	-	DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL AND ASPIRIN ATTENUATES PLATELET REACTIVITY AND PROTHROMBOTIC EFFECT OF ERYTHROCYTES IN PATIENTS AFTER CAROTID STENTING
	-	INSUFFICIENT INHIBITION OF PLATELET THROMBOXANE SYNTHESIS IS ASSOCIATED WITH GREATER CORONARY ARTERY DISEASE EVALUATED BY ANGIOGRAPHY
	-	EPINEPHRINE REDUCES THE EFFECT OF ANTIPLATELET THERAPIES IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS). ROLE OF PI3K
Moschi G.	-	LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
Mosena L.	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AMONG HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN OR PROTHROMBIN G20210A MUTATION. A SYSTEMATIC REVIEW OF PROSPECTIVE STUDIES
Moser M.	-	HOT TOPIC DEFECTIVE ACTIVATION OF PLATELET INTEGRINS IN TALIN-DEFICIENT MICE
Mosnier L.O.	-	ACTIVATED PROTEIN C
	-	ACTIVATED PROTEIN C (APC) REQUIRES RESIDUES 176-178 FOR NORMAL ANTICOAGULANT, ANTI-APOPTOTIC AND ANTI-INFLAMMATORY ACTIVITIES
	-	DISSECTION OF STRUCTURAL REQUIREMENTS FOR ACTIVATED PROTEIN C ANTICOAGULANT VERSUS CYTOPROTECTIVE ACTIVITIES
Mosqueda-Garcia R.	-	APIXABAN, AN ORAL DIRECT FACTOR XA INHIBITOR: MULTIPLE-DOSE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
	-	APIXABAN, AN ORAL DIRECT, FACTOR XA INHIBITOR: SINGLE-DOSE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
Moss R.	-	VWF A2 DOMAIN SEQUENCE 1533-1553: ITS ROLE IN CONTROLLING ADAMTS13 ACCESS TO THE Y1605-M1606 SCISSILE BOND
Møss J.	-	EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF A RAPID-ACTING RECOMBINANT FVII ANALOGUE, NN1731, IN HEALTHY MALE SUBJECTS
Mota A.P.L.	-	HEMOSTATIC PROFILE IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD): ASSOCIATION TO ANKLE-BRACHIAL INDEX (ABI)
	-	LIPOPROTEIN(A) IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD), ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	LIPID ALTERATIONS IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND OTHER PARAMETERS INTERRELATED IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	RISK FACTORS ASSOCIATED TO THE DEVELOPMENT OF PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
Mota R.	-	BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS
	-	IN VIVO EFFECTS OF HYPERTHERMIA ON THE FUNCTIONAL AND CONFORMATIONAL CHARACTERISTICS OF ANTITHROMBIN
Mota A.P.L.	-	ASSOCIATION BETWEEN PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND SMOKING IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
Mota L.	-	CONTRIBUTION OF NATURAL ANTICOAGULANT AND FIBRINOLYTIC FACTORS IN MODULATING THE CLINICAL SEVERITY OF HEMOPHILIA PATIENTS
Motte S.	-	USEFULNESS OF PERFUSION LUNG SCAN COMBINED WITH CLINICAL ASSESSMENT TO RULE OUT PULMONARY EMBOLISM
	-	IS D-DIMER TESTING COST-EFFECTIVE IN ELDERLY PATIENTS CLINICALLY SUSPECTED OF DEEP VEIN THROMBOSIS?
Mottier D.	-	RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD?
	-	DETECTING PROTHROMBOTIC STATES USING A THROMBIN GENERATION TEST IN RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND FACTOR V LEIDEN
	-	VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY
	-	BODY MASS INDEX, MILD HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOEMBOLISM RISK
	-	RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE RELATIVES (FDRS) OF PATIENTS WITH UNPROVOKED VTE WHO DO NOT HAVE FACTOR V LEIDEN (FVL) OR THE G20210A PROTHROMBIN GENE MUTATION (PGM)
Motto D.G.	-	ABSENCE OF ADAMTS13 ON A VWF DEFICIENT BACKGROUND IS NO LONGER PROTHROMBOTIC IN A MURINE MODEL OF ARTERIAL THROMBOSIS
	-	A MOUSE MODEL OF HEREDITARY THROMBOTIC THROMBOCYTOPENIC PURPURA
Mougiou A.	-	FV LEIDEN, FII G20210A AND MTHFR T677T GENOTYPES: IS THEIR EVALUATION A USEFUL TOOL IN THE ETIOLOGICAL APPROACH OF THE EARLY RECURRENT PREGNANCY LOSSES IN THE GREEK POPULATION?
	-	INHERITED THROMBOPHILIA: INCIDENCE AND IMPACT ON PERINATAL OUTCOME IN SOUTH-WESTERN GREECE
Moulin N.	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) AND CANCER SURVIVAL. A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS IN PATIENTS WITH AND WITHOUT VTE
	-	RETRIEVABLE VENA CAVA FILTERS FOR SECONDARY PREVENTION OF PULMONARY EMBOLISM IN ORTHOPAEDIC SURGERY
Mouquet F.	-	METABOLIC SYNDROME, PAI-1 AND COLLATERAL VESSEL FORMATION IN PATIENTS WITH DOCUMENTED OCCLUDED CORONARY ARTERIES
Moura R.	-	THROMBOSPONDIN1 GENE DEFICIENCY MODULATES VASCULAR MEDIAL SMOOTH MUSCLE CELL ACTIVATION AND NEOINTIMA FORMATION
Moura A.	-	CHAOTIC ADVECTION IN STENOSED ARTERIES
Moura R.	-	THROMBOSPONDIN1 GENE DEFICIENCY ATTENUATES ATHEROSCLEROTIC PLAQUE BURDEN BUT ACCENTUATES INFLAMMATORY CELL PLAQUE CONTENT IN APOE-DEFICIENT MICE
Mousa S.A.	-	EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON HUMAN ENDOTHELIAL TISSUE FACTOR PATHWAY INHIBITOR RELEASE
Mousa L.	-	CORONARY ARTERY BYPASS GRAFTING (CABG) IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA (ITP)
Mousa S.A.	-	ROLE OF THYROID HORMONE ANALOGS IN ANGIOGENESIS AND THE DEVELOPMENT OF COLLATERALS IN RABBIT HIND LIMB ISCHEMIA MODEL
	-	MODULATION OF HEPARIN-PF4 ANTIBODY-MEDIATED PLATELET ACTIVATION BY A NOVEL GPIIB/IIIA RECEPTOR ANTAGONIST: IMPLICATIONS IN THE MANAGEMENT OF HIT
	-	ANTITHROMBOTIC EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN HYPERCOAGULATION STATES AND CANCER-ASSOCIATED THROMBOSIS
	-	INHIBITION OF CANCER AND INFLAMMATION-ASSOCIATED THROMBOSIS USING NOVEL INHIBITORS OF NFKB AND OXIDATIVE STRESS PATHWAYS
	-	ANTI-METASTASIS EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN EXPERIMENTAL METASTASIS MODEL
	-	EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON ANGIOGENESIS
	-	RENAL ELIMINATION OF TINZAPARIN VERSUS ENOXAPARIN IN NORMAL VERSUS NEPHRECTOMIZED RATS
	-	ANTI-CANCER EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN THROMBOSIS-ASSOCIATED TUMOR GROWTH
	-	DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
	-	FACTOR XI MEDIATES PLATELET LAMELLIPODIA FORMATION AND TETHERING AND ROLLING UNDER SHEAR CONDITIONS
Mowinckel M.	-	DIFFERENTIAL EFFECTS OF CONVENTIONAL AND LOW DOSE ORAL HORMONE THERAPY, TIBOLONE AND RALOXIFENE ON FUNCTIONALITY OF THE ACTIVATED PROTEIN C SYSTEM
Mt-Isa S.	-	LACK OF EFFECT OF INFLUENZA IMMUNISATION ON ANTICOAGULANT CONTROL IN PATIENTS ON LONG-TERM WARFARIN
Muchitsch E.M.	-	PHARMACOKINETICS (PK) OF RVWF IN DOGS AND MICE WITH SEVERE VWD
	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
	-	PRIMARY HEMOSTATIC EFFICACY OF RVWF IN A NOVEL MODEL OF VASCULAR INJURY IN MICE WITH SEVERE VWF DEFICIENCY
	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
Mudde G.C.	-	IGA CLASS OF AUTOANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
	-	IGG SUBCLASS DISTRIBUTION OF ANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
Mueck W.	-	EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR
	-	THE EFFECT OF AGE AND GENDER ON THE PHARMACOLOGY AND SAFETY OF THE ORAL, DIRECT FACTOR XA INHIBITOR RIVAROXABAN
	-	RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR HAS NO CLINICALLY RELEVANT INTERACTION WITH ACETYLSALICYLIC ACID OR NAPROXEN
	-	PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF RIVAROXABAN: A COMPARISON OF ONCE- AND TWICE-DAILY DOSING IN PATIENTS UNDERGOING TOTAL HIP REPLACEMENT (THR)
Mueller J.	-	FVIII CONCENTRATES OF RECOMBINANT ORIGIN SHOW A HIGHER THROMBIN SENSITIVITY THAN PLASMA-DERIVED FVIII CONCENTRATES BUT NEARLY IDENTICAL APC-MEDIATED INACTIVATION KINETICS
	-	FACTOR VIII CONCENTRATES OF RECOMBINANT ORIGIN SHOW A HIGHER SUSCEPTIBILITY TO THROMBIN PROTEOLYSIS THAN PLASMA-DERIVED CONCENTRATES BUT NEARLY IDENTICAL INACTIVATION RATES BY ACTIVATED PROTEIN C
Mueller-Reible C.R.	-	IN VIVO-ASSAY FOR WARFARIN-RESISTANCE BY COEXPRESSION OF VKORC1 AND VITAMIN K-DEPENDENT COAGULATION FACTORS
Muhl L.	-	FACTOR VII ACTIVATING PROTEASE INHIBITS VASCULAR ENDOTHELIAL GROWTH FACTOR-MEDIATED PROGENITOR CELL HOMING AND DIFFERENTIATION INTO ENDOTHELIAL CELLS
	-	INHIBITION OF PLATELET-DERIVED GROWTH FACTOR-BB (PDGF-BB) FUNCTION BY FACTOR VII ACTIVATING PROTEASE (FSAP): ROLE OF PROTEASE NEXIN-1 (PN-1) AND LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP)
	-	STRUCTURE-FUNCTION ANALYSIS OF THE BINDING PROPERTIES AND ENZYMATIC ACTIVITY OF FACTOR VII ACTIVATING PROTEASE (FSAP) USING RECOMBINANT MUTANT PROTEINS
	-	FACTOR VII ACTIVATING PROTEASE (FSAP)
	-	FACTOR VII ACTIVATING PROTEASE INHIBITS THE UROKINASE PLASMINOGEN ACTIVATION SYSTEM AND STIMULATES GELATINASES (MATRIX METALLOPROTEINASES-2 AND -9) IN VASCULAR SMOOTH MUSCLE AND ENDOTHELIAL CELLS
	-	HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS
Mühle C.	-	BREAKPOINT CHARACTERIZATION IN HEMOPHILIA PATIENTS WITH LARGE DELETIONS IN THE FVIII GENE REVEALS INVOLVEMENT OF VARIOUS MUTATION MECHANISMS
Muhlstedt S.	-	AN EF-HAND MUTATION IN STIM1 CAUSES PREMATURE PLATELET ACTIVATION AND BLEEDING IN MICE
Mukamel M.	-	THROMBOPHILIA DOES NOT INCREASE THE RISK FOR RECURRENT THROMBOSIS IN PEDIATRIC APS
Mukhametova L.I.	-	INHIBITION OF PLASMINOGEN/PLASMINOGEN ACTIVATOR SYSTEM BY ANGIOSTATIN-LIKE PLASMINOGEN FRAGMENTS IS INVOLVED IN MECHANISM OF ANTIANGIOGENESIS
	-	FIBRINOLYTIC SYSTEM COMPONENTS IN RABBIT TEARS AFTER CHEMICAL BURN OF CORNEA
	-	MODULATION OF STAPHYLOKINASE-DEPENDENT PLASMINOGEN ACTIVATION BY OMEGA-AMINE ACIDS
Mukherjee M.	-	ASSOCIATION OF CYTOMEGALOVIRUS (CMV) AND PROATHEROGENIC BIOMARKERS IN CORONARY ARTERY DISEASE (CAD)
	-	APPLICATION OF THREE SEPARATE CVD PREDICTIVE SCORES AND THE RELEVANCE OF NOVEL BIOMARKERS TO RISK STRATIFICATION OF ASIAN INDIANS USING THE FRAMINGHAM RISK SCORE
	-	FVII ACTIVITY AND R353Q POLYMORPHISM IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE
	-	CONSIDERATION OF MODIFIED CUT-OFFS FOR ANTHROPOMETRIC VARIABLES IN DEFINING METABOLIC SYNDROME AMONG ASIAN INDIANS WITH CORONARY ARTERY DISEASE (CAD)
	-	PLASMA LEVELS OF COAGULATION AND INFLAMMATORY MARKERS IN SUBJECTS AFFECTED WITH CORONARY ARTERY DISEASE
	-	CORRELATION OF METABOLIC SYNDROME WITH ATHEROGENIC PHENOTYPES IN INDIAN POPULATION
	-	CIRCULATING ANTIBODIES TO HEAT SHOCK PROTEINS AND THEIR ASSOCIATION WITH ATHEROTHROMBOTIC PHENOTYPES
	-	POLYMORPHISMS IN THE IL6 GENE IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE (CAD) -INDIAN ATHEROSCLEROSIS RESEARCH STUDY
	-	HERITABILITY OF C-REACTIVE PROTEIN AND INTERLEUKIN 6 AMONG THE ASIAN INDIAN POPULATION
	-	APOA1 PROMOTER POLYMORPHISMS AND THEIR ASSOCIATION WITH LIPOPROTEINS IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE (CAD)
	-	PATHOGEN BURDEN AND CORONARY ARTERY DISEASE
	-	CHLAMYDIA PNEUMONIA INFECTION AND ITS RELATION TO LIPIDS AND INFLAMMATORY MARKERS IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
	-	SERUM ADIPONECTIN LEVELS & ITS CORRELATION WITH LIPIDS AND PROINFLAMMATORY MARKERS IN ASIAN INDIAN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
Mul F.P.J.	-	FVIII-SPECIFIC MEMORY B CELLS IN PATIENTS WITH HEMOPHILIA A
Mulder R.	-	PROS1 ANALYSIS IN 87 PEDIGREES WITH HEREDITARY PROTEIN S DEFICIENCY DEMONSTRATES STRIKING GENOTYPE-PHENOTYPE ASSOCIATIONS
	-	VALIDATION OF THE PROTEIN C/S RATIO TO IDENTIFY CARRIERS OF A PROTEIN S GENE MUTATION
Mulder A.B.	-	VALIDATION OF THE PROTEIN C/S RATIO TO IDENTIFY CARRIERS OF A PROTEIN S GENE MUTATION
Muleo G.	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
	-	VENOUS THROMBOSIS IN UNUSUAL SITES: A SINGLE INSTITUTION EXPERIENCE
Muller L.	-	SIMPLE COAGULATION TESTS IMPROVE EARLY MORTALITY PREDICTION IN ICU PATIENTS WITH SEPTIC SHOCK
	-	PROSPECTIVE EVALUATION OF A SIMPLIFIED SCORE FOR THE PREDICTION OF DISSEMINATED INTRAVASCULAR COAGULATION IN SEPSIS
Muller F.	-	HEREDITARY ANGIOEDEMA TYPE III ARE CAUSED BY A GAIN OF FUNCTION MUTATION IN COAGULATION FACTOR XII, WHICH INCREASES VASCULAR PERMEABILITY MEDIATED BY BRADYKININ GENERATION
Müller C.R.	-	VKORC1: MOLECULAR TARGET OF COUMARINS
Müller J.	-	DESIGN AND IN VITRO CHARACTERIZATION OF A PHOTODYNAMIC ANTICOAGULANT
	-	ACTIVATED PROTEIN C INHIBITION BY PROTEIN C INHIBITOR IS NOT ACCELERATED BY THE SYNTHETIC PENTASACCHARIDE FONDAPARINUX
Müller A.	-	INFLUENCE OF PERINATAL RISK FACTORS ON THE DEVELOPMENT OF PLASMATIC COAGULATION IN EXTREMELY PRETERM INFANTS
Müller T.H.	-	STERILIZATION OF PLATELET CONCENTRATES BY IRRADIATION WITH SHORT-WAVE ULTRAVIOLET LIGHT
Müller C.	-	A NEW,BI-DIRECTIONAL POINT-OF-CARE TESTING-NETWORK FOR THE INR DETECTION FROM CAPILLARY WHOLE BLOOD WITH A POSITIVE PATIENT IDENTIFICATION IN ORALLY ANTICOAGULATED OUT-PATIENTS
Müllner C.	-	SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE
Mulloy B.	-	OLIGOSACCHARIDES FROM DIFFERENT LOW MOLECULAR WEIGHT HEPARINS HAVE DIFFERENT ANTICOAGULANT AND PROTAMINE SULPHATE NEUTRALIZATION PROFILES
Munari M.	-	INTRACRANIAL STENTING IN FOUR PATIENTS WITH ACUTE ISCHEMIC STROKE
Mundo J.	-	NATIONAL STUDY OF INHIBITOR KINETICS AND TREATMENT RESPONSE IN HEMOPHILIA A AND B MEXICAN PATIENTS
Munnix I.C.A.	-	FLOW-INDUCED THROMBUS FORMATION ON IMMOBILIZED COLLAGEN RECEPTOR-BINDING PEPTIDES
	-	SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
	-	CONTRIBUTIONS OF COLLAGEN AND GLYCOPROTEIN VI SIGNALLING IN THE INTRINSIC PATHWAY OF COAGULATION
Munoz M.	-	SPANISH CONSENSUS STATEMENT ON PHARMACOLOGIC ALTERNATIVES TO ALLOGENEIC BLOOD TRANSFUSIONS: THE SEVILLE'S DOCUMENT*
Munoz B.	-	PLASMA PROCPU (TAFI) AND CLOT LYSIS TIME ARE CORRELATED WITH CLOTTING FACTOR LEVELS AND THROMBIN GENERATION: A NOVEL APPROACH TO ASSESS THROMBOSIS RISK?
Muñoz B.	-	PLASMA LEVELS OF CLOTTING FACTORS ARE POSITIVELY CORRELATED IN HEALTHY POPULATION: A COMPREHENSIVE PERSPECTIVE TO ASSESS THROMBOTIC RISK?
Muñoz C.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH POLYCYTEMIA VERA: A THREATENING ASSOCIATION
Munro K.A.	-	THE DYNAMICS OF THE BINDING OF PLASMINOGEN AND TPA TO IMMOBILIZED HIGH MOLECULAR WEIGHT FIBRIN DEGRADATION PRODUCTS
Muntean W.E.	-	THROMBIN GENERATION IN NORMAL UNCOMPLICATED PREGNANCY
Muntean W.	-	THROMBIN GENERATION IN OBESE CHILDREN AFTER WEIGHT REDUCTION
Muntjewerff J.	-	CATECHOL-O-METHYLTRANSFERASE GENOTYPE IS ASSOCIATED WITH PLASMA TOTAL HOMOCYSTEINE LEVELS AND MAY INCREASE RECURRENT VENOUS THROMBOSIS RISK
Muntz J.E.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
Muramatsu S.	-	THE PHARMACOLOGICAL PROFILE OF DZ-697B, A NOVEL ANTI-PLATELET AGENT
Murari M.	-	ROLE OF HEMATOLOGIC AND SCREENING HEMOSTATIC PROFILE ON ADMISSION, IN PREDICTION OF DEVELOPMENT OF COMPLICATIONS IN HOSPITALIZED PATIENTS WITH DENGUE FEVER
Murasaki K.M.	-	THE RISK FACTORS FOR THROMBOEMBOLISM IN PATIENTS WITH MECHANICAL VALVE
	-	OPTIMAL ANTICOAGULANT INTENSITY FOR JAPANESE PATIENTS WITH MECHANICAL VALVE
Murata M.	-	EFFECT OF HUMAN TERT TRANSFECTION ON GENE EXPRESSION PROFILING IN NORMAL HUMAN CORONARY ARTERY ENDOTHELIAL CELLS
	-	GENETIC FACTORS FOR DETERMINATION OF PLASMA VWF LEVELS IN A GENERAL POPULATION
	-	ULTRASTRUCTURAL ANALYSIS OF CULTURED MEGAKARYOCYTES GROWN FROM BONE MARROW MONONUCLEAR CELLS OF A NEWLY DIAGNOSED JAPANESE PATIENT WITH GRAY PLATELET SYNDROME
	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
Murate T.	-	FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
	-	MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
Muratovska O.	-	HOSPITALISATION FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD- IS IT ALWAYS NECESSARY?
	-	A RARE CONGENITAL BLEEDING DISORDER: F.VII DEFICIENCY (CASE REPORT)
Murciano J.-C.	-	PARTIAL FIBRIN ADHESION AND DIFFUSION SUGGESTED RETEPLASE AS THE THERAPEUTIC CHOICE FOR CATHETER DRIVEN THROMBOLYSIS
Murer E.H.	-	IN VITRO STUDY OF THE EFFECT OF EXPOSURE OF HUMAN BLOOD TO ADDED INSULIN AND GLUCOSE OVER 24 HOURS AT 20 DEGREES C AND ITS MODULATION BY WORTMANNIN (W)
Murin S.	-	LONG TERM OUTCOMES AMONG PATIENTS UNDER THE AGE OF 55 YEARS WHO ARE DIAGNOSED WITH FIRST-TIME IDIOPATHIC PULMONARY EMBOLISM (PE)
	-	HIGH RISK FOR VENOUS THROMBOEMBOLISM IN DIABETICS WITH HYPEROSMOLAR STATE: COMPARISON WITH OTHER ACUTE MEDICAL ILLNESSES
Muro A.F.	-	PROTHROMBOTIC EFFECTS OF FIBRONECTIN ISOFORMS CONTAINING THE EDA DOMAIN
Murphy J.E.	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
Murphy A.	-	PHASE 3 STUDY COMPARING RECOMBINANT HUMAN THROMBIN AND BOVINE THROMBIN FOR SURGICAL HEMOSTASIS
Murphy J.E.	-	PEGYLATION PROTECTS FACTOR VIII FROM THE INHIBITION OF ANTIBODY INHIBITORS
Murphy R.P.	-	MOLECULAR AND CELLULAR DYNAMICS OF MOESIN IN VASCULAR CELLS VIA MECHANO-TRANSDUCTION
	-	THE MECHANO-REGULATION OF LASP-1 IN THE PATHOGENESIS OF CARDIOVASCULAR DISEASE
Murphy M.	-	LACTADHERIN IS MORE SENSITIVE THAN ANNEXIN-V AT DETECTING PHOSPHATIDYLSERINE EXPOSURE WITHIN PLATELETS
Murphy J.E.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Murray A.	-	CIRCADIAN VARIATION IN THE PLATELET RESPONSE AND THE EFFECT OF MELATONIN
Murray P.	-	THE USE OF THE WARKENTIN ET AL 4T CLINICAL SCORING SYSTEM TO DETERMINE PROSPECTIVELY THE APPROPRIATENESS OF HIT ANTIBODY TESTING AT THE REGIONAL HAEMOSTASIS LABORATORY, BELFAST CITY HOSPITAL, N IRELAND
Murray E.	-	BAYESIAN STATISTICAL MODELLING OF PATIENTS INR RECORDS USING REPEATED MEASURES MODELS AND INDIVIDUAL TIME SERIES
Murray-Segal L.	-	MICE TRANSGENIC FOR THROMBOMODULIN EXHIBIT PROTECTION FROM VENOUS THROMBOSIS
	-	INCREASED CD39 EXPRESSION PROTECTS KIDNEYS FROM ISCHEMIA REPERFUSION INJURY VIA A REDUCTION IN INFILTRATING CD4+T CELLS: PROTECTION IS AFFORDED BY BOTH EXPRESSIONS ON EITHER TISSUE OR ON CELLULAR BLOOD
Murthi P.	-	IDIOPATHIC FETAL GROWTH RESTRICTION (FGR) IS ASSOCIATED WITH DECREASED ANTICOAGULANT PROTEOGLYCAN DECORIN EXPRESSION IN HUMAN PLACENTA
Murugesan G.	-	P2RY12 RECEPTOR POLYMORPHISMS (SNPS) IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
	-	CLINICAL EXPERIENCE WITH PLATELET AGGREGATION TESTING FOR ASPIRIN AND CLOPIDOGREL
Muscolo V.	-	LDL-CHOLESTEROL ENHANCES PLATELET RECRUITMENT VIA GP91PHOX-MEDIATED CD40L UPREGULATION
Musial J.	-	THROMBIN GENERATION IN CHRONICALLY ANTICOAGULATED PATIENTS
	-	ASSOCIATION OF POLYMORPHIC SHORT TANDEM REPEAT -755 (CA)N IN THE HUMAN ALPHA2 INTEGRIN GENE PROMOTER WITH DEVELOPMENT AND EXTENT OF EARLY-ONSET CORONARY ARTERY DISEASE IN MEN: A CASE-CONTROL STUDY
	-	STICKY PLATELET SYNDROME (SPS) AND PLATELET GLYCOPROTEIN POLYMORPHISMS
	-	THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) DIAGNOSED USING UPDATED CLASSIFICATION CRITERIA
Mussardo M.	-	PLATELET P-SELECTIN IS ASSOCIATED WITH CIRCULATING NEUTROPHIL ACTIVATION AT THE VERY ONSET OF MYOCARDIAL INFARCTION
Musso R.	-	PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN
Musso M.	-	PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN
Musso A.	-	PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN
Musso R.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
	-	POSTMARKETING SURVEILLANCE STUDY OF SUCROSE-FORMULATED RECOMBINANT FACTOR VIII FOR SEVERE HEMOPHILIA A: FINAL RESULTS
	-	THE HYPERCOAGULABILITY AND VASCULAR ENDOTHELIUM ABNORMAL CYTOKINES' RELEASE MAY INFLUENCE THE PROGRESSION OF THE OSTEOPATHY IN HOMOZYGOUS B-THALASSEMIA PATIENTS
Musso M.	-	THE HYPERCOAGULABILITY AND VASCULAR ENDOTHELIUM ABNORMAL CYTOKINES' RELEASE MAY INFLUENCE THE PROGRESSION OF THE OSTEOPATHY IN HOMOZYGOUS B-THALASSEMIA PATIENTS
Musso A.	-	THE HYPERCOAGULABILITY AND VASCULAR ENDOTHELIUM ABNORMAL CYTOKINES' RELEASE MAY INFLUENCE THE PROGRESSION OF THE OSTEOPATHY IN HOMOZYGOUS B-THALASSEMIA PATIENTS
Musso R.	-	THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS
Musso M.	-	THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS
Musso A.	-	THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS
Mussoni L.	-	ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
	-	PROTEOME OF ENDOTHELIAL CELL-DERIVED PROCOAGULANT MICROPARTICLES
	-	TISSUE FACTOR INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 REQUIRES INTACT CAVEOLIN-ENRICHED MEMBRANE MICRODOMAINS IN HUMAN ENDOTHELIAL CELLS
	-	PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY
Mustard J.F.	-	PLATELET DEPOSITION IN RABBIT COMMON CAROTID ARTERIES PROMOTED BY ARTERIAL STENOSIS AND SPASM
Muszbek L.	-	PRODUCTION AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES AGAINST THE B SUBUNIT OF FACTOR XIII THAT INHIBIT THE FORMATION OF HETEROTETRAMERIC COMPLEX OF A AND B SUBUNITS
	-	MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION
	-	TWO NOVEL MISSENSE MUTATIONS (THR233MET AND TRP308LEU) IN THE FACTOR X GENE AND THEIR FUNCTIONAL CONSEQUENCES IN A PATIENT WITH SEVERE FACTOR X DEFICIENCY
	-	ELEVATED FACTOR XIII LEVEL IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION IN WOMEN
	-	MOLECULAR MECHANISM OF INTERACTION BETWEEN ACTIVATED FACTOR XIII AND ITS ACYL DONOR PEPTIDE SUBSTRATE
	-	TRANSIENT ACTIVATION OF BLOOD COAGULATION FACTOR XIII BY POLYMORPHONUCLEAR GRANULOCYTE ELASTASE
	-	DOWN-REGULATION OF ACTIVATED FACTOR XIII BY POLYMORPHONUCLEAR GRANULOCYTE PROTEASES WITHIN THE FIBRIN CLOT
	-	FACTOR XIII VAL34LEU VARIANT PROTECTS AGAINST CORONARY ARTERY DISEASE: A META-ANALYSIS
	-	POLYCYTHAEMIA VERA, ANTIPHOSPHOLPID ANTIBODIES AND ACQUIRED PLATELET FUNCTION ABNORMALITIES
Mutch N.J.	-	PLATELET POLYPHOSPHATE MODULATES PLATELET COAGULATION PROTEIN RESPONSES
	-	NON-ANTICOAGULANT SULFATED POLYSACCHARIDES ENHANCE THROMBIN GENERATION BY ACCELERATING FACTOR V ACTIVATION
	-	POLYPHOSPHATE ENHANCES FACTOR XII ACTIVATION
	-	POLYPHOSPHATE INTERACTS WITH THROMBIN EXOSITE II WITH HIGH AFFINITY
Muvarak N.E.	-	OVEREXPRESSION OF ADAMTS13 BY LENTIVIRAL VECTOR ENCODING HUMAN ADAMTS13 GENE OFFERS SYSTEMIC PROTECTION AGAINST ARTERIAL THROMBOSIS IN A MOUSE MODEL
Muzard J.	-	GENERATION AND CHARACTERIZATION OF A RECOMBINANT BLOCKING ANTI-GLYCOPROTEIN VI SINGLE CHAIN ANTIBODY FRAGMENT
Muzik J.	-	EFFECT OF THE FIRST DOSE SIZE OF RECOMBINANT FACTOR VIIa ON TREATMENT EFFICACY OF FREQUENT JOINT BLEEDS IN PATIENT WITH HAEMOPHILIA A AND INHIBITOR
Muzykantov V.R.	-	PARTIAL FIBRIN ADHESION AND DIFFUSION SUGGESTED RETEPLASE AS THE THERAPEUTIC CHOICE FOR CATHETER DRIVEN THROMBOLYSIS
Myers B.	-	RAISED LEVELS OF CD39 IN LEUCOCYTOSIS RESULT IN MARKED INHIBITION OF ADP-INDUCED PLATELET AGGREGATION VIA RAPID ADP HYDROLYSIS
Myles T.	-	POLYPHOSPHATE INTERACTS WITH THROMBIN EXOSITE II WITH HIGH AFFINITY
Mysliwiec M.	-	HEPCIDIN IN HEMODIALYZED AND PERITONEALLY DIALYZED PATIENTS: A LINK BETWEEN ANEMIA AND INFLAMMATION?
	-	ADIPOCYTOKINES AND VASCULAR ENDOTHELIUM IN DIABETIC AND NON-DIABETIC PERITONEALLY DIALYZED PATIENTS
	-	ACTIVATION OF INTRAVASCULAR COAGULATION DURING HEMODIALYSIS WITH DIFFERENT HEPARINS: A CROSS-OVER STUDY

| ISTH 2009